Processing 00000000.tx.1: Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* Dick Terwel, Reena Lasrado, Johan Snauwaert, Erno Vandeweert, Chris Van Haesendonck, Peter Borghgraef, and Fred Van Leuven|| From the Experimental Genetics Group, Department of Human Genetics, KU Leuven, B-3000 Leuven, Belgium and the Laboratory of Solid State Physics and Magnetism, KU Leuven, B-3001 Leuven, Belgium Received for publication, August 27, 2004 , and in revised form, October 20, 2004.  

Phrase: "Changed Conformation of Mutant Tau-P301L Underlies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026377:Conformation [Spatial Concept]
   721   C0301641:Conformational change [Molecular Function]

Phrase: "the Moribund Tauopathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0332197:Absent [Quantitative Concept]
   738   C2699517:ABSENT [Finding]

Phrase: "* Dick Terwel,"

Phrase: "Reena Lasrado,"

Phrase: "Johan Snauwaert,"

Phrase: "Erno Vandeweert,"

Phrase: "Chris Van Haesendonck,"

Phrase: "Peter Borghgraef,"

Phrase: "and"

Phrase: "Fred Van Leuven||"

Phrase: "From the Experimental Genetics Group,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C1517005:Experimental Genetics [Biomedical Occupation or Discipline]

Phrase: "Department of Human Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587466:Genetics department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "KU Leuven,"

Phrase: "B-3000 Leuven,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "and"

Phrase: "the Laboratory of Solid State Physics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C3244292:laboratory [Functional Concept]

Phrase: "and"

Phrase: "Magnetism,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0563532:Magnetism [Natural Phenomenon or Process]
   928 E C0024488:Magnetic [Occupation or Discipline]
   900 E C0024483:Magnet [Manufactured Object]
   900 E C0885556:magnets [Pharmacologic Substance]
   900 E C1706318:Magnet [Manufactured Object]

Phrase: "KU Leuven,"

Phrase: "B-3001 Leuven,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "August 27,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "October 20,"

Phrase: "2004."
Processing 00000000.tx.2: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Protein tau-3R/4R isoform ratio and phosphorylation regulates binding to microtubules and, when disturbed by aging or mutations, results in diverse tauopathies and in neurodegeneration. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Protein tau-3R/4R isoform ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0456603:Ratio [Quantitative Concept]
   799   C1547037:Ratio [Intellectual Product]
   709   C0597298:protein isoform [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "regulates"

Phrase: "binding to microtubules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C1149274:microtubule binding [Molecular Function]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: ","

Phrase: "when"

Phrase: "disturbed by aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001811:Ageing [Organism Function]

Phrase: "or"

Phrase: "mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "results in diverse tauopathies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0949664:Tauopathies [Disease or Syndrome]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1880371:Diverse [Qualitative Concept]
   770   C2825142:Result [Finding]

Phrase: "and in neurodegeneration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.3: The underlying mechanisms were studied here in three transgenic mouse strains with identical genetic background, all expressing the tau-4R/2N isoform driven specifically in neurons by the thy1 gene promoter. 

Phrase: "The underlying mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "here in three transgenic mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0025936:Mouse, Transgenic [Mammal]
   760   C0003069:Transgenic [Animal]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0205449:Three [Quantitative Concept]

Phrase: "strains with identical genetic background,"
Meta Candidates (Total=22; Excluded=13; Pruned=0; Remaining=9)
   797   C0596615:genetic strain [Biologic Function]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0080194:Strain [Injury or Poisoning]
   760   C0205280:Identical [Qualitative Concept]
   760   C0314603:Genetic [Functional Concept]
   760   C0456178:strain [Intellectual Product]
   760   C1518614:Strain [Organism]
   760   C1706907:Background [Conceptual Entity]
   760   C2987481:Strain [Mental Process]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0180860:Filter [Manufactured Object]
   704 E C0439659:Origin [Temporal Concept]
   704 E C0581406:Filter [Medical Device]
   704 E C1522664:Filter [Intellectual Product]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C1704449:Filter [Conceptual Entity]
   704 E C1704684:Filter [Medical Device]
   704 E C1875155:FILTER [Medical Device]
   704 E C3245487:birth [Intellectual Product]

Phrase: "all"

Phrase: "expressing"

Phrase: "the tau-4R/2N isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "specifically in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "by the thy1 gene promoter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1420728:THY1 gene [Gene or Genome]
Processing 00000000.tx.4: Two strains, expressing human tau-4R/2N or mutant tau-4R/2N-P301L at similar, moderate levels, developed very different phenotypes. 

Phrase: "Two strains,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "expressing"

Phrase: "human tau-4R/2N"

Phrase: "or"

Phrase: "mutant tau-4R/2N-P301L at similar, moderate levels,"

Phrase: "developed"

Phrase: "very different phenotypes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.5: Tau-4R/2N mice became motor-impaired already around age 68 weeks, accompanied by axonopathy (dilatations, spheroids), but no tau aggregates, and surviving normally. 

Phrase: "Tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "became"

Phrase: "motor-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513492:Motor [Functional Concept]
  1000   C1705994:Motor [Manufactured Object]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "already around age 68 weeks,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0001779:Age [Organism Attribute]
   760   C0439230:weeks [Temporal Concept]
   760   C0450387:68 [Intellectual Product]
   726 E C0332174:/week [Temporal Concept]

Phrase: "accompanied by axonopathy"

Phrase: "(dilatations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012356:Dilatations [Therapeutic or Preventive Procedure]
  1000   C0012359:Dilatations [Pathologic Function]

Phrase: "spheroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1844596:Spheroids [Finding]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "no tau aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "surviving normally."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0310255:SURVIVE [Pharmacologic Substance]
Processing 00000000.tx.6: In contrast, tau-P301L mice developed neurofibrillary tangles from age 6 months, without axonal dilatations and, despite only minor motor problems, all succumbing before the age of 13 months. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "neurofibrillary tangles from age 6 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "without axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "and"

Phrase: ","

Phrase: "despite only minor motor problems,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1546466:Problems [Idea or Concept]
   779 E C0033213:Problem [Finding]

Phrase: "all"

Phrase: "succumbing before the age of 13 months."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C1510828:Age-Months [Organism Attribute]
   748   C0001779:Age [Organism Attribute]
   748   C0439231:months [Temporal Concept]
   714 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.7: The third strain, obtained by tau knock-out/knock-in (tau-KOKI), expressed normal levels of wild-type human tau-4R/2N replacing all mouse tau isoforms. 

Phrase: "The third strain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]

Phrase: "obtained by tau knock-out/knock-in (tau-KOKI),"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0560617:knock out [Injury or Poisoning]
   778   C1522225:Knock-out [Experimental Model of Disease]
   774   C1517676:Knock-in [Research Activity]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1301820:Obtained [Functional Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   714 E C1706701:Obtain [Activity]

Phrase: "expressed"

Phrase: "normal levels of wild-type human tau-4R/2N"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "replacing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299987:replacing [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "all mouse tau isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.8: Tau-KOKI mice survived normally with minor motor problems late in life and without any obvious pathology. 

Phrase: "Tau-KOKI mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "survived"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "normally with minor motor problems"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0026193:Minor [Population Group]
   760   C0205165:Minor [Qualitative Concept]
   760   C1513492:Motor [Functional Concept]
   760   C1546466:Problems [Idea or Concept]
   760   C1705994:Motor [Manufactured Object]
   726 E C0033213:Problem [Finding]

Phrase: "late in life"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205087:Late [Temporal Concept]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "and without any obvious pathology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.9: Biochemically, a fraction of neuronal tau in aging tau-P301L mice was hyperphosphorylated concomitant with conformational changes and aggregation, but overall, tau-4R/2N was actually more phosphorylated than tau-P301L. 

Phrase: "Biochemically,"

Phrase: "a fraction of neuronal tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "in aging tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "hyperphosphorylated"

Phrase: "concomitant with conformational changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0521115:Concomitant [Temporal Concept]

Phrase: "and"

Phrase: "aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "but"

Phrase: "overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "tau-4R/2N"

Phrase: "was"

Phrase: "actually more"

Phrase: "phosphorylated than tau-P301L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.10: Significantly, tau with changed conformation and with hyperphosphorylation colocalized in the same neurons in aging tau-P301L mice. 

Phrase: "Significantly,"

Phrase: "tau with changed conformation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "and with hyperphosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "colocalized in the same neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027882:Neurons [Cell]
   760   C0445247:Same [Qualitative Concept]

Phrase: "in aging tau-P301L mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.11: Taken together, we conclude that excessive binding of tau-4R/2N as opposed to reduced binding of tau-P301L to microtubules is responsible for the development of axonopathy and tauopathy, respectively, in tau-4R/2N and tau-P301L mice and that the conformational change of tau-P301L is a major determinant in triggering the tauopathy.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that excessive binding of tau-4R/2N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "as"

Phrase: "opposed to reduced binding of tau-P301L"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0243122:binding [Functional Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "is"

Phrase: "responsible for the development of axonopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "tauopathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "respectively,"

Phrase: "in tau-4R/2N"

Phrase: "and"

Phrase: "tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "that"

Phrase: "the conformational change of tau-P301L"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0301641:Conformational change [Molecular Function]
   783   C0025320:The change [Physiologic Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "a major determinant in triggering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521761:Determinant [Functional Concept]

Phrase: "the tauopathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathy [Disease or Syndrome]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The transcriptional and post-translational molecular heterogeneity of protein tau is extensive (reviewed in Refs. 13), giving rise to very complex biochemical patterns (35). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcriptional [Genetic Function]

Phrase: "and"

Phrase: "post-translational molecular heterogeneity of protein tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "is"

Phrase: "extensive"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205231:Extensive [Qualitative Concept]
   928 E C0439795:Extensiveness [Qualitative Concept]

Phrase: "("

Phrase: "reviewed in Refs. 13"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise"

Phrase: "to very complex biochemical patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0449774:Patterns [Spatial Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.13: The only known function of tau is binding to microtubules to aid their initiation and stabilization, essential for axonal transport and thereby for synaptic integrity (reviewed in Ref. 6). 

Phrase: "The only known function of tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "binding to microtubules to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1149274:microtubule binding [Molecular Function]
   770   C0026046:Microtubules [Cell Component]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "aid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018896:Aid [Social Behavior]
  1000   C0449435:Aid [Manufactured Object]
  1000   C3540469:AID [Gene or Genome]

Phrase: "their initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "and"

Phrase: "stabilization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "essential for axonal transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "thereby for synaptic integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205266:integrity [Qualitative Concept]
   770   C0872403:integrity [Individual Behavior]
   770   C1947912:Integrity [Qualitative Concept]

Phrase: "("

Phrase: "reviewed in Ref. 6"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.14: Binding of tau to microtubules is dynamically regulated by phosphorylation and varying the isoform ratio tau-3R/4R (i.e. with three or four microtubule binding domains). 

Phrase: "Binding of tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "is"

Phrase: "dynamically"

Phrase: "regulated by phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "varying"

Phrase: "the isoform ratio tau-3R/4R"

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "with three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "or"

Phrase: "four microtubule binding domains"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1149274:microtubule binding [Molecular Function]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.15: Binding is affected by mutations associated with fronto-temporal dementia with parkinsonism linked to chromosome 17 (FTDP-17)1. 

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "affected by mutations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with fronto-temporal dementia"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0442043:Temporal [Spatial Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C2362314:Temporal [Temporal Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: ")"

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.16: These comprise both amino acid substitutions, many located in exon 10 coding for the second microtubule binding domain, as well as intronic mutations that increase splicing-in of exon 10, to produce more tau-4R (3, 79). 

Phrase: "These"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "both amino acid substitutions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   793   C1555721:Substitution [Idea or Concept]
   793   C1706204:Substitution [Activity]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "many"

Phrase: "located in exon 10 coding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0009219:Coding [Occupational Activity]
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for the second microtubule binding domain,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1149274:microtubule binding [Molecular Function]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "as well as"

Phrase: "intronic mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1881250:Intronic Mutation [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "splicing-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "in"

Phrase: "of exon 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "more tau-4R"

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "79"

Phrase: ")."
Processing 00000000.tx.17: Tauopathies are characterized by intracellular aggregates of tau that are invariably hyperphosphorylated, supporting the longstanding hypothesis that phosphorylation drives the process of self-aggregation. 

Phrase: "Tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "are"

Phrase: "characterized by intracellular aggregates of tau"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0205418:aggregates [Qualitative Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1880022:Characterized [Activity]
   753   C1947974:Tau [Research Activity]

Phrase: "that"

Phrase: "are"

Phrase: "invariably"

Phrase: "hyperphosphorylated"

Phrase: ","

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the longstanding hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "that phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "drives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the process of self-aggregation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.18: Remarkably, protein tau is a naturally unfolded protein that is very soluble and heat-stable but readily forms filaments in vitro and in vivo (1014), whereas it is amazingly resistant to aggregation in transfected cells. 

Phrase: "Remarkably,"

Phrase: "protein tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1421563:protein tau [Gene or Genome]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a naturally unfolded protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "very soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "heat-stable"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018837:Heat [Natural Phenomenon or Process]
   861   C0205360:Stable [Qualitative Concept]
   861   C1547311:Stable [Intellectual Product]

Phrase: "but"

Phrase: "readily"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(1014"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "it"

Phrase: "is"

Phrase: "amazingly resistant to aggregation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "in transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.19: In vivo models are needed to define the patho-physiological repercussions of tau isoforms and mutants. 

Phrase: "In vivo models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1515657:In Vivo Model [Research Activity]
   827   C3161035:Models [Intellectual Product]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the patho-physiological repercussions of tau isoforms"

Phrase: "and"

Phrase: "mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.20: Modeling tauopathy in terms of tau aggregation failed in transgenic mice expressing wild-type human tau (reviewed in Ref. 15). 

Phrase: "Modeling tauopathy in terms of tau aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "failed in transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0231175:Failed [Functional Concept]

Phrase: "expressing"

Phrase: "wild-type human tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "reviewed in Ref. 15"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.21: Our tau-4R/2N transgenic mice developed severe axonopathy due to axonal dilatations (spheroids) with Wallerian degeneration and severe motor problems but no tau aggregates (16). 

Phrase: "Our tau-4R/2N transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "severe axonopathy due to axonal dilatations"

Phrase: "(spheroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1844596:Spheroids [Finding]

Phrase: ")"

Phrase: "with Wallerian degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043020:Wallerian Degeneration [Cell or Molecular Dysfunction]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "severe motor problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1546466:Problems [Idea or Concept]
   793 E C0033213:Problem [Finding]

Phrase: "but"

Phrase: "no tau aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.22: The axonopathy was fully corrected by co-expression of GSK-3, demonstrating for the first time in vivo that phosphorylation of tau is essential to prevent "clogging" of the axons (17), as in cells (18) by reducing binding of tau to microtubules. 

Phrase: "The axonopathy"

Phrase: "was"

Phrase: "fully"

Phrase: "corrected by co-expression of GSK-3,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205202:Corrected [Qualitative Concept]
   748   C1325174:GSK [Molecular Function]
   714 E C2349182:Correct [Qualitative Concept]

Phrase: "demonstrating for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "that phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "essential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205224:Essential [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: """clogging"""

Phrase: "of the axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axons [Cell Component]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "as in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "(18"

Phrase: ")"

Phrase: "by reducing binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "to microtubules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]
Processing 00000000.tx.23: Expression of mutant tau in transgenic mice produced tau aggregates (1922; reviewed in Ref. 15), demonstrating that tauopathy can be modeled in the short life span of mice. 

Phrase: "Expression of mutant tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "produced"

Phrase: "tau aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "(1922"

Phrase: ";"

Phrase: "reviewed in Ref. 15"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "demonstrating"

Phrase: "that tauopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "can"

Phrase: "be"

Phrase: "modeled in the short life span of mice."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0870809:life span [Group Attribute]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0376558:Life [Idea or Concept]
   744   C1282927:short [Qualitative Concept]
   744   C1711300:Span [Conceptual Entity]
   744   C1806781:Short [Quantitative Concept]
   744   C2350002:Short [Quantitative Concept]
   744   C2700613:Span [Quantitative Concept]
   734   C2986594:Mouse Model [Experimental Model of Disease]
   711   C3161035:Model [Intellectual Product]
Processing 00000000.tx.24: Alzheimer's disease (AD) is the most common tauopathy and pathologically defined by extracelullar amyloid plaques and neurofibrillary tangles (23). 

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "the most common tauopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "and"

Phrase: "pathologically"

Phrase: "defined by extracelullar amyloid plaques"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   806   C2936349:Plaques, Amyloid [Acquired Abnormality]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.25: Mutant APP transgenic mice do not, however, develop tauopathy despite robust recapitulation of parenchymal and vascular amyloid pathology (reviewed in Refs. 19 and 24). 

Phrase: "Mutant APP transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "do"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "however,"

Phrase: "develop"

Phrase: "tauopathy despite robust recapitulation of parenchymal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "and"

Phrase: "vascular amyloid pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "("

Phrase: "reviewed in Refs. 19"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.26: Double transgenic mice, expressing mutant APP and mutant tau, combine amyloid and tau pathology but also amyotrophy and severe motor problems, atypical for AD (20, 25). 

Phrase: "Double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "mutant APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "mutant tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "combine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336789:Combine [Manufactured Object]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tau pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "but"

Phrase: "also amyotrophy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026846:Amyotrophy [Disease or Syndrome]

Phrase: "and"

Phrase: "severe motor problems,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1546466:Problems [Idea or Concept]
   793 E C0033213:Problem [Finding]

Phrase: "atypical for AD (20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205182:Atypical [Qualitative Concept]
   770   C0741302:Atypical [Finding]

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.27: Most recently, transgenic mice expressing three mutant human proteins (i.e. APP, PS1, and tau) displayed a combined amyloid and tau pathology (26). 

Phrase: "Most recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "three mutant human proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   861   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(i.e. APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3538722:APP [Laboratory Procedure]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: ")"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a combined amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tau pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.28: Their behavioral and synaptic deficits appeared similar to those in APP and APPxPS1 transgenic mice (2731), obscuring the exact contribution of the tau pathology. 

Phrase: "Their behavioral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004927:Behavioral [Individual Behavior]
  1000   C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "synaptic deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "similar to those in APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "APPxPS1 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(2731"

Phrase: ")"

Phrase: ","

Phrase: "obscuring"

Phrase: "the exact contribution of the tau pathology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]
Processing 00000000.tx.29: The vast clinical heterogeneity of human tauopathies, even in the inherited cases, is due to different types of mutations as well as to genetic and epigenetic factors, since differences are even observed between patients with the same mutation in the same family (9). 

Phrase: "The vast clinical heterogeneity of human tauopathies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1850620:Clinical heterogeneity [Finding]
   748   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "even in the inherited cases,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0439660:Inherited [Functional Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "is due to different types of mutations"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0026882:Mutations [Genetic Function]
   748   C0332307:Types [Qualitative Concept]
   748   C1705242:Different [Qualitative Concept]
   748   C3146286:Due [Idea or Concept]
   714 E C1547052:*Type [Quantitative Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "as well as to genetic"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0205170:Well [Qualitative Concept]
   760   C0314603:Genetic [Functional Concept]
   760   C3146287:Well [Manufactured Object]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "and"

Phrase: "epigenetic factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "since"

Phrase: "differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "even"

Phrase: "observed between patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "with the same mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the same family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.30: In sporadic tauopathies, more confounding factors must act (i.e. tau at different concentrations in different cell types; immunological, hormonal, and nutritional status; cholesterol and lipids; ApoE genotype; and more). 

Phrase: "In sporadic tauopathies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "more confounding factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "must"

Phrase: "act (i.e. tau at different concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "in different cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "; immunological, hormonal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "nutritional status"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0392209:Nutritional status [Organism Attribute]
   861   C0449438:Status [Qualitative Concept]
   861   C1521739:Nutritional [Qualitative Concept]
   861   C2707262:Nutritional [Clinical Attribute]

Phrase: "; cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "; ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: ";"

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: ")."
Processing 00000000.tx.31: This results in different clinical phenotypes, including or not including parkinsonism and motor and behavioral problems, and is reflected at the molecular level in different phosphorylation patterns of tau and in different morphology of tau filaments (paired helical, twisted, straight...). 

Phrase: "This results in different clinical phenotypes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and"

Phrase: "motor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513492:Motor [Functional Concept]
  1000   C1705994:Motor [Manufactured Object]

Phrase: "and"

Phrase: "behavioral problems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0233514:Behavioral problems [Mental or Behavioral Dysfunction]
  1000   C0260657:behavioral problems [Finding]
   861   C1546466:Problems [Idea or Concept]
   827 E C0033213:Problem [Finding]

Phrase: "and"

Phrase: "is"

Phrase: "reflected at the molecular level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C0558058:reflected [Mental Process]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in different phosphorylation patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "and in different morphology of tau filaments"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0332437:Morphology [Qualitative Concept]
   748   C0543482:morphology [Spatial Concept]
   748   C0700329:Morphology, NOS [Finding]
   748   C0700619:Morphology [Biomedical Occupation or Discipline]
   748   C1515981:And [Idea or Concept]
   748   C1705242:Different [Qualitative Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   714   C0010851:Filament [Cell Component]

Phrase: "(paired helical,"

Phrase: "twisted"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0231467:Twisted [Spatial Concept]
   966 E C0040480:twist [Physiologic Function]
   928 E C0231458:Rotated [Spatial Concept]
   907 E C1265748:Twisting [Pathologic Function]
   907 E C1881716:TWISTING [Phenomenon or Process]

Phrase: ","

Phrase: "straight..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445291:Straight [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.32: This baffling variability must and can be reduced in model systems to understand the basic molecular control mechanisms that underlie the physiological role of tau and the exact etiology in tauopathies. 

Phrase: "This baffling variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2827666:Variability [Conceptual Entity]
   789 E C0439828:Variable [Qualitative Concept]

Phrase: "must"

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "reduced in model systems to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0026339:Model System [Intellectual Product,Research Device]
   790   C3161035:Model System [Intellectual Product]
           Model
   760   C0392756:Reduced [Qualitative Concept]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the basic molecular control mechanisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0243148:control [Qualitative Concept]
   812   C0441712:Mechanisms [Functional Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "underlie"

Phrase: "the physiological role of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "the exact etiology in tauopathies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015127:aetiology [Functional Concept]
   760   C1314792:Aetiology [Functional Concept]
   760   C1524003:Etiology [Conceptual Entity]
Processing 00000000.tx.33: To this end, we have generated and comprehensively phenotyped tau knock-out/wild-type tau-4R/2N knock-in mice (tau-KOKI) and tau-P301L transgenic mice and compared them to tau-4R/2N mice (16). 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "comprehensively"

Phrase: "phenotyped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0031437:Phenotype [Organism Attribute]
   966   C1285572:Phenotype [Laboratory Procedure]

Phrase: "tau knock-out/wild-type tau-4R/2N knock-in mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   883   C0206745:Knock-out Mice [Mammal]
   870   C1517676:Knock-in [Research Activity]
   846   C1520150:Wild Type Mouse [Mammal]
   788   C0025914:Mice [Mammal]
   788   C0025929:mice [Mammal]
   788   C0026809:Mice [Mammal]

Phrase: "(tau-KOKI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "tau-P301L transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "them to tau-4R/2N mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.34: Significantly, all three strains express the same tau-4R/2N isoform, with the P301L mutation in the tau-P301L mice at moderate levels from the same thy1 gene promoter and all in the same genetic background. 

Phrase: "Significantly,"

Phrase: "all three strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "express"

Phrase: "the same tau-4R/2N isoform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "with the P301L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "at moderate levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "from the same thy1 gene promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "all in the same genetic background."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]
   753   C0444868:All [Quantitative Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1706907:Background [Conceptual Entity]
   753   C3539085:All [Idea or Concept]
Processing 00000000.tx.35: This strategy allowed us to separate the early, severe motor deficit in tau-4R/2N mice due to axonal dilatations, but not tau aggregates, from the late minor motor impairment in tau-P301L mice, showing widespread intraneuronal tau aggregates and moribund neurodegeneration. 

Phrase: "This strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "the early,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "severe motor deficit in tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0746626:motor deficit [Pathologic Function]
   744   C0162429:Deficit, NOS [Disease or Syndrome]
   744   C2987487:Deficit [Qualitative Concept]

Phrase: "due to axonal dilatations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "but"

Phrase: "not tau aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "from the late minor motor impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0684336:Impairment [Pathologic Function]

Phrase: "in tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "widespread intraneuronal tau aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "moribund neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.36: This profound distinction is reflected at the molecular level by conformational changes of tau-P301L, not seen in wild-type tau-4R/2N.  

Phrase: "This profound distinction"

Phrase: "is"

Phrase: "reflected at the molecular level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C0558058:reflected [Mental Process]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "by conformational changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0301641:Conformational change [Molecular Function]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "of tau-P301L,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in wild-type tau-4R/2N."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0205397:Seen [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]
Processing 00000000.tx.37: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Generation of Tau-P301L Transgenic MiceThe tau-4R/2N mice were generated and characterized previously (16, 17, 32). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of Tau-P301L Transgenic MiceThe tau-4R/2N mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0079411:Generation [Temporal Concept]
   739   C3146294:Generation [Activity]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "previously"

Phrase: "(16,"

Phrase: "17,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.38: The same methods were used to generate transgenic mice expressing the longest human tau isoform with the P301L mutation (tau-4R/2N-P301L) under control of the same mouse thy1 gene promoter (16, 27). 

Phrase: "The same methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "the longest human tau isoform with the P301L mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(tau-4R/2N-P301L"

Phrase: ")"

Phrase: "under control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the same mouse thy1 gene promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(16,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.39: Mutant tau-P301L was obtained by site-directed mutagenesis of tau-4R/2N and cloned into the blunted XhoI site of the thy1 gene expression cassette. 

Phrase: "Mutant tau-P301L"

Phrase: "was"

Phrase: "obtained by site-directed mutagenesis of tau-4R/2N"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   762   C2945843:Site of [Qualitative Concept]
   742   C0079866:Mutagenesis [Molecular Function]
   742   C0205145:Site [Spatial Concept]
   742   C1301820:Obtained [Functional Concept]
   742   C1515974:Site [Body Location or Region]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   742   C2825164:Site [Spatial Concept]
   742   C3146302:Mutagenesis [Laboratory Procedure]
   708   C0439851:Direct [Qualitative Concept]
   708 E C1706701:Obtain [Activity]
   708   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "cloned into the blunted XhoI site of the thy1 gene expression cassette."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   753   C0017262:Gene Expression [Genetic Function]
   753   C1420728:THY1 gene [Gene or Genome]
           THY1
   753   C2945843:Site of [Qualitative Concept]
   751   C0598888:cloned gene [Laboratory Procedure,Molecular Biology Research Technique]
   736   C0009013:cloned [Cell]
   736   C0017337:Gene [Gene or Genome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205145:Site [Spatial Concept]
   736   C0450240:Cassette [Medical Device]
   736   C1515974:Site [Body Location or Region]
   736   C1706210:Cassette [Manufactured Object]
   736   C1997138:Blunted [Qualitative Concept]
   736   C2825164:Site [Spatial Concept]
   703 E C1522642:Clone [Tissue]
Processing 00000000.tx.40: The construct was linearized with NotI and PvuI and injected into prenuclear mouse embryos (0.5-day) of the FVB/N strain. 

Phrase: "The construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "linearized with NotI"

Phrase: "and"

Phrase: "PvuI"

Phrase: "and"

Phrase: "injected into prenuclear mouse embryos"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0013935:Embryos [Embryonic Structure]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   726 E C1305370:Embryo [Embryonic Structure]
   726   C1720154:Inject [Functional Concept]

Phrase: "(0.5-day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "of the FVB/N strain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0080194:Strain [Injury or Poisoning]
   827   C0456178:strain [Intellectual Product]
   827   C1518614:Strain [Organism]
   827   C2987481:Strain [Mental Process]
   734   C1517102:FVB/N [Mammal]
Processing 00000000.tx.41: Embryos in the two-cell stage were transferred into the ampulla of synchronized foster CD1 or FVB/N female mice, and offspring were screened by PCR and Southern blotting of tail biopsy DNA according to standard procedures. 

Phrase: "Embryos in the two-cell stage"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   783   C0231008:embryos stage [Embryonic Structure]
   783   C0920487:cell embryos [Embryonic Structure]
   767 E C1281484:Embryo stage [Embryonic Structure]
   753   C0013935:Embryos [Embryonic Structure]
   719 E C1305370:Embryo [Embryonic Structure]

Phrase: "were"

Phrase: "transferred into the ampulla of synchronized foster CD1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   744   C0242298:foster [Daily or Recreational Activity]
   744   C0344349:foster [Family Group]
   744   C0348011:transferred [Functional Concept]
   744   C0439580:Synchronized [Temporal Concept]
   744   C1413207:CD1 [Gene or Genome]
   744   C2985507:Ampulla [Conceptual Entity]
   744   C3273701:CD1 [Gene or Genome]
   744   C3541222:CD1 [Laboratory Procedure]
   711 E C0040671:Transfer [Mental Process]
   711 E C1705822:Transfer [Activity]

Phrase: "or"

Phrase: "FVB/N female mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   912   C1517102:FVB/N Mouse [Mammal]
   886   C1517101:FVB Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "screened by PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]

Phrase: "and"

Phrase: "Southern blotting of tail biopsy DNA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0005862:Blotting, Southern [Molecular Biology Research Technique]
           DNA blotting
   773 E C1148472:Blot, Southern [Laboratory or Test Result]
   753   C1710133:Southern [Spatial Concept]

Phrase: "according to standard procedures."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.42: The PCR primers for thy1-tau-P301L were 5'-CTGGGGCGGTCAATAAT-3' and 5'-CAAGGTCCCCGTTTCTCC-3'. 

Phrase: "The PCR primers for thy1-tau-P301L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "5'-CTGGGGCGGTCAATAAT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CAAGGTCCCCGTTTCTCC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.43: The amplicon was used as probe in Southern blotting of genomic DNA, digested with StuI. 

Phrase: "The amplicon"

Phrase: "was"

Phrase: "used as probe"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0182400:Probe [Medical Device]
   790   C1273517:used [Finding]
   790   C1704681:Probe [Gene or Genome]
   790   C2347609:Probe [Chemical Viewed Functionally]
   790   C3536729:Probe [Manufactured Object]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "in Southern blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005862:Blotting, Southern [Molecular Biology Research Technique]
   983 E C1148472:Blot, Southern [Laboratory or Test Result]
   861   C1710133:Southern [Spatial Concept]

Phrase: "of genomic DNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "digested with StuI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]
Processing 00000000.tx.44: The resulting four founders were mated, and offspring were genotyped and analyzed by Western blotting and by immunohistochemistry. 

Phrase: "The resulting four founders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0263541:founders [Disease or Syndrome]

Phrase: "were"

Phrase: "mated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1254211:mated [Pharmacologic Substance]
  1000   C1260875:Mated [Organism Function]
   966 E C0682323:mate [Family Group]

Phrase: ","

Phrase: "and"

Phrase: "offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "and by immunohistochemistry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.45: Founder 2 with about 2-fold overexpression of tau-P301L transgene relative to endogenous tau was used for establishing a colony for further studies. 

Phrase: "Founder 2 with about 2-fold overexpression of tau-P301L transgene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0263541:Founder [Disease or Syndrome]
   738   C0282641:Transgene [Gene or Genome]
   738   C0332462:Fold [Spatial Concept]
   738   C1514559:Overexpression [Genetic Function]
   738   C1720655:Tau [Intellectual Product]
   738   C1880834:FOLD [Phenomenon or Process]
   738   C1947974:Tau [Research Activity]

Phrase: "relative to endogenous tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "used for establishing"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0443211:establishing [Qualitative Concept]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "a colony for further studies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439158:colony [Quantitative Concept]
   760   C1947989:Colony [Cell]
Processing 00000000.tx.46: Homozygous tau-P301L mice, obtained by inbreeding, were normally fertile and transmitted the transgene stably to their offspring. 

Phrase: "Homozygous tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "obtained by inbreeding,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0021144:Inbreeding [Organism Function]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "were"

Phrase: "normally fertile"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0015895:Fertile [Organism Function]
   789 E C0200069:Fertility [Diagnostic Procedure]
   789 E C2986895:Fertility [Idea or Concept]

Phrase: "and"

Phrase: "transmitted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242781:Transmitted [Pathologic Function]
  1000   C0332289:transmitted [Functional Concept]
  1000   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "the transgene stably to their offspring."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.47: In this study, only homozygous tau-P301L mice were used in comparison with heterozygous tau-4R/2N mice (16), so as to have very comparable overall expression levels of respectively mutant and wildtype human tau-4R/2N in their brains. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "only homozygous tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used in comparison"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C1707455:Comparison [Activity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "with heterozygous tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "so as to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037640:SO [Geographic Area]

Phrase: "have"

Phrase: "very comparable overall expression levels of respectively mutant"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "wildtype human tau-4R/2N in their brains."
Processing 00000000.tx.48: Generation of Tau-KOKI MiceThe tau knock-out/knock-in strain of human wild-type tau-4R/2N (tau-KOKI) aimed to inactivate the endogenous murine tau gene and to replace it with a single copy of the thy1-tau-4R/2N recombinant DNA construct. 

Phrase: "Generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of Tau-KOKI MiceThe tau knock-out/knock-in strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0080194:Strain [Injury or Poisoning]
   791   C0456178:strain [Intellectual Product]
   791   C1518614:Strain [Organism]
   791   C2987481:Strain [Mental Process]

Phrase: "of human wild-type tau-4R/2N"

Phrase: "(tau-KOKI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: ")"

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inactivate"

Phrase: "the endogenous murine tau gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "it with a single copy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1948062:Copy [Manufactured Object]

Phrase: "of the thy1-tau-4R/2N recombinant DNA construct."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0012931:DNA Construct [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C2827421:Construct [Classification]
Processing 00000000.tx.49: This construct, previously used to generate tau-4R/2N mice (16), was linearized and ligated in a unique NcoI site in exon 1 of the mouse tau gene, partially subcloned from the 129 mouse strain (33). 

Phrase: "This construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "previously"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "linearized"

Phrase: "and"

Phrase: "ligated in a unique NcoI site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1710548:Unique [Qualitative Concept]
   753   C2825164:Site [Spatial Concept]

Phrase: "in exon 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the mouse tau gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "partially subcloned from the 129 mouse strain"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.50: A 1.9-kb NotI fragment encoding the marker gene hygromycin B phosphotransferase driven by the phosphoglycerate kinase gene promoter was further ligated into a unique SmaI site. 

Phrase: "A 1.9-kb NotI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the marker gene hygromycin B phosphotransferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0082958:Hygromycin B phosphotransferase [Amino Acid, Peptide, or Protein,Enzyme]
           hygromycin phosphotransferase
   804   C0031727:Phosphotransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "driven by the phosphoglycerate kinase gene promoter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0031656:PHOSPHOGLYCERATE KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0314621:Promoter gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0597219:phosphoglycerate [Carbohydrate]
   714   C0013126:Drive [Mental Process]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "ligated into a unique SmaI site."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1710548:Unique [Qualitative Concept]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.51: The targeting vector was linearized by NotI restriction and purified before electroporation into ES cells that were cultured in selective medium (hygromycin) and selected by standard procedures as described (34). 

Phrase: "The targeting vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "linearized by NotI restriction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443288:Restriction [Functional Concept]

Phrase: "and"

Phrase: "purified before electroporation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206691:Electroporation [Laboratory Procedure,Research Activity]
   790   C1998793:Purified [Functional Concept]

Phrase: "into ES cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0596508:ES cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "cultured in selective medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   802   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(hygromycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063201:hygromycin [Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "selected by standard procedures"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1442989:Standard [Qualitative Concept]
   770   C2700391:procedures [Activity]
   770   C2828392:Standard [Intellectual Product]
   737   C1707391:Select [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.52: Single colonies were expanded for genotyping using different probes including external and internal fragments of the murine and human tau gene and of the marker gene. 

Phrase: "Single colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "expanded for genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205229:expanded [Spatial Concept]
   790   C1285573:Genotyping [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "external"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:External [Spatial Concept]

Phrase: "and"

Phrase: "internal fragments of the murine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "human tau gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0314604:Human gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "and of the marker gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005516:Marker [Clinical Attribute]
   760   C0017337:Gene [Gene or Genome]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.53: ES cell colonies with the wanted homologous recombination were subcultured and genotyped before microinjection into 4-day-old blastocysts isolated from pregnant C57Bl/6 female mice. 

Phrase: "ES cell colonies with the wanted homologous recombination"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439158:colonies [Quantitative Concept]
   711 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "subcultured"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0200940:Subculture [Laboratory Procedure]
   966   C0699799:subculture [Population Group]

Phrase: "and"

Phrase: "genotyped before microinjection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0025991:Microinjection [Therapeutic or Preventive Procedure]
   756   C0017431:Genotype [Organism Attribute]

Phrase: "into 4-day-old blastocysts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1281743:Blastocysts [Embryonic Structure]
   779 E C0005705:Blastocyst [Embryonic Structure]
   779 E C1281786:Blastocyst [Embryonic Structure]

Phrase: "isolated from pregnant C57Bl/6 female mice."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   793   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   774   C0025921:Mice, C57BL [Mammal]
           C57BL
   774   C0033011:pregnant female [Population Group]
   748   C0015780:Female [Finding]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0043210:female [Population Group]
   748   C0086287:female [Population Group]
   748   C0205409:Isolated [Functional Concept]
   748   C0549206:Pregnant [Finding]
   748   C0553641:Pregnant [Functional Concept]
   748   C0600457:PREGNANT [Finding]
   748   C1548221:Isolated [Idea or Concept]
   748   C1705497:Female [Qualitative Concept]
   748   C1705498:Female [Qualitative Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.54: Reimplantation into pseudopregnant CD1 females by uterine transfer resulted in brown coat color chimeric mice proving germ line transmission of the ES cells. 

Phrase: "Reimplantation into pseudopregnant CD1 females"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035139:Re-implantation [Therapeutic or Preventive Procedure]

Phrase: "by uterine transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]

Phrase: "resulted in brown coat"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0453946:Coat [Manufactured Object]
   770   C0678579:Brown [Natural Phenomenon or Process]
   770   C1522408:Coat [Qualitative Concept]
   770   C2987482:Coat [Body Part, Organ, or Organ Component]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "color"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009393:Color [Natural Phenomenon or Process]
  1000   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
  1000   C1705245:Color [Pharmacologic Substance]

Phrase: "chimeric mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "proving"

Phrase: "germ line transmission of the ES cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1707722:Transmission Line [Manufactured Object]
   748   C0040722:transmission [Idea or Concept]
   748   C0242781:Transmission [Pathologic Function]
   748   C1521797:Transmission [Natural Phenomenon or Process]
Processing 00000000.tx.55: Offspring from the chimeras were crossed with FVB/N mice, and their offspring was analyzed by Southern blotting of tail DNA with the same probes described above. 

Phrase: "Offspring from the chimeras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "crossed with FVB/N mice,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   851   C1517102:FVB/N Mouse [Mammal]
           FVB/N
   781   C1517101:FVB Mouse [Mammal]
           FVB
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205203:Crossed [Spatial Concept]
   726 E C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "their offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "was"

Phrase: "analyzed by Southern blotting of tail DNA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0005862:Blotting, Southern [Molecular Biology Research Technique]
           DNA blotting
   762 E C1148472:Blot, Southern [Laboratory or Test Result]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0039259:Tail [Body Part, Organ, or Organ Component]
   748   C0936012:Analyzed [Research Activity]
   748   C1710133:Southern [Spatial Concept]

Phrase: "with the same probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.56: Heterozygous transgenic mice were mated to establish the tau-KOKI strain. 

Phrase: "Heterozygous transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "mated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1254211:mated [Pharmacologic Substance]
  1000   C1260875:Mated [Organism Function]
   966 E C0682323:mate [Family Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the tau-KOKI strain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0080194:Strain [Injury or Poisoning]
   799   C0456178:strain [Intellectual Product]
   799   C1518614:Strain [Organism]
   799   C2987481:Strain [Mental Process]
Processing 00000000.tx.57: The offspring was genotyped routinely at weaning by PCR on tail biopt DNA. 

Phrase: "The offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "was"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "routinely at weaning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0043084:Weaning [Organism Function]

Phrase: "by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "on tail biopt DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.58: Breeding was continued by backcrossing into FVB/N for eight generations to obtain homozygous humanized tau-KOKI mice in the FVB/N background (i.e. the same background as that of the tau-4R/2N and tau-P301L mice). 

Phrase: "Breeding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006159:Breeding [Organism Function]

Phrase: "was"

Phrase: "continued by backcrossing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0524616:Backcrossing [Organism Function]
   790   C0549178:Continued [Idea or Concept]

Phrase: "into FVB/N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517102:FVB/N [Mammal]

Phrase: "for eight generations to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0079411:Generations [Temporal Concept]
   793 E C3146294:Generation [Activity]
   727 E C1414672:Genesis [Gene or Genome]
   727 E C2984892:Genesis [Gene or Genome]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "homozygous humanized tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   855   C0206745:Knock-out Mice [Mammal]
   836   C1517676:Knock-in [Research Activity]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: "in the FVB/N background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706907:Background [Conceptual Entity]
   734   C1517102:FVB/N [Mammal]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the same background as that of the tau-4R/2N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1706907:Background [Conceptual Entity]

Phrase: "and"

Phrase: "tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.59: Homozygous and heterozygous tau-KOKI mice were differentiated by PCR with two sets of primers, one specific for the human tau-4R/2N cDNA and the other for exon 1 of the wild-type mouse tau gene. 

Phrase: "Homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygous [Organism Attribute]

Phrase: "and"

Phrase: "heterozygous tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   868   C0206745:Knock-out Mice [Mammal]
   845   C1517676:Knock-in [Research Activity]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "differentiated by PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007589:Differentiated [Cell Function]
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0205615:Differentiated [Qualitative Concept]
   790   C0677874:pCR [Finding]

Phrase: "with two sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "of primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "specific for the human tau-4R/2N cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "the other for exon 1 of the wild-type mouse tau gene."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C1520150:Wild Type Mouse [Mammal]
   753   C1883559:Wild Type [Organism Attribute]
   751   C0250875:tau-1 [Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   751   C0314611:Gene type [Genetic Function]
   751   C0441729:Type 1 [Classification]
   736   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0017337:Gene [Gene or Genome]
   736   C0025914:Mouse [Mammal]
   736   C0025929:mouse [Mammal]
   736   C0026809:Mouse [Mammal]
   736   C0332307:Type [Qualitative Concept]
   736   C0445392:Wild [Intellectual Product]
   736   C1547052:*Type [Quantitative Concept]
   736   C1720655:Tau [Intellectual Product]
   736   C1947974:Tau [Research Activity]
Processing 00000000.tx.60: Sensorimotor TestsFor the rod walking test, mice were placed in the middle of a 1.5-m-long horizontal rod (diameter 1.5 cm) and allowed a period of 3 min to remain and walk (score 1) or fall off (score 0) on a soft foam substrate. 

Phrase: "Sensorimotor TestsFor"

Phrase: "the rod walking test,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0080331:Walking [Daily or Recreational Activity]
   827   C0392366:test [Intellectual Product]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "placed in the middle of a 1.5-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0444598:Middle [Spatial Concept]
   744   C0549183:middle [Spatial Concept]
   744   C1552826:middle [Idea or Concept]
   711   C0442504:Place [Spatial Concept]
   711   C1704765:Place [Functional Concept]
   711   C1882509:Place [Activity]
   711   C3496241:place [Disease or Syndrome]

Phrase: "m-"

Phrase: "long horizontal rod"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0206427:Rod [Cell]
   827   C1552915:rod [Quantitative Concept]
   827   C1705186:Rod [Medical Device]
   827   C1947942:Rod [Spatial Concept]
   827   C2347970:rod [Quantitative Concept]
   827   C2347971:rod [Quantitative Concept]

Phrase: "(diameter 1.5 cm)"

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "a period of 3 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439531:/period [Temporal Concept]
   753   C1948053:Period [Temporal Concept]

Phrase: "remain"

Phrase: "and"

Phrase: "walk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080331:Walk [Daily or Recreational Activity]

Phrase: "(score 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Score [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "fall off"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085639:Fall [Finding]
   861   C0238715:Fall [Temporal Concept]

Phrase: "(score 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Score [Quantitative Concept]

Phrase: ")"

Phrase: "on a soft foam substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.61: The automated rotarod test compared five mice at a time, placed on a revolving rod (diameter 3.2 cm between opaque side walls) (Med Associates, Georgia, VT). 

Phrase: "The automated rotarod test compared five mice at a time,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "placed on a revolving rod"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0206427:Rod [Cell]
   760   C1552915:rod [Quantitative Concept]
   760   C1705186:Rod [Medical Device]
   760   C1947942:Rod [Spatial Concept]
   760   C2347970:rod [Quantitative Concept]
   760   C2347971:rod [Quantitative Concept]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "(diameter 3.2 cm between opaque side walls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0649800:CM 2-3 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "(Med"

Phrase: "Associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: ","

Phrase: "Georgia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0017452:Georgia [Geographic Area]
  1000   C0017454:Georgia [Geographic Area]
   928 E C0337804:georgian [Population Group]

Phrase: "VT"

Phrase: ")."
Processing 00000000.tx.62: Subsequent to three learning trials on consecutive days (each 3 min at 20 rpm), mice were tested with the rod accelerating from 4 to 40 rpm in a 3-min time span. 

Phrase: "Subsequent to three learning trials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0008976:Trial [Research Activity]

Phrase: "on consecutive days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "("

Phrase: "each 3 min at 20 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "tested with the rod accelerating"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0206427:Rod [Cell]
   760   C0392366:tested [Intellectual Product]
   760   C1552915:rod [Quantitative Concept]
   760   C1705186:Rod [Medical Device]
   760   C1947942:Rod [Spatial Concept]
   760   C2347970:rod [Quantitative Concept]
   760   C2347971:rod [Quantitative Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726   C0521110:accelerate [Functional Concept]

Phrase: "from 4"

Phrase: "to 40 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]

Phrase: "in a 3-min time span."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0040223:Time [Temporal Concept]
   812   C1711300:Span [Conceptual Entity]
   812   C2700613:Span [Quantitative Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.63: The time that the mice remained on the revolving rod was logged automatically. 

Phrase: "The time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "that"

Phrase: "the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "remained on the revolving rod"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0206427:Rod [Cell]
   760   C1552915:rod [Quantitative Concept]
   760   C1705186:Rod [Medical Device]
   760   C1947942:Rod [Spatial Concept]
   760   C2347970:rod [Quantitative Concept]
   760   C2347971:rod [Quantitative Concept]

Phrase: "was"

Phrase: "logged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1708728:Log [Intellectual Product]
   966   C2986775:log [Occupational Activity]

Phrase: "automatically."
Processing 00000000.tx.64: Data on rotarod performance were analyzed by two-way analysis of variance with genotype and age as independent variables and time on the rod as dependent variable. 

Phrase: "Data on rotarod performance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by two-way analysis of variance"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C1710497:Two-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205448:Two [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
           Analyzed
   748   C1524024:analysis [Functional Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]

Phrase: "with genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "age as independent variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "time on the rod"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "as dependent variable."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439828:Variable [Qualitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
Processing 00000000.tx.65: Data were further analyzed by one-way analysis of variance with age or strain as the independent variable and time on the rod as the dependent variable, followed by Student-Newman-Keuls post hoc multiple comparison (set at p < 0.05). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed by one-way analysis of variance"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C1709320:One-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205447:One [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
           Analyzed
   748   C1524024:analysis [Functional Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]

Phrase: "with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "or"

Phrase: "strain as the independent variable"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0080194:Strain [Injury or Poisoning]
   760   C0456178:strain [Intellectual Product]
   760   C1518614:Strain [Organism]
   760   C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "time on the rod"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "as the dependent variable,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439828:Variable [Qualitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "followed by Student-Newman-Keuls post hoc multiple comparison"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0332283:Followed by [Temporal Concept]
           followed
   742   C0038492:student [Professional or Occupational Group]
   742   C0439064:Multiple [Quantitative Concept]
   742   C0687676:Post [Temporal Concept]
   742   C1551041:student [Idea or Concept]
   742   C1552573:student [Intellectual Product]
   742   C1704687:Post [Manufactured Object]
   742   C1707455:Comparison [Activity]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "(set at p < 0.05"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.66: Statistical evaluation of differences in the risk of falling off of the beam between wild-type and transgenic mice was performed by the corrected 2 test, with associated two-sided p values determined. 

Phrase: "Statistical evaluation of differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "in the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of falling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085639:FALLING [Finding]
   966 E C0238715:Fall [Temporal Concept]

Phrase: "off of the beam"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338248:BEAM [Therapeutic or Preventive Procedure]
  1000   C2347880:Beam [Phenomenon or Process]

Phrase: "between wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "performed by the corrected 2 test,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C1550369:Performed By [Qualitative Concept]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0205202:Corrected [Qualitative Concept]
   753   C0392366:test [Intellectual Product]
   753   C0884358:Performed [Functional Concept]
   719 E C2349182:Correct [Qualitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with associated two-sided p values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1709380:P-Value [Quantitative Concept]
   804   C0042295:Values [Qualitative Concept]
   771 E C1522609:Value [Quantitative Concept]

Phrase: "determined."
Processing 00000000.tx.67: AntibodiesThe specifications of antibodies against phosphorylation-independent, phosphorylation-dependent, and conformational epitopes of protein tau used in the present studies are summarized in Table I. 

Phrase: "AntibodiesThe specifications of antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348235:Specifications [Conceptual Entity]

Phrase: "against phosphorylation-independent, phosphorylation-dependent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "conformational epitopes of protein tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003316:Epitopes [Immunologic Factor]

Phrase: "used in the present studies"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   781   C0869040:Use studies [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C1947944:Use [Intellectual Product]
   726 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "summarized in Table I."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.68: In addition, SMI-32 antibody directed against nonphosphorylated neurofilament H (Sternberger, Lutherville, MD) was used to detect axonal dilatations (16, 17). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "SMI-32 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against nonphosphorylated neurofilament H (Sternberger,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1505576:Neurofilament-H [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1518284:Neurofilament-H [Cell Component]
   753   C0027834:Neurofilament [Cell Component]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "Lutherville,"

Phrase: "MD)"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.69: View this table: [in this window] [in a new window]  TABLE I Specifics of the primary antibodies against protein tau  ImmunohistochemistryMice were anesthetized with pentobarbital (120 mg/kg, intraperitoneally), flushed by transcardiac perfusion with ice-cold saline (2 ml/min for 2 min), and fixed with 4% paraformaldehyde in PBS (2 ml/min for 10 min). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Specifics of the primary antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   741   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   714   C0205369:Specific [Qualitative Concept]
   714   C1552740:specific [Intellectual Product]

Phrase: "against protein tau  ImmunohistochemistryMice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1421563:protein tau [Gene or Genome]

Phrase: "were"

Phrase: "anesthetized with pentobarbital"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   790   C1720436:Anesthetized [Finding]

Phrase: "(120 mg/kg,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "intraperitoneally"

Phrase: ")"

Phrase: ","

Phrase: "flushed by transcardiac perfusion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0016382:flushed [Sign or Symptom]
   770   C0031001:Perfusion [Therapeutic or Preventive Procedure]
   737 E C1696091:Flush [Functional Concept]

Phrase: "with ice-cold saline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036082:Saline [Substance]
   734   C0456963:Ice cold [Qualitative Concept]

Phrase: "(2 ml/min for 2 min),"

Phrase: "and"

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in PBS (2 ml/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439445:mL/min [Quantitative Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "for 10 min)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.70: Brain and spinal cord were removed, postfixed overnight in 4% paraformaldehyde in PBS, and stored in 0.1% sodium azide in PBS at 4 C. 

Phrase: "Brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "postfixed"

Phrase: "overnight in 4% paraformaldehyde"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0439583:Overnight [Temporal Concept]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "stored in 0.1% sodium azide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   783   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   753   C0004492:azide [Chemical Viewed Structurally]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   719   C1698986:Store [Functional Concept]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "at 4 C."
Processing 00000000.tx.71: Coronal and saggital 40-m-thick sections were cut, rinsed in PBS, and treated with 1.5% H2O2, 50% methanol in PBS. 

Phrase: "Coronal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205123:Coronal [Spatial Concept]

Phrase: "and"

Phrase: "saggital 40-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "m-"

Phrase: "thick sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "cut,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "rinsed in PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "treated with 1.5% H2O2,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "50% methanol in PBS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.72: Nonspecific binding of antibodies was blocked by treatment with 10% fetal calf serum, 3% bovine serum albumin in PBS (blocking buffer). 

Phrase: "Nonspecific binding of antibodies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C0312590:Nonspecific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0205370:Non-specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C0750540:Nonspecific [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked by treatment"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0028778:Blocked [Pathologic Function]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0332206:Blocked [Functional Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C2983591:BLOCKED [Research Activity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "with 10% fetal calf serum,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "3% bovine serum albumin in PBS (blocking buffer"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   770   C0728877:serum albumin [Laboratory or Test Result]
   767 E C0523465:Albumin - serum [Laboratory Procedure]
   744   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007452:Bovine [Mammal]
   744   C0229671:Serum [Body Substance]
   744   C1140701:bovine [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]

Phrase: ")."
Processing 00000000.tx.73: The sections were incubated with primary antibody in blocking buffer (with 0.1% Triton X-100) at ambient temperature overnight. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with primary antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in blocking buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "with 0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "at ambient temperature overnight."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0428692:Ambient temperature [Natural Phenomenon or Process]
   901   C0542496:Ambient temperature [Finding]
   901   C2348236:Ambient Temperature [Qualitative Concept]
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]
   827   C1879688:Ambient [Qualitative Concept]
Processing 00000000.tx.74: Dilutions of the primary antibodies used (and method of amplification) were as follows: HT7, 1:10,000 (two-step); 

Phrase: "Dilutions of the primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0079240:dilutions [Laboratory Procedure]
   726 E C1948037:Dilution [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "("

Phrase: "and"

Phrase: "method of amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025663:Method [Intellectual Product]
   790   C0449851:Method [Functional Concept]
   790   C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "HT7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450571:HT7 [Body Location or Region]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: "(two-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205448:Two [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.75: AT8, 1:1000 (two-step and three-step); 

Phrase: "AT8,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: "(two-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205448:Two [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "three-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205449:Three [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.76: AT180, 1:250 (two-step); 

Phrase: "AT180,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "250"

Phrase: "(two-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205448:Two [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.77: AT270, 1:5000 (two-step); 

Phrase: "AT270,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: "(two-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205448:Two [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.78: AD2, 1:1000 (two-step); 

Phrase: "AD2,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: "(two-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205448:Two [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.79: AT100, 1:1000 (two-step) or 1:5000 (three-step); 

Phrase: "AT100,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: "(two-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205448:Two [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: "(three-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205449:Three [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.80: AP422, 1:1000 (two-step); 

Phrase: "AP422,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: "(two-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205448:Two [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.81: MC1, 1:1000 (two-step and three-step). 

Phrase: "MC1,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: "(two-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205448:Two [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "three-step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205449:Three [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.82: The sections were then incubated for 1 h with goat anti-mouse or anti-rabbit IgG-horseradish peroxidase (two-step procedure) or goat anti-mouse or anti-rabbit IgG-biotin (three-step procedure), diluted 1:500 in blocking buffer, 0.1% Triton X-100. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with goat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018019:goat [Mammal]
  1000   C1265549:goat [Mammal]
  1000   C1510458:Goat [Mammal]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "anti-rabbit IgG-horseradish peroxidase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0063351:IGG-horseradish peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   804   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0330510:Horseradish [Food]
   804   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   804   C1110641:Horseradish [Plant]
   804   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(two-step procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "goat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018019:goat [Mammal]
  1000   C1265549:goat [Mammal]
  1000   C1510458:Goat [Mammal]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "anti-rabbit IgG-biotin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C2700256:Biotin [Laboratory Procedure]
   708   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(three-step procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500 in blocking buffer,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "0.1% Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]
Processing 00000000.tx.83: In the two-step procedure, the sections were next washed with PBS and 50 mM TrisHCl (pH 7.6) for 5 min and stained with 3,3'-diaminobenzidine, 0.3% H2O2 in 50 mM TrisHCl (pH 7.6) for 35 min. 

Phrase: "In the two-step procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "50 mM TrisHCl"

Phrase: "(pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "stained with 3,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "3'-diaminobenzidine,"

Phrase: "0.3% H2O2 in 50 mM TrisHCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 35 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.84: In the three-step procedure, the sections were incubated with avidin-biotinylated peroxidase complex (Vectastain Elite ABC, Vector, Burlingame, CA) diluted 1:800 in PBS, 0.3% bovine serum albumin for 1 h at ambient temperature and sometimes briefly counterstained with hematoxylin, as indicated. 

Phrase: "In the three-step procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with avidin-biotinylated peroxidase complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439855:Complex [Qualitative Concept]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Vectastain Elite ABC,"

Phrase: "Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA)"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "800 in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "0.3% bovine serum albumin for 1 h"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   770   C0728877:serum albumin [Laboratory or Test Result]
   767 E C0523465:Albumin - serum [Laboratory Procedure]
   744   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007452:Bovine [Mammal]
   744   C0229671:Serum [Body Substance]
   744   C1140701:bovine [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]

Phrase: "at ambient temperature"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0428692:Ambient temperature [Natural Phenomenon or Process]
  1000   C0542496:Ambient temperature [Finding]
  1000   C2348236:Ambient Temperature [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1879688:Ambient [Qualitative Concept]

Phrase: "and"

Phrase: "sometimes briefly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1998882:Sometimes [Temporal Concept]

Phrase: "counterstained with hematoxylin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.85: Finally, the sections were washed and stained as in the two-step procedure. 

Phrase: "Finally,"

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as in the two-step procedure."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0205448:Two [Quantitative Concept]
   753   C1261552:Step [Conceptual Entity]
   753   C1704379:Step [Functional Concept]
   753   C1705117:Step [Quantitative Concept]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C2825408:Step [Manufactured Object]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.86: Sections were dehydrated by passage through a graded series of alcohol and xylol and mounted. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "dehydrated by passage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011175:Dehydrated [Disease or Syndrome]
   790   C0439799:Passage [Spatial Concept]

Phrase: "through a graded series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "of alcohol"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001962:ALCOHOL [Organic Chemical]
  1000   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   928 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "and"

Phrase: "xylol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043367:Xylol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "mounted."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]
Processing 00000000.tx.87: Except where otherwise indicated, double immunolabeling was performed similarly, with sections incubated with primary antibodies in the following dilutions: AP422 and HT7, 1:1000; 

Phrase: "Except where otherwise"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "double immunolabeling"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "similarly,"

Phrase: "with sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "incubated with primary antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in the following dilutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0079240:dilutions [Laboratory Procedure]
   827 E C1948037:Dilution [Functional Concept]

Phrase: ":"

Phrase: "AP422"

Phrase: "and"

Phrase: "HT7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450571:HT7 [Body Location or Region]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.88: AT8, AT100, and MC1, 1:500. 

Phrase: "AT8,"

Phrase: "AT100,"

Phrase: "and"

Phrase: "MC1,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500."
Processing 00000000.tx.89: Sections were incubated with secondary antibodies goat antirabbit IgG-horseradish peroxidase-labeled and goat anti-mouse IgG-alkaline phosphatase labeled and developed with aminoethylcarbazole or with nitro blue tetrazolium as substrates. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with secondary antibodies goat antirabbit IgG-horseradish peroxidase-labeled"
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   782   C0063351:IGG-horseradish peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   766   C0598670:peroxidase labeled antibody [Immunologic Factor]
   760   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   741   C2754943:IgG antibody [Cell Component]
   739   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0018019:goat [Mammal]
   739   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0027627:secondary [Neoplastic Process]
   739   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0175668:Secondary [Temporal Concept]
   739   C0205436:Secondary [Quantitative Concept]
   739   C0330510:Horseradish [Food]
   739   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   739   C1110641:Horseradish [Plant]
   739   C1265549:goat [Mammal]
   739   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1510458:Goat [Mammal]
   739   C1708632:Labeled [Qualitative Concept]
   706 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   706 E C0181496:Label [Manufactured Object]
   706 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "goat anti-mouse IgG-alkaline phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1149880:phosphatase [Molecular Function]
   799   C1979842:Alkaline [Qualitative Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "developed with aminoethylcarbazole"

Phrase: "or with nitro blue tetrazolium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0028147:Nitroblue Tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0039704:tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1260957:Blue [Qualitative Concept]

Phrase: "as substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.90: The sections were mounted on silanized slides in Kaiser's glycerol gelatin. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted on silanized slides"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444330:slides [Research Device]
   770   C0449878:mounted [Finding]
   737 E C0181909:Mount [Medical Device]
   737 E C1705201:Slide [Manufactured Object]

Phrase: "in Kaiser's glycerol gelatin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   827   C1145617:Gelatin [Food]
Processing 00000000.tx.91: HistologySilver impregnation of brain sections was exactly as described (35). 

Phrase: "HistologySilver impregnation of brain sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015914:impregnation [Organism Function]

Phrase: "was"

Phrase: "exactly"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.92: For staining with thioflavin S, sections were washed twice for 1 min in water and incubated with 1% thioflavin S in water for 8 min, washed and refixed with 4% formaldehyde for 10 min, rinsed in water for 1 min, and incubated again with 1% thioflavin S for 4 min. 

Phrase: "For staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with thioflavin S,"

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice for 1 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "incubated with 1% thioflavin S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "for 8 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "refixed with 4% formaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "rinsed in water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "for 1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "again with 1% thioflavin S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for 4 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.93: Excess thioflavin S was removed by washing with 80% ethanol twice for 1 min each. 

Phrase: "Excess thioflavin S"

Phrase: "was"

Phrase: "removed by washing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0441648:Washing [Activity]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "with 80% ethanol twice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001962:Ethanol [Organic Chemical]

Phrase: "for 1 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "each."
Processing 00000000.tx.94: Finally, the sections were mounted in 10% Mowiol, 25% glycerol, 100 mM TrisHCl (pH 8.5), 40 mg/ml triethylenediamine. 

Phrase: "Finally,"

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted in 10% Mowiol,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449878:mounted [Finding]
   737 E C0181909:Mount [Medical Device]

Phrase: "25% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "100 mM TrisHCl"

Phrase: "(pH 8.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "40 mg/ml triethylenediamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0077102:triethylenediamine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.95: Staining with X-34, a derivative of Congo Red that stains -pleated proteins, was carried out essentially as described (36). 

Phrase: "Staining with X-34,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "a derivative of Congo Red"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1527240:Derivative [Functional Concept]

Phrase: "that stains -pleated proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out essentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.96: Sections were washed twice for 2 min in PBS and incubated in 0.1 mM X-34 in 40% ethanol. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice for 2 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "incubated in 0.1 mM X-34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0960674:X-34 [Organic Chemical]
   774   C1418486:MM-1 [Gene or Genome]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 40% ethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]
Processing 00000000.tx.97: Sections were rinsed five times in tap water and treated with 0.2% NaOH in 80% ethanol. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "five times in tap water"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "treated with 0.2% NaOH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "in 80% ethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]
Processing 00000000.tx.98: The sections were washed twice for 5 min in water before mounting in 10% Mowiol, 25% glycerol, 100 mM TrisHCl (pH 8.5), 40 mg/ml triethylenediamine. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice for 5 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "before mounting"

Phrase: "in 10% Mowiol,"

Phrase: "25% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "100 mM TrisHCl"

Phrase: "(pH 8.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "40 mg/ml triethylenediamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0077102:triethylenediamine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.99: Brain Tissue ExtractsBrain tissue was homogenized in 6 volumes of buffer. 

Phrase: "Brain Tissue ExtractsBrain tissue"

Phrase: "was"

Phrase: "homogenized in 6 volumes of buffer."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0449468:volumes [Quantitative Concept]
   719 E C1690016:% volume [Qualitative Concept]
   719 E C1705102:Volume [Intellectual Product]
   719 E C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.100: The homogenate was centrifuged at 150,000 x g for 30 min, and the supernatant was stored at -70 C in aliquots. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged at 150,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -70 C in aliquots."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1510844:Aliquot [Quantitative Concept]
Processing 00000000.tx.101: The pellet was resuspended in 6 volumes of 10 mM TrisHCl (pH 7.6), 0.8 M NaCl, 10% sucrose, 1 mM phenylmethylsulfonyl fluoride and again centrifuged at 20,000 x g for 30 min. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 6 volumes of 10 mM TrisHCl"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0439187:/10^6 [Quantitative Concept]
   767   C1881839:10^6 [Quantitative Concept]
   744   C0449468:volumes [Quantitative Concept]
   711 E C1690016:% volume [Qualitative Concept]
   711 E C1705102:Volume [Intellectual Product]
   711 E C2700258:Volume [Laboratory Procedure]

Phrase: "(pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "0.8 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "10% sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "1 mM phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "again"

Phrase: "centrifuged at 20,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.102: The supernatant was made 1% in Sarkosyl and incubated for 1 h at room temperature before centrifugation at 150,000 x g for 30 min. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "1% in Sarkosyl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0074071:sarkosyl [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "before centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 150,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.103: The pellet comprising the Sarkosyl-insoluble material was resuspended in TBS. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "comprising"

Phrase: "the Sarkosyl-insoluble material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "was"

Phrase: "resuspended in TBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1532188:Tbsp [Quantitative Concept]
Processing 00000000.tx.104: Western BlottingMice were killed by decapitation, brain was removed from the skull and spinal cord from the chorda, and tissues were snap-frozen in liquid nitrogen. 

Phrase: "Western BlottingMice"

Phrase: "were"

Phrase: "killed by decapitation,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0152232:Decapitation [Injury or Poisoning]
   790   C0162388:killed [Social Behavior]
   790   C0413398:Decapitation [Injury or Poisoning]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed from the skull"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0037303:Skull [Body Part, Organ, or Organ Component]
   770   C0849355:Removed [Qualitative Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "spinal cord from the chorda,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   806   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   760   C0521329:Spinal [Spatial Concept]
   760   C1550235:Cord [Body Part, Organ, or Organ Component]
   760   C1552938:cord [Quantitative Concept]
   760   C1706500:Cord [Manufactured Object]

Phrase: "and"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "snap-"

Phrase: "frozen in liquid nitrogen."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
Processing 00000000.tx.105: Brain and spinal cord were homogenized in 6 volumes of homogenization buffer (25 mM TrisHCl (pH 7.6), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 5 mM sodium pyrophosphate, 30 mM sodium fluoride, 2 mM sodium vanadate, 1 M okadaic acid, 1 mM phenylmethylsulfonyl fluoride, 5 g/ml leupeptin, 5 g/ml pepstatin, 5 g/ml soy bean trypsin inhibitor) in a Potter-Elvejhem homogenizer with 20 up-and-down strokes of a Teflon pestle rotating at 700 rpm. 

Phrase: "Brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "were"

Phrase: "homogenized in 6 volumes of homogenization buffer"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0449468:volumes [Quantitative Concept]
   714 E C1690016:% volume [Qualitative Concept]
   714 E C1705102:Volume [Intellectual Product]
   714 E C2700258:Volume [Laboratory Procedure]

Phrase: "(25 mM TrisHCl"

Phrase: "(pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "5 mM sodium pyrophosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0074764:sodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "30 mM sodium fluoride,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0037508:Sodium Fluoride [Biomedical or Dental Material,Inorganic Chemical]
   861   C1171560:sodium fluoride [Pharmacologic Substance]
   861   C1556062:Sodium Fluoride [Intellectual Product]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   805 E C0721463:Luride [Organic Chemical,Pharmacologic Substance]

Phrase: "2 mM sodium vanadate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037568:Sodium Vanadate [Inorganic Chemical,Pharmacologic Substance]
   812   C0042305:Vanadate [Inorganic Chemical]

Phrase: "1 M okadaic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "5 g/ml soy bean trypsin inhibitor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0037733:Soy bean [Food]
           soy
   818   C0041242:trypsin inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0947608:SOYBEAN [Pharmacologic Substance]
   818   C1262902:Soybean [Plant]
   818   C3257531:soybean [Pharmacologic Substance]
   795   C0004896:Bean [Food]
   795   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C1999216:Inhibitor [Qualitative Concept]
   795   C2756587:Soy [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "in a Potter-Elvejhem homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0181200:homogenizer [Medical Device]

Phrase: "with 20 up-and-down strokes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0038454:Strokes [Disease or Syndrome]

Phrase: "of a Teflon pestle rotating"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0231458:rotating [Spatial Concept]
   755 E C0040480:Twisting [Physiologic Function]
   755 E C0231467:Twisted [Spatial Concept]
   755 E C1265748:Twisting [Pathologic Function]
   755 E C1881716:TWISTING [Phenomenon or Process]

Phrase: "at 700 rpm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]
Processing 00000000.tx.106: Brain and spinal cord homogenates were diluted appropriately in sample buffer for SDS-PAGE on 8% polyacrylamide gels (Novex, San Diego, CA). 

Phrase: "Brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord homogenates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   901   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   827   C0521329:Spinal [Spatial Concept]
   827   C1550235:Cord [Body Part, Organ, or Organ Component]
   827   C1552938:cord [Quantitative Concept]
   827   C1706500:Cord [Manufactured Object]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "appropriately in sample buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "for SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "on 8% polyacrylamide gels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gels [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793 E C1382104:Gel [Substance]

Phrase: "(Novex,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.107: Proteins were transferred to nitrocellulose filters (Hybond-ECL) at 70 mA overnight, in 25 mM Tris/HCl (pH 8.6), 190 mM glycine, 20% methanol. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0180860:Filters [Manufactured Object]
   793 E C0581406:Filter [Medical Device]
   793 E C1522664:Filter [Intellectual Product]
   793 E C1704449:Filter [Conceptual Entity]
   793 E C1704684:Filter [Medical Device]
   793 E C1875155:FILTER [Medical Device]

Phrase: "(Hybond-ECL) at 70 mA overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1332684:ECL [Gene or Genome]

Phrase: "in 25 mM Tris/HCl (pH 8.6"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "190 mM glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0522461:Glycine [Plant]

Phrase: "20% methanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.108: Filters were stained with Ponceau Red to visualize proteins as loading control and washed three times in 50 mM TrisHCl (pH 7.6), 150 mM NaCl, 0.1% Tween (TBS-Tween) for 10 min. 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "stained with Ponceau Red to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   781   C0491958:STAIN, PONCEAU [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "visualize"

Phrase: "proteins as loading control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "washed three times in 50 mM TrisHCl"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "(pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% Tween"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   771 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(TBS-Tween"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   805 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.109: To prevent nonspecific binding of antibody, the blots were blocked by 5% nonfatty milk in TBS-Tween. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "nonspecific binding of antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0312590:Nonspecific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0205370:Non-specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C0750540:Nonspecific [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "the blots"

Phrase: "were"

Phrase: "blocked by 5% nonfatty milk"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0026131:Milk [Body Substance]
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in TBS-Tween."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   805 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.110: The blots were incubated at 4 C for 2 h with the primary antibody diluted in the same buffer. 

Phrase: "The blots"

Phrase: "were"

Phrase: "incubated at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "diluted in the same buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0445247:Same [Qualitative Concept]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]
Processing 00000000.tx.111: The dilutions of the primary antibodies were as follows: Tau-5, 1:1000; 

Phrase: "The dilutions of the primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0079240:dilutions [Laboratory Procedure]
   719 E C1948037:Dilution [Functional Concept]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Tau-5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.112: AT8, 1:200; 

Phrase: "AT8,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.113: AT180, 1:200; 

Phrase: "AT180,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.114: AT100, 1:200; 

Phrase: "AT100,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.115: AT270, 1:500; 

Phrase: "AT270,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.116: AD2, 1:5000. 

Phrase: "AD2,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000."
Processing 00000000.tx.117: Primary antibody was removed by washing four times with TBS-Tween for 8 min. 

Phrase: "Primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "removed by washing four times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0040223:times [Temporal Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C0441648:Washing [Activity]
   760   C0849355:Removed [Qualitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with TBS-Tween"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   805 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "for 8 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.118: Blots were incubated for 1 h with labeled secondary antibody (goat anti-mouse or anti-rabbit IgG-horseradish peroxidase, 1:10,000; 

Phrase: "Blots"

Phrase: "were"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with labeled secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(goat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018019:goat [Mammal]
  1000   C1265549:goat [Mammal]
  1000   C1510458:Goat [Mammal]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "anti-rabbit IgG-horseradish peroxidase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0063351:IGG-horseradish peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   804   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0330510:Horseradish [Food]
   804   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   804   C1110641:Horseradish [Plant]
   804   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ";"
Processing 00000000.tx.119: Bio-Rad), and reactions were visualized by ECL (Amersham Biosciences). 

Phrase: "Bio-Rad"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "visualized by ECL (Amersham Biosciences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0234621:Visualized [Functional Concept]
   760   C1332684:ECL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.120: Immunogold Electron MicroscopySarkosyl insoluble fractions were applied on 200-mesh Formvar carbon-coated nickel grids in drops of 5 l and allowed to air-dry overnight. 

Phrase: "Immunogold Electron MicroscopySarkosyl insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "applied on 200-mesh Formvar carbon-coated nickel grids"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   742   C0007009:Carbon [Element, Ion, or Isotope]
   742   C0028013:nickel [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0181805:Mesh [Medical Device]
   742   C0185125:Applied [Health Care Activity]
   742   C0950318:Formvar [Hazardous or Poisonous Substance,Organic Chemical]
   742   C1135584:MeSH [Intellectual Product]
   742   C1522408:Coated [Qualitative Concept]
   742   C1552983:Mesh [Quantitative Concept]
   742   C2348274:Nickel [Element, Ion, or Isotope]
   708 E C0453946:Coat [Manufactured Object]
   708   C1415284:GRID [Gene or Genome]
   708 E C1632850:Apply [Functional Concept]
   708 E C1879355:Apply [Functional Concept]
   708   C2348395:Grid [Medical Device]
   708   C2825313:Grid [Manufactured Object]
   708 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "in drops"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0991568:Drops [Biomedical or Dental Material]
  1000   C1321095:Drops [Quantitative Concept]
  1000   C2347093:drops [Quantitative Concept]
   966 E C1705648:Drop [Activity]
   966 E C2348338:Drop [Quantitative Concept]

Phrase: "of 5 l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348935:.5 L [Quantitative Concept]

Phrase: "and"

Phrase: "allowed to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0683607:allowed [Social Behavior]

Phrase: "air-dry"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0001861:Air [Substance]
   861   C0011682:Dry [Natural Phenomenon or Process]
   861   C0205222:Dry [Qualitative Concept]
   861   C1512080:Dry [Qualitative Concept]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.121: Grids were incubated with diluted primary antibody in PBS, 0.1% gelatin (cold water fish) for 90 min at room temperature. 

Phrase: "Grids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1415284:GRID [Gene or Genome]
   966   C2348395:Grid [Medical Device]
   966   C2825313:Grid [Manufactured Object]

Phrase: "were"

Phrase: "incubated with diluted primary antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1439852:Incubated [Laboratory Procedure]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "0.1% gelatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   827   C1145617:Gelatin [Food]

Phrase: "(cold water fish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016163:Fish [Fish]
   827   C2349190:Fish [Food]
   827   C2700184:FISH [Qualitative Concept]

Phrase: ")"

Phrase: "for 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.122: Primary antibody dilutions were as follows: HT7, 1:50; 

Phrase: "Primary antibody dilutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0079240:dilutions [Laboratory Procedure]
   793 E C1948037:Dilution [Functional Concept]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "HT7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450571:HT7 [Body Location or Region]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50"

Phrase: ";"
Processing 00000000.tx.123: AT8, 1:50; 

Phrase: "AT8,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50"

Phrase: ";"
Processing 00000000.tx.124: AT100, 1:50; 

Phrase: "AT100,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50"

Phrase: ";"
Processing 00000000.tx.125: MC1, 1:2; 

Phrase: "MC1,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.126: TG3, 1:2. 

Phrase: "TG3,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.127: Grids were washed in 0.1% cold water fish gelatin and incubated with secondary antibody (goat anti-mouse IgG/M) labeled with 10-nm gold particles (Aurion) diluted 1:30 in PBS, 1% cold water fish gelatin. 

Phrase: "Grids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1415284:GRID [Gene or Genome]
   966   C2348395:Grid [Medical Device]
   966   C2825313:Grid [Manufactured Object]

Phrase: "were"

Phrase: "washed in 0.1% cold water fish gelatin"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0016163:Fish [Fish]
   744   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   744   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   744   C0234192:Cold [Physiologic Function]
   744   C0599638:WATER [Substance]
   744   C1145617:Gelatin [Food]
   744   C1548982:Washed [Idea or Concept]
   744   C1550678:Water [Inorganic Chemical]
   744   C2349190:Fish [Food]
   744   C2700184:FISH [Qualitative Concept]
   711 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "incubated with secondary antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0027627:secondary [Neoplastic Process]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(goat anti-mouse IgG/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "M)"

Phrase: "labeled with 10-nm gold particles"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0312860:NM [Cell Function]
   753   C0597177:particles [Chemical Viewed Structurally]
   753   C1304897:Gold [Functional Concept]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Aurion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006129:Aurion [Fish]

Phrase: ")"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "30 in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "1% cold water fish gelatin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   804   C1145617:Gelatin [Food]
Processing 00000000.tx.128: After washing in PBS, tau filaments were negatively stained with 2% uranyl acetate for 5 min. 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "tau filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "were"

Phrase: "negatively"

Phrase: "stained with 2% uranyl acetate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C2984971:URANYL ACETATE STAIN [Laboratory Procedure]
   806   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   760   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.129: After air drying, the grids were examined by transmission electron microscopy (Philips CM10) at 80 kV, and images were obtained at magnifications of x52,000 and x105,000. 

Phrase: "After"

Phrase: "air drying"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1879673:Air-Drying [Therapeutic or Preventive Procedure]
   861   C0001861:Air [Substance]
   861   C0011682:drying [Natural Phenomenon or Process]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0205222:Dry [Qualitative Concept]
   827 E C1512080:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ","

Phrase: "the grids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1415284:GRID [Gene or Genome]
   966   C2348395:Grid [Medical Device]
   966   C2825313:Grid [Manufactured Object]

Phrase: "were"

Phrase: "examined by transmission electron microscopy"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0678118:Transmission Electron Microscopy [Laboratory Procedure]
   806   C0026019:Electron Microscopy [Laboratory Procedure]
   806   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   760   C0013852:Electron [Quantitative Concept]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0040722:transmission [Idea or Concept]
   760   C0242781:Transmission [Pathologic Function]
   760   C0332128:Examined [Finding]
   760   C1521797:Transmission [Natural Phenomenon or Process]
   760   C3463986:Electron [Bird]

Phrase: "(Philips CM10"

Phrase: ")"

Phrase: "at 80 kV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556639:kV [Quantitative Concept]

Phrase: "and"

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "obtained at magnifications of x52,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "000"

Phrase: "and"

Phrase: "x105,"

Phrase: "000."
Processing 00000000.tx.130: Atomic Force MicroscopyTau filaments resuspended in TBS were deposited on silanized silicon supports and washed twice with distilled water before analysis by atomic force microscopy in tapping mode on the Nanoscope III (Digital Instruments, Santa Barbara, CA) equipped with a SuperSharpSiliconTM cantilever (Nanoworld AG, Neuchatel, Switzerland).  

Phrase: "Atomic Force MicroscopyTau filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   779   C0010851:Filament [Cell Component]
   729 E C1979891:Filamentous [Qualitative Concept]

Phrase: "resuspended in TBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1532188:Tbsp [Quantitative Concept]

Phrase: "were"

Phrase: "deposited on silanized silicon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037107:Silicon [Element, Ion, or Isotope]
   770   C0333562:deposited [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with distilled water"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "before analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "by atomic force microscopy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "in tapping mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]

Phrase: "on the Nanoscope III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "(Digital Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Santa Barbara,"

Phrase: "CA)"

Phrase: "equipped with a SuperSharpSiliconTM cantilever"

Phrase: "(Nanoworld AG,"

Phrase: "Neuchatel,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.131: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Generation of Tau-KOKI Mice and Tau-P301L MiceTo generate transgenic mice that lack the heterogeneity of the six tau isoforms due to alternative RNA splicing, we inactivated the endogenous tau gene by introducing into exon 1 a single copy of the human tau-4R/2N cDNA under control of the mouse thy1 promoter. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of Tau-KOKI Mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "Tau-P301L MiceTo"

Phrase: "generate"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the heterogeneity of the six tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "due to alternative RNA splicing,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0002345:RNA Splicing, Alternative [Genetic Function]
           Alternative Splicing
   901   C0035687:RNA Splicing [Genetic Function]
           Splicing
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C2610186:splicing [Genetic Function]

Phrase: "we"

Phrase: "inactivated"

Phrase: "the endogenous tau gene by introducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Gene [Gene or Genome]

Phrase: "into exon 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a single copy of the human tau-4R/2N cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0205171:Single [Quantitative Concept]
   739   C1948062:Copy [Manufactured Object]

Phrase: "under control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the mouse thy1 promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.132: This construct was based on the same cassette used to generate the tau-4R/2N mice (16), now incorporated into a genomic DNA fragment containing the first exon of the mouse tau gene (33). 

Phrase: "This construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "based on the same cassette"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0445247:Same [Qualitative Concept]
   760   C0450240:Cassette [Medical Device]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1706210:Cassette [Manufactured Object]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "the tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "incorporated into a genomic DNA fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017428:Genomic [Gene or Genome]
   753   C0332255:fragment [Functional Concept]
   753   C0887950:genomic [Biomedical Occupation or Discipline]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the first exon of the mouse tau gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.133: Standard methods of homologous recombination in ES cells and of analysis by Southern blotting of 336 independent ES clones yielded six ES clones that had undergone correct homologous recombination (results not shown). 

Phrase: "Standard methods of homologous recombination"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "in ES cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0596508:ES cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and of analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1515981:And [Idea or Concept]
   790   C1524024:analysis [Functional Concept]

Phrase: "by Southern blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005862:Blotting, Southern [Molecular Biology Research Technique]
   983 E C1148472:Blot, Southern [Laboratory or Test Result]
   861   C1710133:Southern [Spatial Concept]

Phrase: "of 336 independent ES"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "yielded six ES"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "that"

Phrase: "had"

Phrase: "undergone correct homologous recombination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0599773:Homologous Recombination [Genetic Function]
   861   C2984295:Homologous recombination [Functional Concept]
   812   C0034865:Recombination [Genetic Function]
   812   C1334043:Homologous [Gene or Genome]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: One ES cell line yielded germ line chimeras that were mated to FVB mice, and the F1 offspring were back-crossed for eight generations into the FVB strain before crossing to yield homozygous tau-KOKI mice, analyzed here. 

Phrase: "One ES cell line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C1512140:ES Cell Line [Cell]
   861   C0007600:Cell Line [Cell]
   861   C0596508:ES cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "yielded"

Phrase: "germ line chimeras"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0008109:Chimeras [Organism]
   793 E C1318484:Chimera [Disease or Syndrome]
   734   C0017473:Germ Line [Cell]

Phrase: "that"

Phrase: "were"

Phrase: "mated to FVB mice,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   816   C1517101:FVB Mouse [Mammal]
           FVB
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1254211:mated [Pharmacologic Substance]
   770   C1260875:Mated [Organism Function]
   737 E C0682323:mate [Family Group]

Phrase: "and"

Phrase: "the F1 offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "back-crossed for eight generations"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0004600:Back [Body Location or Region]
   760   C0079411:Generations [Temporal Concept]
   760   C0205095:Back [Spatial Concept]
   760   C0205203:Crossed [Spatial Concept]
   760   C0205454:Eight [Quantitative Concept]
   760   C0460009:Back [Body Location or Region]
   760   C1995000:Back [Body Location or Region]
   726 E C2828360:Cross [Conceptual Entity]
   726 E C3146294:Generation [Activity]

Phrase: "into the FVB strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]

Phrase: "before crossing to"

Phrase: "yield"

Phrase: "homozygous tau-KOKI mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   868   C0206745:Knock-out Mice [Mammal]
   845   C1517676:Knock-in [Research Activity]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "here."
Processing 00000000.tx.135: In the tau-KOKI mice, mouse tau was completely lacking, whereas neuronal expression of the human tau-4R/2N transgene was biochemically demonstrated to begin in the second week after birth, similar to other transgenes driven by the same mouse thy1 gene promoter (16, 17, 27). 

Phrase: "In the tau-KOKI mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "mouse tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "completely lacking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332268:Lacking [Qualitative Concept]

Phrase: "whereas"

Phrase: "neuronal expression of the human tau-4R/2N transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "biochemically"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "begin in the second week after birth, similar"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0005615:Birth [Organism Function]
   744   C0205436:Second [Quantitative Concept]
   744   C0332174:/week [Temporal Concept]
   744   C0439230:week [Temporal Concept]
   744   C0439659:Begin [Temporal Concept]
   744   C0457385:Second [Temporal Concept]
   744   C0565930:/second [Quantitative Concept]
   744   C1550722:birth [Idea or Concept]
   744   C1561503:second [Idea or Concept]
   744   C1705190:Second [Qualitative Concept]
   744   C2348205:Similar [Qualitative Concept]
   744   C3245487:birth [Intellectual Product]

Phrase: "to other transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgenes [Gene or Genome]

Phrase: "driven by the same mouse thy1 gene promoter"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C1420728:THY1 gene [Gene or Genome]
           THY1
   767   C0314621:Promoter gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0445247:Same [Qualitative Concept]
   711   C0013126:Drive [Mental Process]

Phrase: "(16,"

Phrase: "17,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.136: This independently demonstrates that the impact of the absence of endogenous mouse tau on the developing mouse embryo is practically negligible (33), indicating that its function is taken over by other microtubule-associated proteins. 

Phrase: "This independently"

Phrase: "demonstrates"

Phrase: "that"

Phrase: "the impact of the absence of endogenous mouse tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1825598:IMPACT [Gene or Genome]

Phrase: "on the developing mouse embryo"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0013935:Embryo [Embryonic Structure]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C1305370:Embryo [Embryonic Structure]

Phrase: "is"

Phrase: "practically negligible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332269:Negligible [Qualitative Concept]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "its function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "over by other microtubule-associated proteins."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0026045:Microtubule-Associated Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0026042:Microtubule Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0026046:Micro-tubule [Cell Component]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205136:Over [Spatial Concept]
   753   C0332281:Associated [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.137: Phenotypically, until the age of about 6 months, homozygous tau-KOKI mice were indistinguishable from wild-type mice, with normal body weight, normal behavior in the home cage, normal rearing and grooming, and normal fertility with normal frequency and size of litters. 

Phrase: "Phenotypically,"

Phrase: "until"

Phrase: "the age of about 6 months,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1510828:Age-Months [Organism Attribute]
   753   C0001779:Age [Organism Attribute]

Phrase: "homozygous tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   868   C0206745:Knock-out Mice [Mammal]
   845   C1517676:Knock-in [Research Activity]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "indistinguishable from wild-type mice,"

Phrase: "with normal body weight,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0421272:Normal Body Weight [Clinical Attribute]
  1000   C1285592:Normal body weight [Clinical Attribute]
   913   C2712185:Normal weight [Finding]
   901   C0005910:Body Weight [Organism Attribute]
           weight
   901   C1305866:body weight [Diagnostic Procedure]
           weight
   827   C0043100:Weight [Quantitative Concept]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1705104:Weight [Idea or Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "normal behavior in the home cage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0233512:Normal behavior [Social Behavior]
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "normal rearing"

Phrase: "and"

Phrase: "grooming,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018249:Grooming [Individual Behavior]
  1000   C0518461:grooming [Finding]

Phrase: "and"

Phrase: "normal fertility with normal frequency"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0577275:Normal fertility [Finding]
   760   C0015895:Fertility [Organism Function]
   760   C0200069:Fertility [Diagnostic Procedure]
   760   C2986895:Fertility [Idea or Concept]

Phrase: "and"

Phrase: "size of litters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0023881:Litter Size [Quantitative Concept]
   790   C0456389:size [Spatial Concept]
Processing 00000000.tx.138: In parallel, we generated tau-4R/2N-P301L mice in which the P301L FTDP-17 mutation was introduced by site-directed mutagenesis in the tau-4R/2N isoform cloned in the mouse thy1 gene promoter cassette and microinjected as described (16, 27). 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "tau-4R/2N-P301L mice in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "the P301L FTDP-17 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "introduced by site-directed mutagenesis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   760   C0079866:Mutagenesis [Molecular Function]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   760   C3146302:Mutagenesis [Laboratory Procedure]
   726   C0439851:Direct [Qualitative Concept]
   726   C1292748:introduce [Functional Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "in the tau-4R/2N isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "cloned in the mouse thy1 gene promoter cassette"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C1420728:THY1 gene [Gene or Genome]
           THY1
   767   C0314621:Promoter gene [Gene or Genome]
   767   C0598888:cloned gene [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0009013:cloned [Cell]
   744   C0017337:Gene [Gene or Genome]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0450240:Cassette [Medical Device]
   744   C1706210:Cassette [Manufactured Object]
   711 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "microinjected as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "(16,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.139: Three independent founder strains of tau-P301L mice were compared for expression of human tau by Western blotting and by immunohistochemistry. 

Phrase: "Three independent founder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0263541:Founder [Disease or Syndrome]

Phrase: "strains of tau-P301L mice"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   781   C1513684:Mouse Strains [Mammal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0080194:Strain [Injury or Poisoning]
   760   C0456178:strain [Intellectual Product]
   760   C1518614:Strain [Organism]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   760   C2987481:Strain [Mental Process]
   704 E C0180860:Filter [Manufactured Object]
   704 E C0581406:Filter [Medical Device]
   704 E C1522664:Filter [Intellectual Product]
   704 E C1704449:Filter [Conceptual Entity]
   704 E C1704684:Filter [Medical Device]
   704 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "compared for expression of human tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0086418:Human [Human]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1707455:Compared [Activity]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and by immunohistochemistry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.140: Offspring of all three founders expressed human protein tau in neurons in layers II, V, and VI of the neocortex, in layer III of the entorhinal cortex, in the basolateral amygdala, hippocampus, zona incerta of the thalamus, brain stem nuclei, deep cerebellar nuclei, and spinal cord (results not shown). 

Phrase: "Offspring of all three founders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Offspring [Family Group]

Phrase: "expressed"

Phrase: "human protein tau in neurons"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   835   C1454489:Tau protein, human [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   806   C1421563:protein tau [Gene or Genome]
   797 E C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "in layers II,"

Phrase: "V,"

Phrase: "and"

Phrase: "VI of the neocortex,"

Phrase: "in layer III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "of the entorhinal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "in the basolateral amygdala,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "zona incerta of the thalamus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0152350:Zona Incerta [Body Part, Organ, or Organ Component]
   806   C1289613:Zona incerta [Body Part, Organ, or Organ Component]
   760   C0019360:Zona [Disease or Syndrome]

Phrase: "brain stem nuclei,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
   901   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   896   C1706993:Brain nucleus [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0007610:Nucleus [Cell Component]

Phrase: "deep cerebellar nuclei,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007763:Deep cerebellar nuclei [Body Part, Organ, or Organ Component]
           Cerebellar Nuclei
   827   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   827   C0205125:Deep [Spatial Concept]
   827   C1707522:Cerebellar [Tissue]
   793   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.141: Strain 2 was selected for experiments because the expression of human tau-P301L was robust in neurons throughout the central nervous system (CNS), including spinal cord and thereby quantitatively and qualitatively similar to the tau-4R/2N mice as characterized before (16). 

Phrase: "Strain 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]

Phrase: "was"

Phrase: "selected for experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   756   C1707391:Select [Activity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "because"

Phrase: "the expression of human tau-P301L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "robust in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986815:Robust [Qualitative Concept]

Phrase: "throughout the central nervous system (CNS),"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "and"

Phrase: "thereby quantitatively"

Phrase: "and"

Phrase: "qualitatively similar to the tau-4R/2N mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "as"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.142: Important to note is that all three mouse strains expressed the human tau-4R/2N isoform, evidently containing the mutation in the tau-P301L mice. 

Phrase: "Important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "is"

Phrase: "that"

Phrase: "all three mouse strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C1513684:Mouse Strains [Mammal]
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]

Phrase: "expressed"

Phrase: "the human tau-4R/2N isoform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "evidently"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the mutation in the tau-P301L mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.143: Moreover, all transgenes are under control of the mouse thy1 gene promoter, and all mice have the identical pure FVB genetic background. 

Phrase: "Moreover,"

Phrase: "all transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgenes [Gene or Genome]

Phrase: "are under control of the mouse thy1 gene promoter,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C1420728:THY1 gene [Gene or Genome]
           THY1
   762   C0314621:Promoter gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1551058:Are [Quantitative Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "all mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "the identical pure FVB genetic background."
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   804   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   804   C0314603:Genetic [Functional Concept]
   804   C1706907:Background [Conceptual Entity]
   748 E C0005615:Birth [Organism Function]
   748 E C0035150:Reproduction [Organism Function]
   748 E C0079946:origin [Classification]
   748 E C0439659:Origin [Temporal Concept]
   748 E C1550512:origin [Intellectual Product]
   748 E C1550722:birth [Idea or Concept]
   748 E C3245487:birth [Intellectual Product]
   721 E C0454729:Natal [Geographic Area]
   721 E C0559522:Genital [Body System]
   721 E C1546649:Genital [Intellectual Product]
   721 E C1550642:Genital [Body Substance]
   711 E C0205313:Original [Idea or Concept]
   711 E C2347409:Original [Occupational Activity]
Processing 00000000.tx.144: This strict strategy warranted that the temporal and regional and neuron-specific expression throughout the CNS was similar in all three mouse strains. 

Phrase: "This strict strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "warranted"

Phrase: "that"

Phrase: "the temporal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442043:Temporal [Spatial Concept]
  1000   C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "regional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205147:regional [Spatial Concept]
  1000   C0205276:Regional [Spatial Concept]
  1000   C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "neuron-specific expression throughout the CNS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "similar in all three mouse strains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.145: In all experiments reported here, we analyzed heterozygous tau-4R/2N mice and homozygous tau-P301L mice that have very comparable concentrations of human tau in their brain and spinal cord at moderate overexpression levels (i.e. about 4-fold higher than endogenous mouse protein tau) (Fig. 1A). 

Phrase: "In all experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "heterozygous tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "homozygous tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "have"

Phrase: "very comparable concentrations of human tau"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "in their brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord at moderate overexpression levels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   790   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   753   C0521329:Spinal [Spatial Concept]
   753   C1550235:Cord [Body Part, Organ, or Organ Component]
   753   C1552938:cord [Quantitative Concept]
   753   C1706500:Cord [Manufactured Object]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "about 4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher than endogenous mouse protein tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: ")"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.146: Therefore, the only difference between the tau-4R/2N and tau-P301L mice is the presence of the P301L mutation, whereas the only difference between the tau-4R/2N and tau-KOKI mice is the level of expression (i.e. endogenous and 4-fold increased, respectively). 

Phrase: "Therefore,"

Phrase: "the only difference between the tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "the presence of the P301L mutation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "the only difference between the tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "the level of expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C3244092:expression level [Idea or Concept]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "(i.e. endogenous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205227:Endogenous [Functional Concept]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.147: View larger version (43K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.148: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.149: Major characteristics of tau-KOKI, tau-P301L, and tau-4R/2N mice. 

Phrase: "Major characteristics of tau-KOKI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1521970:Characteristics [Qualitative Concept]

Phrase: "tau-P301L,"

Phrase: "and"

Phrase: "tau-4R/2N mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.150: A, Western blotting with mAb Tau-5 defines the level of protein tau in brain and spinal cord of three mice with each of the genotypes specified. 

Phrase: "A,"

Phrase: "Western blotting with mAb Tau-5"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   773 E C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "defines"

Phrase: "the level of protein tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord of three mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1522592:Mouse Spinal Cord [Tissue]
   806   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   806   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   760   C0521329:Spinal [Spatial Concept]
   760   C1550235:Cord [Body Part, Organ, or Organ Component]
   760   C1552938:cord [Quantitative Concept]
   760   C1706500:Cord [Manufactured Object]

Phrase: "with each"

Phrase: "of the genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "specified."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]
Processing 00000000.tx.151: Apparent molecular mass is indicated in kDa on the left. 

Phrase: "Apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "is"

Phrase: "indicated in kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C1532717:kDa [Quantitative Concept]

Phrase: "on the left."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]
Processing 00000000.tx.152: Approximate positions of major isoforms of tau-4R with 0, 1, and 2 N-terminal inserts (0N, 4R; 1N, 4R; and 2N, 4R) are indicated on the right. 

Phrase: "Approximate positions of major isoforms of tau-4R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0733755:positions [Spatial Concept]

Phrase: "with 0,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2 N-terminal inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0813036:Inserts [Medical Device]
   779 E C0441587:Insert [Health Care Activity]
   779 E C1743766:Insert [Medical Device]
   779 E C1883719:Insert [Functional Concept]

Phrase: "(0N,"

Phrase: "4R"

Phrase: "; 1N,"

Phrase: "4R"

Phrase: ";"

Phrase: "and"

Phrase: "2N,"

Phrase: "4R"

Phrase: ")"

Phrase: "are"

Phrase: "indicated on the right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.153: Different exposure times were used to highlight the major issues as discussed throughout. 

Phrase: "Different exposure times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348485:Exposure Time [Quantitative Concept]
   827   C0040223:times [Temporal Concept]
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "highlight"

Phrase: "the major issues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033213:Issue [Finding]
   827   C1706387:Issue [Intellectual Product]

Phrase: "as"

Phrase: "discussed"

Phrase: "throughout."
Processing 00000000.tx.154: The high molecular weight bands are typical in tau-4R/2N mice and represent dimers of tau-4R/2N (16). 

Phrase: "The high molecular weight bands"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0175723:Bands [Medical Device]
   779 E C0439645:Band [Spatial Concept]
   779 E C1521913:band [Cell Component]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "are"

Phrase: "typical in tau-4R/2N mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3538928:Typical [Qualitative Concept]

Phrase: "and"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "dimers of tau-4R/2N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.155: B, typical clasping of the limbs when lifted by the tail is much less severe in tau-P301L mice, showing only partial retraction and still spreading of toes, as opposed to tau-4R/2N mice. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "typical clasping of the limbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1425051:CLASP [Gene or Genome]

Phrase: "when"

Phrase: "lifted by the tail"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   770   C0206244:Lifted [Activity]
   737 E C0181620:Lift [Medical Device]

Phrase: "is"

Phrase: "much less severe in tau-P301L mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205082:Severe [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only partial retraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332523:Retraction [Finding]
   827   C2825977:Retraction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "still"

Phrase: "spreading of toes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0040357:Toes [Body Part, Organ, or Organ Component]
   790   C0332261:Spreading [Qualitative Concept]
   756 E C1281589:Toe [Body Part, Organ, or Organ Component]
   756 E C1947932:Spread [Activity]

Phrase: "as"

Phrase: "opposed to tau-4R/2N mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
Processing 00000000.tx.156: Tau-KOKI never showed clasping even when very old. 

Phrase: "Tau-KOKI never"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "clasping even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425051:CLASP [Gene or Genome]

Phrase: "when"

Phrase: "very old."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0580836:Old [Temporal Concept]
Processing 00000000.tx.157: Mice depicted were 9 months. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "depicted"

Phrase: "were"

Phrase: "9 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.158: C, beam walk test of wild-type (WT), tau-P301L, tau-KOKI, and tau-4R/2N mice at the specified ages. 

Phrase: "C,"

Phrase: "beam walk test of wild-type (WT), tau-P301L,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0449570:Test type [Intellectual Product]
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]

Phrase: "tau-KOKI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "tau-4R/2N mice at the specified ages."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
Processing 00000000.tx.159: Values represent the number of mice that succeeded in staying on the beam for 3 min (yes or no score). 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the number of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "succeeded in staying"

Phrase: "on the beam"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338248:BEAM [Therapeutic or Preventive Procedure]
  1000   C2347880:Beam [Phenomenon or Process]

Phrase: "for 3 min (yes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1549445:Yes [Idea or Concept]
   827   C1705108:Yes [Conceptual Entity]

Phrase: "or"

Phrase: "no score"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:Score [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.160: The number of mice analyzed were as follows: at 3 months, n = 15, 6, 10, and 8; 

Phrase: "The number of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "at 3 months,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "n = 15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "6,"

Phrase: "10,"

Phrase: "and"

Phrase: "8"

Phrase: ";"
Processing 00000000.tx.161: at 6 months, n = 15, 8, 10, and 3; 

Phrase: "at 6 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "n = 15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "8,"

Phrase: "10,"

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ";"
Processing 00000000.tx.162: at 912 months, n = 18, 11, 10, and 8, respectively, for the four genotypes specified. 

Phrase: "at 912 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "n = 18,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "11,"

Phrase: "10,"

Phrase: "and"

Phrase: "8,"

Phrase: "respectively,"

Phrase: "for the four genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "specified."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]
Processing 00000000.tx.163: The asterisks denote significant difference with respect to age-matched nontransgenic mice (p < 0.01). 

Phrase: "The asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "denote"

Phrase: "significant difference with respect to age-matched nontransgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0699810:age difference [Age Group]
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.164: D, Rotarod test of wild-type, tau-P301L, tau-KOKI, and tau-4R/2N mice at the specified ages. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rotarod test of wild-type, tau-P301L,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1258024:Rotarod Test [Research Activity]
   774   C0449570:Test type [Intellectual Product]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]

Phrase: "tau-KOKI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "tau-4R/2N mice at the specified ages."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
Processing 00000000.tx.165: Values represent the time spent on the rotating rod (mean  S.E.). 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "spent on the rotating rod"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0206427:Rod [Cell]
   760   C0231458:rotating [Spatial Concept]
   760   C1552915:rod [Quantitative Concept]
   760   C1705186:Rod [Medical Device]
   760   C1947942:Rod [Spatial Concept]
   760   C2347970:rod [Quantitative Concept]
   760   C2347971:rod [Quantitative Concept]
   726   C0680968:spend [Quantitative Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ")."
Processing 00000000.tx.166: The number of mice analyzed was as follows: at 3 months, n = 9, 8, 10, and 5; 

Phrase: "The number of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "was"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "at 3 months,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "n = 9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "8,"

Phrase: "10,"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.167: at 912 months, n = 10, 9, 10, and 5, respectively, for the four genotypes specified. 

Phrase: "at 912 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "n = 10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "9,"

Phrase: "10,"

Phrase: "and"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "respectively,"

Phrase: "for the four genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "specified."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]
Processing 00000000.tx.168: The asterisks denote significant difference with respect to age-matched nontransgenic mice (p < 0.05). 

Phrase: "The asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "denote"

Phrase: "significant difference with respect to age-matched nontransgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0699810:age difference [Age Group]
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "(p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.169: E, immunohistochemistry with SMI-32 on saggital sections of trigeminal nucleus of 3-month-old mice of the specified genotypes (original magnification x40). 

Phrase: "E,"

Phrase: "immunohistochemistry with SMI-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "on saggital sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "of trigeminal nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040999:Trigeminal nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "of 3-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "of the specified genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "(original magnification x40"

Phrase: ")."
Processing 00000000.tx.170: Note the axonal dilatations or spheroids in tau-4R/2N mice, completely absent in tau-KOKI and tau-P301L mice.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "or"

Phrase: "spheroids in tau-4R/2N mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1844596:Spheroids [Finding]

Phrase: "completely absent in tau-KOKI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:Absent [Quantitative Concept]
   744   C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "tau-P301L mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.171: The tau-KOKI mice were bred homozygous for the recombined tau-locus so as to have expression of human tau-4R/2N only, and at levels that were similar to those of endogenous mouse tau in nontransgenic mice, but evidently without the isoform variety (Fig. 1A, right). 

Phrase: "The tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "bred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0006159:breed [Organism Function]
   966   C1704650:Breed [Classification]

Phrase: "homozygous for the recombined tau-locus so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019904:Homozygous [Organism Attribute]

Phrase: "as to"

Phrase: "have"

Phrase: "expression of human tau-4R/2N only,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and at levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0441889:Levels [Qualitative Concept]
   790   C1515981:And [Idea or Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "similar to those of endogenous mouse tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "in nontransgenic mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "but"

Phrase: "evidently without the isoform variety"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.172: mAb Tau-5 reacts with all human and mouse tau isoforms independent of their phosphorylation status and was used to estimate the total level of tau at about 4 times higher in tau-4R/2N and tau-P301L mice than in the tau-KOKI mice (Fig. 1A). 

Phrase: "mAb Tau-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "reacts with all human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse tau isoforms independent of their phosphorylation status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the total level of tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "at about 4 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "higher in tau-4R/2N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "tau-P301L mice than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "in the tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.173: Tau-4R/2N but Not Tau-P301L Caused Severe Motor Impairment and AxonopathyThe most conspicuous phenotypic aspect of tau-4R/2N mice was their severe motor defect, first observed as clasping, by caretakers in the home cages (Fig. 1B) (16). 

Phrase: "Tau-4R/2N"

Phrase: "but"

Phrase: "Not Tau-P301L"

Phrase: "Caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "Severe Motor Impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "AxonopathyThe most conspicuous phenotypic aspect of tau-4R/2N mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1547011:Aspect [Quantitative Concept]
   739   C1879746:Aspect [Qualitative Concept]

Phrase: "was"

Phrase: "their severe motor defect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1457869:Defect [Functional Concept]
   827   C1861101:DEFECT [Disease or Syndrome]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "observed as clasping,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441672:Observed [Functional Concept]
   756   C1425051:CLASP [Gene or Genome]

Phrase: "by caretakers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335350:caretakers [Professional or Occupational Group]

Phrase: "in the home cages"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0337189:cages [Manufactured Object]
   861   C0442519:Home [Conceptual Entity]
   827 E C0441239:Cage [Medical Device]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.174: The motoric deficit developed early in life (i.e. at about 68 weeks in heterozygous tau-4R/2N mice) and is caused by a progressing axonopathy, typified by numerous axonal dilatations (spheroids) in brain and spinal cord, followed by Wallerian degeneration and muscle wasting as studied extensively before (16). 

Phrase: "The motoric deficit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C0746626:motor deficit [Pathologic Function]
   861   C0162429:Deficit, NOS [Disease or Syndrome]
   861   C2987487:Deficit [Qualitative Concept]

Phrase: "developed"

Phrase: "early in life"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0376558:Life [Idea or Concept]
   827   C1279919:Early [Temporal Concept]
   743 E C0595998:lives [Finding]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at about 68 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439230:weeks [Temporal Concept]
   793 E C0332174:/week [Temporal Concept]

Phrase: "in heterozygous tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "caused by a progressing axonopathy,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205329:progressing [Functional Concept]
   726   C0015127:cause [Functional Concept]
   726 E C1272688:progress [Functional Concept]
   726 E C1280477:Progress [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "typified by numerous axonal dilatations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   760   C0012359:Dilatations [Pathologic Function]
   760   C0439064:Numerous [Quantitative Concept]

Phrase: "(spheroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1844596:Spheroids [Finding]

Phrase: ")"

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "followed by Wallerian degeneration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0043020:Wallerian Degeneration [Cell or Molecular Dysfunction]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "muscle wasting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0026846:Muscle wasting [Disease or Syndrome]
   861   C0026845:Muscle [Tissue]
   861   C0235394:Wasting [Disease or Syndrome]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "as"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "extensively before"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.175: Only old tau-P301L mice (912 months) typically retracted their hind limbs, and only some retracted all four limbs (Fig. 1B). 

Phrase: "Only old tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(912 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "typically"

Phrase: "retracted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332523:Retracted [Finding]
  1000   C3245508:retracted [Idea or Concept]

Phrase: "their hind limbs,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C1269079:Hind limb [Body Part, Organ, or Organ Component]
   861   C0015385:Limbs [Body Part, Organ, or Organ Component]
   861   C2983612:Hind [Spatial Concept]
   827 E C1280090:Limb [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "some"

Phrase: "retracted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332523:Retracted [Finding]
  1000   C3245508:retracted [Idea or Concept]

Phrase: "all four limbs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0015385:Limbs [Body Part, Organ, or Organ Component]
   827 E C1280090:Limb [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.176: This clasping occurred later in life and was different and less severe than in tau-4R/2N mice, which displayed this simple but clear phenotypic trait already at age 68 weeks (Fig. 1B) (16). 

Phrase: "This clasping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1425051:CLASP [Gene or Genome]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "later in life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "and"

Phrase: "was"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "less severe than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205082:Severe [Qualitative Concept]

Phrase: "in tau-4R/2N mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "which"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "this simple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205352:Simple [Qualitative Concept]

Phrase: "but"

Phrase: "clear phenotypic trait already at age 68 weeks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0599883:Trait [Organism Attribute]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.177: No motor problems were observed before age 6 months in tau-P301L mice when minor paresis of the hind limbs began to appear in some mice. 

Phrase: "No motor problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1546466:Problems [Idea or Concept]
   827 E C0033213:Problem [Finding]

Phrase: "were"

Phrase: "observed before age 6 months"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C1510828:Age-Months [Organism Attribute]
   760   C0001779:Age [Organism Attribute]
   760   C0439231:months [Temporal Concept]
   760   C1441672:Observed [Functional Concept]
   726 E C0439507:/month [Temporal Concept]

Phrase: "in tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "when"

Phrase: "minor paresis of the hind limbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030552:Paresis [Sign or Symptom]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "appear in some mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0700364:APPEAR [Qualitative Concept]
Processing 00000000.tx.178: This progressed with age in all tau-P301L mice to include also the forelimbs, so that around age 910 months, most tau-P301L mice showed moderate to severe decline in ambulation in the home cage. 

Phrase: "This"

Phrase: "progressed with age"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C1272688:progressed [Functional Concept]
   756 E C1280477:Progress [Functional Concept]

Phrase: "in all tau-P301L mice to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "also"

Phrase: "the forelimbs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016555:Forelimbs [Body Location or Region]
   966 E C1140618:Forelimb [Body Part, Organ, or Organ Component]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that around age 910 months,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C1510828:Age-Months [Organism Attribute]
   760   C0001779:Age [Organism Attribute]
   760   C0439231:months [Temporal Concept]
   726 E C0439507:/month [Temporal Concept]

Phrase: "most tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "moderate to severe decline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C1299393:Moderate to severe [Qualitative Concept]
           severe moderate
   770   C0205081:Moderate [Qualitative Concept]
   770   C1881878:Moderate [Qualitative Concept]

Phrase: "in ambulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0080331:Ambulation [Daily or Recreational Activity]
  1000   C0945826:Ambulation [Organism Function]

Phrase: "in the home cage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337189:Cage [Manufactured Object]
   861   C0441239:Cage [Medical Device]
   861   C0442519:Home [Conceptual Entity]
Processing 00000000.tx.179: They began to lose weight due to muscle and tissue wasting, and this moribund condition was terminal for all homozygous tau-P301L mice at 1113 months of age. 

Phrase: "They"

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lose"

Phrase: "weight due to muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005910:weight [Organism Attribute]
   770   C0043100:Weight [Quantitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1705104:Weight [Idea or Concept]

Phrase: "and"

Phrase: "tissue wasting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0235394:Wasting [Disease or Syndrome]

Phrase: "and"

Phrase: "this moribund condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was"

Phrase: "terminal for all homozygous tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "at 1113 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.180: The direct cause of death could not be determined on necropsy, nor by examination of old, terminally ill tau-P301L mice. 

Phrase: "The direct cause of death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0007465:Cause of Death [Finding]
           Death Cause
   862   C0804771:Cause of death [Clinical Attribute]
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "determined on necropsy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004398:Necropsy [Diagnostic Procedure]

Phrase: "nor by examination of old,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0028423:NOR [Geographic Area]
   760   C0028609:NOR [Cell Component]
   760   C0580836:Old [Temporal Concept]
   760   C1513854:NOR [Mammal]

Phrase: "terminally ill tau-P301L mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.181: Since only neurons express the transgene, but in all regions of the CNS, widespread neurodegeneration must be retained as the prime candidate. 

Phrase: "Since only neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "express"

Phrase: "the transgene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]

Phrase: "but in all regions of the CNS,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0927232:Central Nervous System [Body System]
   790   C1269563:Central nervous system [Body System]
   764   C0027763:Nervous System [Body System]
   764   C0422837:NERVOUS SYSTEM [Finding]
   764   C1269560:Nervous system [Body System]
   745   C0454907:Central region [Geographic Area]
   742   C0027769:Nervous [Sign or Symptom]
   742   C0205099:Central [Spatial Concept]
   742   C0233535:but [Mental or Behavioral Dysfunction]
   742   C0449913:System [Functional Concept]
   742   C0599851:Nervous [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   742   C1879652:Central - [Laboratory Procedure]
   709 E C0205494:Neurologic [Qualitative Concept]
   708   C0017446:Region [Geographic Area]
   708   C0205147:Region [Spatial Concept]

Phrase: "widespread neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "must"

Phrase: "be"

Phrase: "retained as the prime candidate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333118:Retained [Functional Concept]
   760   C0871133:prime [Functional Concept]
Processing 00000000.tx.182: The pronounced difference and age dependence of the motor deficit were measured by two objective tests (i.e. beam-walking and rotarod). 

Phrase: "The pronounced difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "age dependence of the motor deficit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "were"

Phrase: "measured by two objective tests"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0018017:Objective [Intellectual Product]
   760   C0022885:Tests [Laboratory Procedure]
   760   C0205448:Two [Quantitative Concept]
   760   C0392366:Tests [Intellectual Product]
   760   C0444706:Measured [Qualitative Concept]
   760   C1571702:Objective [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0039593:Test [Functional Concept]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(i.e. beam-walking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0080331:Walking [Daily or Recreational Activity]

Phrase: "and"

Phrase: "rotarod"

Phrase: ")."
Processing 00000000.tx.183: Both tests unequivocally confirmed that the original tau-4R/2N mice were the most early and the most severely affected; 

Phrase: "Both"

Phrase: "tests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:Tests [Intellectual Product]

Phrase: "unequivocally"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the original tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "the most early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "the most severely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205082:Severely [Qualitative Concept]
   861   C0205393:Most [Quantitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ";"
Processing 00000000.tx.184: no tau-4R/2N mouse was able to stay on the beam even at 3 months of age (Fig. 1C). 

Phrase: "no tau-4R/2N mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "stay on the beam even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0338248:BEAM [Therapeutic or Preventive Procedure]
   760   C2347880:Beam [Phenomenon or Process]

Phrase: "at 3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age (Fig. 1C"

Phrase: ")."
Processing 00000000.tx.185: Also on the rotarod, tau-4R/2N mice performed worst both at 3 and 9 months of age (Fig. 1D). 

Phrase: "Also on the rotarod,"

Phrase: "tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "worst"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1522166:Worst [Qualitative Concept]
   966 E C0205169:Bad [Qualitative Concept]
   966 E C0231218:Ill [Sign or Symptom]
   916 E C0221423:Illness [Finding]

Phrase: "both at 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "9 months of age (Fig. 1D"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C1510828:Age-Months [Organism Attribute]
   753   C0439231:months [Temporal Concept]
   719 E C0439507:/month [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.186: This contrasted sharply with the nearly normal rotarod performance of the tau-P301L mice; 

Phrase: "This contrasted sharply with the nearly normal rotarod performance"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0449900:contrasted [Diagnostic Procedure]
   742   C0597198:Performance [Individual Behavior]
   742   C1080058:This [Eukaryote]
   742   C1882330:Performance [Activity]
   742   C2347086:% Normal [Quantitative Concept]
   708 E C1979874:Contrast [Qualitative Concept]

Phrase: "of the tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.187: neither at 3 nor at 912 months were tau-P301L mice significantly impaired, neither during acquisition (not shown) nor in the final test (Fig. 1D). 

Phrase: "neither at 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "nor at 912 months"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0028423:NOR [Geographic Area]
   770   C0028609:NOR [Cell Component]
   770   C0439231:months [Temporal Concept]
   770   C1513854:NOR [Mammal]
   737 E C0439507:/month [Temporal Concept]

Phrase: "were"

Phrase: "tau-P301L mice significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: ","

Phrase: "neither during acquisition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1706701:Acquisition [Activity]
   790   C3274651:Neither [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "nor in the final test"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0022885:Test [Laboratory Procedure]
   760   C0028423:NOR [Geographic Area]
   760   C0028609:NOR [Cell Component]
   760   C0039593:Test [Functional Concept]
   760   C0205088:Final [Temporal Concept]
   760   C0392366:test [Intellectual Product]
   760   C1513854:NOR [Mammal]
   760   C1546485:Final [Idea or Concept]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.188: This clear difference between tau-4R/2N and tau-P301L mice was confirmed by the beam walk test at 3 and 6 months of age, revealing a deficit only in some of the oldest tau-P301L mice (Fig. 1C). 

Phrase: "This clear difference between tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "confirmed by the beam walk test"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0080331:Walk [Daily or Recreational Activity]
   753   C0338248:BEAM [Therapeutic or Preventive Procedure]
   753   C0392366:test [Intellectual Product]
   753   C0750484:Confirmed [Idea or Concept]
   753   C2347880:Beam [Phenomenon or Process]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "at 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "6 months of age,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]

Phrase: "revealing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:revealing [Qualitative Concept]

Phrase: "a deficit only in some of the oldest tau-P301L mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0162429:Deficit, NOS [Disease or Syndrome]
   738   C2987487:Deficit [Qualitative Concept]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.189: Both tests objectively extended the simple clasping test to demonstrate the pronounced difference in phenotypic repercussions of the mutant tau-4R/2N-P301L relative to the tau-4R/2N transgene. 

Phrase: "Both"

Phrase: "tests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:Tests [Intellectual Product]

Phrase: "objectively"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "the simple clasping test to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "demonstrate"

Phrase: "the pronounced difference in phenotypic repercussions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "of the mutant tau-4R/2N-P301L"

Phrase: "relative to the tau-4R/2N transgene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.190: The tau-KOKI mice did not show limb clasping when lifted by the tail at any age, even when very old (2 years) (Fig. 1B). 

Phrase: "The tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "limb clasping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425051:CLASP [Gene or Genome]

Phrase: "when"

Phrase: "lifted by the tail"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   770   C0206244:Lifted [Activity]
   737 E C0181620:Lift [Medical Device]

Phrase: "at any age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "even"

Phrase: "when"

Phrase: "very old (2 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.191: Nevertheless, tau-KOKI mice of 912 months were impaired in rotarod performance (Fig. 1D), whereas almost all tau-KOKI mice of 912 months and many already at 6 months failed the beam walk test (Fig. 1B). 

Phrase: "Nevertheless,"

Phrase: "tau-KOKI mice of 912 months"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C0206745:Knock-out Mice [Mammal]
   762   C1517676:Knock-in [Research Activity]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "impaired in rotarod performance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221099:Impaired [Functional Concept]
   770   C0597198:Performance [Individual Behavior]
   770   C0684336:Impaired [Pathologic Function]
   770   C1882330:Performance [Activity]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "almost"

Phrase: "all tau-KOKI mice of 912 months"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   777   C0206745:Knock-out Mice [Mammal]
   757   C1517676:Knock-in [Research Activity]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "many already at 6 months"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0439064:Many [Quantitative Concept]
   760   C0439231:months [Temporal Concept]
   760   C0747726:many [Conceptual Entity]
   726 E C0439507:/month [Temporal Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "the beam walk test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.192: These marked exterior phenotypic differences were underlined by the pathological analysis of brain and spinal cord. 

Phrase: "These marked exterior phenotypic differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "underlined by the pathological analysis of brain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0030664:Pathological [Biomedical Occupation or Discipline]
   748   C0936012:Analysis [Research Activity]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1521733:Pathological [Functional Concept]
   748   C1524024:analysis [Functional Concept]
   738   C0006119:Brain Pathology [Pathologic Function]

Phrase: "and"

Phrase: "spinal cord."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]
Processing 00000000.tx.193: The widespread abundance of axonal dilatations in the brain and spinal cord of tau-4R/2N mice was again evident (Fig. 1E) (16). 

Phrase: "The widespread abundance of axonal dilatations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346714:Abundance [Qualitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord of tau-4R/2N mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   788   C1522592:Mouse Spinal Cord [Tissue]
   778   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   778   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   748   C0521329:Spinal [Spatial Concept]
   748   C1550235:Cord [Body Part, Organ, or Organ Component]
   748   C1552938:cord [Quantitative Concept]
   748   C1706500:Cord [Manufactured Object]

Phrase: "was"

Phrase: "again evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "(Fig. 1E"

Phrase: ")"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.194: On the contrary, axonal dilatations were completely absent in brain and spinal cord of tau-P301L mice at any age (3, 6, and 912 months, n = 6 each), even when terminally ill. 

Phrase: "On the contrary,"

Phrase: "axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "were"

Phrase: "completely absent in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "spinal cord of tau-P301L mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1522592:Mouse Spinal Cord [Tissue]
   790   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   790   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   753   C0521329:Spinal [Spatial Concept]
   753   C1550235:Cord [Body Part, Organ, or Organ Component]
   753   C1552938:cord [Quantitative Concept]
   753   C1706500:Cord [Manufactured Object]

Phrase: "at any age (3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "6,"

Phrase: "and"

Phrase: "912 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "each"

Phrase: ")"

Phrase: ","

Phrase: "even"

Phrase: "when"

Phrase: "terminally ill."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039552:Terminally Ill [Patient or Disabled Group]
   861   C0231218:Ill [Sign or Symptom]
Processing 00000000.tx.195: Likewise, axonal dilatations were never observed in tau-KOKI mice (n = 32; analyzed at different ages, including eight mice of 1820 months). 

Phrase: "Likewise,"

Phrase: "axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "were"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "observed in tau-KOKI mice"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   793   C0206745:Knock-out Mice [Mammal]
   770   C0560617:knock out [Injury or Poisoning]
   770   C1522225:Knock-out [Experimental Model of Disease]
   767   C1517676:Knock-in [Research Activity]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0439787:Out [Spatial Concept]
   744   C0849355:Out [Qualitative Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]

Phrase: "(n = 32"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"

Phrase: "analyzed at different ages,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0699810:age difference [Age Group]
   770   C0001779:Age [Organism Attribute]
   770   C0936012:Analyzed [Research Activity]
   770   C1705242:Different [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "eight mice of 1820 months"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.196: Quantitative analysis of axonal dilatations in the trigeminal nucleus of tau-4R/2N mice at 3 months of age amounted to 25  5 dilatations/mm2 (mean  S.E., n = 3), whereas in aged-matched tau-KOKI and tau-P301L mice, no dilatations were present. 

Phrase: "Quantitative analysis of axonal dilatations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in the trigeminal nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040999:Trigeminal nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "of tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "at 3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "amounted to 25  5 dilatations/mm2 (mean"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   748   C0012359:Dilatations [Pathologic Function]
   748   C0444504:Mean [Quantitative Concept]
   748   C0456786:mm2 [Quantitative Concept]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   714   C1265611:Amount [Quantitative Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas in aged-matched tau-KOKI"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0560617:knock out [Injury or Poisoning]
   764   C1522225:Knock-out [Experimental Model of Disease]
   762   C1517676:Knock-in [Research Activity]
   742   C0001779:Aged [Organism Attribute]
   742   C0001792:Aged [Population Group]
   742   C0150103:matched [Research Activity]
   742   C0439787:Out [Spatial Concept]
   742   C0849355:Out [Qualitative Concept]
   742   C1708943:Matched [Qualitative Concept]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   742   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "no dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012356:Dilatations [Therapeutic or Preventive Procedure]
  1000   C0012359:Dilatations [Pathologic Function]

Phrase: "were"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.197: The combined data demonstrate that the severe motor deficit of the tau-4R/2N mice was related to the higher level of tau-4R/2N, whereas remarkably, even normal levels of tau-4R/2N in the tau-KOKI mice resulted in a motor deficit that was more pronounced than in tau-P301L mice. 

Phrase: "The combined data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the severe motor deficit of the tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0746626:motor deficit [Pathologic Function]
   739   C0162429:Deficit, NOS [Disease or Syndrome]
   739   C2987487:Deficit [Qualitative Concept]

Phrase: "was"

Phrase: "related to the higher level of tau-4R/2N,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   742   C0439849:Related [Qualitative Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   742   C2946261:Level [Pharmacologic Substance]
   708 E C0163712:Relate [Organic Chemical]
   708   C0205250:High [Qualitative Concept]
   708   C1299351:High [Qualitative Concept]
   708   C2700149:HIGH [Intellectual Product]

Phrase: "whereas"

Phrase: "remarkably,"

Phrase: "even normal levels of tau-4R/2N"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "resulted in a motor deficit"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0746626:motor deficit [Pathologic Function]
   760   C0162429:Deficit, NOS [Disease or Syndrome]
   760   C1513492:Motor [Functional Concept]
   760   C1705994:Motor [Manufactured Object]
   760   C2987487:Deficit [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "that"

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced than"

Phrase: "in tau-P301L mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.198: This can be due to the absence of the tau-3R isoforms but is more likely due to the fact that the level of tau-4R/2N is higher than in the brain of nontransgenic mice (Fig. 1, C and D), and, moreover, tau is present only in neurons due to the use of the thy1 gene promoter. 

Phrase: "This"

Phrase: "can"

Phrase: "be due to the absence of the tau-3R isoforms"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0332197:absence [Quantitative Concept]
   739   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   739   C1689985:Absence [Anatomical Abnormality]
   739   C1720655:Tau [Intellectual Product]
   739   C1947974:Tau [Research Activity]
   739   C2987476:Be [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]

Phrase: "but"

Phrase: "is"

Phrase: "more likely due to the fact"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0205172:More [Functional Concept]
   753   C0332148:Likely [Qualitative Concept]
   753   C0750492:Likely [Idea or Concept]
   753   C3146286:Due [Idea or Concept]

Phrase: "that"

Phrase: "the level of tau-4R/2N"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of nontransgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "and"

Phrase: ","

Phrase: "moreover,"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0027882:Neurons [Cell]
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "due to the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of the thy1 gene promoter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1420728:THY1 gene [Gene or Genome]
Processing 00000000.tx.199: The evident gene-dosage effect earmarks the wild-type human tau-4R/2N isoform as the cause of the motor deficit, itself manifested by the axonal dilatations (16) that are due to "clogging" of the axons by the excessive binding of tau-4R/2N to microtubules (17, 18). 

Phrase: "The evident gene-dosage effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]

Phrase: "earmarks"

Phrase: "the wild-type human tau-4R/2N isoform as the cause"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "of the motor deficit,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0746626:motor deficit [Pathologic Function]
   861   C0162429:Deficit, NOS [Disease or Syndrome]
   861   C2987487:Deficit [Qualitative Concept]

Phrase: "itself"

Phrase: "manifested by the axonal dilatations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1280444:Manifested by [Qualitative Concept]
           manifested
   760   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   760   C0012359:Dilatations [Pathologic Function]
   760   C0205319:manifested [Functional Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "that"

Phrase: "are due to ""clogging"" of the axons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0004461:Axons [Cell Component]
   748   C1551058:Are [Quantitative Concept]
   748   C3146286:Due [Idea or Concept]

Phrase: "by the excessive binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "of tau-4R/2N"

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.200: The P301L mutation prevented the tau-4R/2N isoform to cause axonal dilatations and to a large extent the motor deficit, most likely by its lesser affinity for binding to microtubules (37) allowing normal axonal transport (6). 

Phrase: "The P301L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the tau-4R/2N isoform to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "and to a large extent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1555602:Large extent [Qualitative Concept]
   760   C0439792:Extent [Spatial Concept]
   760   C0549177:Large [Quantitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "the motor deficit,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0746626:motor deficit [Pathologic Function]
   861   C0162429:Deficit, NOS [Disease or Syndrome]
   861   C2987487:Deficit [Qualitative Concept]

Phrase: "most likely by its lesser affinity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0750501:most likely [Idea or Concept]
   753   C0332148:Likely [Qualitative Concept]
   753   C0750492:Likely [Idea or Concept]

Phrase: "for binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "(37"

Phrase: ")"

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "normal axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0004462:Axonal Transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
   755   C0004461:Axon [Cell Component]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.201: Clearly, axonal dilatations are not a prerequisite for the mild motor deficit in either tau-KOKI or tau-P301L mice, but are the externalization of the severe axonopathy in tau-4R/2N mice. 

Phrase: "Clearly,"

Phrase: "axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a prerequisite for the mild motor deficit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679209:prerequisite [Idea or Concept]

Phrase: "in either tau-KOKI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   858   C1517676:Knock-in [Research Activity]

Phrase: "or"

Phrase: "tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "but"

Phrase: "are"

Phrase: "the externalization of the severe axonopathy"

Phrase: "in tau-4R/2N mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.202: It is envisaged that at lower expression levels, tau-4R/2N impairs transport in the longer axons of motor neurons, causing motor problems without axonal dilatations. 

Phrase: "It"

Phrase: "is"

Phrase: "envisaged"

Phrase: "that at lower expression levels,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "tau-4R/2N"

Phrase: "impairs"

Phrase: "transport in the longer axons of motor neurons,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C0178766:neuron transport [Cell Function]
   744   C0005528:Transport, NOS [Cell Function]
   744   C1317949:Transport [Manufactured Object]
   744   C3495449:transport [Medical Device]
   725   C0004462:Axonal Transport [Cell Function]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "motor problems without axonal dilatations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1546466:Problems [Idea or Concept]
   726 E C0033213:Problem [Finding]
Processing 00000000.tx.203: In fact, even in tau-4R/2N mice, the vast majority of neurons have normal axons and no dilatations. 

Phrase: "In fact,"

Phrase: "even in tau-4R/2N mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "the vast majority of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "have"

Phrase: "normal axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004461:Axons [Cell Component]

Phrase: "and"

Phrase: "no dilatations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012356:Dilatations [Therapeutic or Preventive Procedure]
  1000   C0012359:Dilatations [Pathologic Function]
Processing 00000000.tx.204: In the tau-P301L mice, the motor neurons probably become functionally impaired due to the aggregates of tau that eventually cause the minor motor impairment, as described and discussed further. 

Phrase: "In the tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "the motor neurons probably"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0026609:Motor Neurons [Cell]
   827   C0027882:Neurons [Cell]
   827   C1513492:Motor [Functional Concept]
   827   C1705994:Motor [Manufactured Object]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "become"

Phrase: "functionally"

Phrase: "impaired due to the aggregates of tau"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0205418:aggregates [Qualitative Concept]
   748   C0221099:Impaired [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   748   C3146286:Due [Idea or Concept]

Phrase: "that eventually"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the minor motor impairment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0684336:Impairment [Pathologic Function]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "discussed"

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.205: Tau-4R/2N Is More Phosphorylated than Tau-P301L in Brains of Young MiceSince the affinity of tau for microtubules depends on its phosphorylation, the brains of mice of the three genotypes were analyzed biochemically with antibodies specific for relevant phosphorylation sites on tau. 

Phrase: "Tau-4R/2N"

Phrase: "Is"

Phrase: "More"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "Phosphorylated than Tau-P301L"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "in Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of Young MiceSince"

Phrase: "the affinity of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "depends on its phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0725813:depend [Medical Device]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "the brains of mice of the three genotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0006104:Brains [Body Part, Organ, or Organ Component]
   734   C1521713:Mouse Brain [Tissue]
   711 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "biochemically with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for relevant phosphorylation sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0449604:Specific site [Spatial Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "on tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]
Processing 00000000.tx.206: We compared different groups of individual tau-KOKI and tau-P301L mice each to age-matched tau-4R/2N mice (representative analysis of three mice at age 3 months is shown in Fig. 2). 

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "different groups of individual tau-KOKI"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0441833:Group [Idea or Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1552516:Group [Health Care Related Organization]
   742   C1552839:groups [Idea or Concept]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "each to age-matched tau-4R/2N mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0001779:Age [Organism Attribute]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0150103:matched [Research Activity]
   744   C1457900:Each [Quantitative Concept]
   744   C1708943:Matched [Qualitative Concept]
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]

Phrase: "(representative analysis of three mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "at age 3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510828:Age-Months [Organism Attribute]
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "is"

Phrase: "shown in Fig. 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.207: Total levels of tau were determined by Western blotting with mAb Tau-5 that defines a stable epitope not affected by phosphorylation. 

Phrase: "Total levels of tau"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with mAb Tau-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "that"

Phrase: "defines"

Phrase: "a stable epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by phosphorylation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0392760:Affected [Functional Concept]
   790   C1158886:Phosphorylation [Molecular Function]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.208: This made already clear that the overall electrophoretic mobility of tau-4R/2N was slower than that of tau-P301L (Fig. 2, upper left; see also Fig. 1A), which must be attributed to post-translational modifications, mainly phosphorylation. 

Phrase: "This made already"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881534:Make [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "the overall electrophoretic mobility of tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0425245:Mobility [Finding]
   744   C0449580:Mobility [Qualitative Concept]

Phrase: "was"

Phrase: "slower than that of tau-P301L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0439834:Slow [Qualitative Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "upper left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205091:Left [Spatial Concept]
   861   C1552822:left [Functional Concept]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "also Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "must"

Phrase: "be"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "to post-translational modifications,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0033666:Post-Translational Modifications [Molecular Function]
   812   C0687676:Post [Temporal Concept]
   812   C1519614:Translational [Genetic Function]
   812   C1704687:Post [Manufactured Object]
   779   C0392747:Modification [Functional Concept]
   779   C1554963:modification [Qualitative Concept]
   741 E C0040712:Translation [Intellectual Product]
   741 E C0597295:translation [Molecular Function]
   741 E C1514253:Postal [Functional Concept]

Phrase: "mainly phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.209: View larger version (91K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(91K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.210: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.211: Phosphorylation of tau in brain of tau-4R/2N, tau-P301L, and tau-KOKI mice. 

Phrase: "Phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of tau-4R/2N,"

Phrase: "tau-P301L,"

Phrase: "and"

Phrase: "tau-KOKI mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.212: Shown is Western blotting for the phosphorylation-dependent epitopes specified, in extracts from three individual mice at age 3 months with the specified genotypes. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "Western blotting for the phosphorylation-dependent epitopes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   762 E C0949466:Western Blot [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]

Phrase: "specified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]

Phrase: ","

Phrase: "in extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "from three individual mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "at age 3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510828:Age-Months [Organism Attribute]
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "with the specified genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.213: For blotting with tau-5, AD2, and AT270, the equivalent of 0.4 g of brain protein was loaded per lane, whereas 4 g was loaded for detection with AT8 and AT180. 

Phrase: "For blotting"

Phrase: "with tau-5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "AD2,"

Phrase: "and"

Phrase: "AT270,"

Phrase: "the equivalent of 0.4 g of brain protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205163:Equivalent [Qualitative Concept]
   742   C0439185:equivalent [Quantitative Concept]

Phrase: "was"

Phrase: "loaded per lane,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708639:Lane [Spatial Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "whereas"

Phrase: "4 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "loaded for detection"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "with AT8"

Phrase: "and"

Phrase: "AT180."
Processing 00000000.tx.214: For the tau-KOKI mice, 4 times more protein was loaded per lane. 

Phrase: "For the tau-KOKI mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "4 times more protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "loaded per lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708639:Lane [Spatial Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.215: Different exposure times were used for the different antibodies. 

Phrase: "Different exposure times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348485:Exposure Time [Quantitative Concept]
   827   C0040223:times [Temporal Concept]
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "were"

Phrase: "used for the different antibodies."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1273517:used [Finding]
   760   C1705242:Different [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.216: Apparent molecular mass is indicated on the right in kDa.  

Phrase: "Apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "is"

Phrase: "indicated on the right"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C1444656:Indicated [Finding]

Phrase: "in kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.217: All phosphorylation-dependent epitopes were detected in all mice, but the brains of tau-P301L mice contained consistently less phosphorylated tau at 3 months of age than age-matched tau-4R/2N mice (Fig. 2, left). 

Phrase: "All phosphorylation-dependent epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]

Phrase: "were"

Phrase: "detected in all mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "the brains of tau-P301L mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   750   C1521713:Mouse Brain [Tissue]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "consistently less phosphorylated tau at 3 months of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C2362079:TAU 3 [Immunologic Factor]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]

Phrase: "than age-matched tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.218: This was most conspicuous for AT8 and AT180 epitopes (Fig. 2), whereas no immunoreactivity was observed by Western blotting with mAb AT100, defining a typical disease-associated epitope, in brain extracts of young mice of any genotype at 3 months of age. 

Phrase: "This"

Phrase: "was"

Phrase: "most conspicuous for AT8"

Phrase: "and"

Phrase: "AT180 epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "no immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "observed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1441672:Observed [Functional Concept]
   770   C1705493:Western [Spatial Concept]

Phrase: "with mAb AT100,"

Phrase: "defining"

Phrase: "a typical disease-associated epitope,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003316:Epitope [Immunologic Factor]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "extracts of young mice of any genotype"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017431:Genotype [Organism Attribute]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0332239:Young [Temporal Concept]
   748   C2828366:Extract [Substance]

Phrase: "at 3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.219: For comparison of tau-KOKI with tau-4R/2N mice, 4 times more brain protein extract was loaded from the tau-KOKI mice to compensate for the lower expression of tau-4R/2N (Fig. 2, right; compare also with Fig. 1A). 

Phrase: "For comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "of tau-KOKI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: "with tau-4R/2N mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "4 times more brain protein extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "loaded from the tau-KOKI mice to"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   777   C0206745:Knock-out Mice [Mammal]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1522225:Knock-out [Experimental Model of Disease]
   757   C1517676:Knock-in [Research Activity]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0439787:Out [Spatial Concept]
   739   C0849355:Out [Qualitative Concept]
   739   C1708715:Loaded [Activity]
   739   C1720655:Tau [Intellectual Product]
   739   C1947974:Tau [Research Activity]
   706 E C1550025:Load [Idea or Concept]
   706 E C1704782:Load [Manufactured Object]

Phrase: "compensate for the lower expression of tau-4R/2N"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205432:compensate [Qualitative Concept]
   742   C0441994:Lower [Spatial Concept]
   742   C1548802:Lower [Body Location or Region]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   742   C2003888:Lower [Activity]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ";"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "also with Fig. 1A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0349966:Fig [Food]
   770   C0450344:1A [Intellectual Product]
   770   C1337208:FIG [Food]
   770   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.220: No marked differences were observed in reaction with any of the mAbs (Fig. 2, right), demonstrating that the relative phosphorylation of tau-4R/2N in the tau-KOKI mice was very similar to that in the tau-4R/2N mice when normalized for the difference in expression. 

Phrase: "No marked differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed in reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443286:Reaction [Functional Concept]
   790   C1114821:Reaction [Clinical Attribute]
   790   C1441672:Observed [Functional Concept]

Phrase: "with any"

Phrase: "of the mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the relative phosphorylation of tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "in the tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "very similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in the tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "when"

Phrase: "normalized for the difference"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]
   770   C1882115:Normalized [Research Activity]

Phrase: "in expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.221: Tau-P301L but Not Tau-4R/2N Becomes Hyperphosphorylated and Sarkosyl-insoluble with AgingSince, somewhat unexpectedly, tau-P301L appeared underphosphorylated at a young age, we analyzed biochemically in more detail the progression and the distribution of phosphorylated tau with age. 

Phrase: "Tau-P301L"

Phrase: "but"

Phrase: "Not Tau-4R/2N"

Phrase: "Becomes"

Phrase: "Hyperphosphorylated"

Phrase: "and"

Phrase: "Sarkosyl-insoluble with AgingSince,"

Phrase: "somewhat unexpectedly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2984079:Somewhat [Intellectual Product]

Phrase: "tau-P301L"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "underphosphorylated at a young age,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "biochemically in more detail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "the progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "the distribution of phosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "with age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.222: The progressive phosphorylation of tau with age was analyzed by Western blotting with a panel of monoclonal antibodies on total homogenates of brain from individual mice of each genotype at 3, 6, and 9 months of age. 

Phrase: "The progressive phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with a panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "of monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "on total homogenates"

Phrase: "of brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from individual mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "of each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "at 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "9 months of age."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.223: Surprisingly, aging affected phosphorylation of tau mainly in the tau-P301L mice, both in the brain and spinal cord (Fig. 3A, left), whereas practically no changes were observed in tau-4R/2N (Fig. 3, A (right) and B, and results not shown) and tau-KOKI mice within this time frame (results not shown). 

Phrase: "Surprisingly,"

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "affected phosphorylation of tau mainly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "in the tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "both in the brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0238767:Both [Spatial Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "(Fig. 3A,"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "practically"

Phrase: "no changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "observed in tau-4R/2N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1441672:Observed [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A (right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "tau-KOKI mice within this time frame"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   777   C0206745:Knock-out Mice [Mammal]
   757   C1517676:Knock-in [Research Activity]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.224: Besides the distinct increased AT8 reactivity, the very prominent appearance of the AT100 epitope was conspicuous in brain of all old tau-P301L mice (>9 months) (Fig. 3A). 

Phrase: "Besides the distinct increased AT8 reactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   741   C0205332:Reactive [Qualitative Concept]

Phrase: "the very prominent appearance of the AT100 epitope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0233426:Appearance [Organism Attribute]
   744   C0700364:Appearance [Qualitative Concept]

Phrase: "was"

Phrase: "conspicuous in brain of all old tau-P301L mice"

Phrase: "("

Phrase: ">9 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.225: The AT100 epitope was carried largely by the slowest migrating tau subspecies that also carried AT8 and to a lesser extent AT180, AT270, and AD2 epitopes (Fig. 3A, arrowheads). 

Phrase: "The AT100 epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "largely by the slowest migrating tau subspecies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0232902:migrating [Functional Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1883207:Subspecies [Conceptual Entity]
   748   C1947974:Tau [Research Activity]
   714   C0439834:Slow [Qualitative Concept]

Phrase: "that also carried AT8"

Phrase: "and to a lesser extent AT180,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439792:Extent [Spatial Concept]
   753   C0547044:Lesser [Qualitative Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "AT270,"

Phrase: "and"

Phrase: "AD2 epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "(Fig. 3A,"

Phrase: "arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.226: View larger version (61K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(61K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.227: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.228: Progression with age of phosphorylation-dependent epitopes in brain of tau-P301L and tau-4R/2N mice. 

Phrase: "Progression with age of phosphorylation-dependent epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of tau-P301L"

Phrase: "and"

Phrase: "tau-4R/2N mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.229: A, Western blotting of brain extracts from tau-P301L mice (right) and tau-4R/2N mice (left) with Tau-5, AD2, AT8, AT180, AT270, and AT100. 

Phrase: "A,"

Phrase: "Western blotting of brain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "extracts from tau-P301L mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   760   C2828366:Extract [Substance]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "with Tau-5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "AD2,"

Phrase: "AT8,"

Phrase: "AT180,"

Phrase: "AT270,"

Phrase: "and"

Phrase: "AT100."
Processing 00000000.tx.230: The equivalent of 0.4 g of protein was loaded per lane for detection with Tau-5, AD2, and AT270, whereas 4 g was loaded for detection with AT8, AT100, and AT180. 

Phrase: "The equivalent of 0.4 g of protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205163:Equivalent [Qualitative Concept]
   744   C0439185:equivalent [Quantitative Concept]

Phrase: "was"

Phrase: "loaded per lane"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708639:Lane [Spatial Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "for detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "with Tau-5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "AD2,"

Phrase: "and"

Phrase: "AT270,"

Phrase: "whereas"

Phrase: "4 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "loaded for detection"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "with AT8,"

Phrase: "AT100,"

Phrase: "and"

Phrase: "AT180."
Processing 00000000.tx.231: Shown are data for four and 34 individual tau-P301L and tau-4R/2N mice, respectively, for each specified age. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "data for four"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "34 individual tau-P301L"

Phrase: "and"

Phrase: "tau-4R/2N mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "respectively,"

Phrase: "for each specified age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]
Processing 00000000.tx.232: Since results for the left and right panels were not obtained at the same time, samples for 9-month-old tau-P301L mice were loaded twice for reference. 

Phrase: "Since"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711239:Since [Temporal Concept]

Phrase: "results for the left"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205091:Left [Spatial Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1552822:left [Functional Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "obtained at the same time,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C3541383:Time [Temporal Concept]
   726 E C1706701:Obtain [Activity]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "samples for 9-month-old tau-P301L mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "twice for reference."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.233: B, Western blotting with AT8 and AT100 of the specified fractions isolated from spinal cords of tau-P301L mice 3 and 9 months old. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Western blotting with AT8"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "AT100 of the specified fractions"

Phrase: "isolated from spinal cords of tau-P301L mice 3"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   764   C0037925:Spinal Cords [Body Part, Organ, or Organ Component]
   762   C2362079:TAU 3 [Immunologic Factor]
   751   C1522592:Mouse Spinal Cord [Tissue]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0521329:Spinal [Spatial Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   731 E C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   708 E C0370215:Isolate [Substance]
   708   C1550235:Cord [Body Part, Organ, or Organ Component]
   708   C1552938:cord [Quantitative Concept]
   708   C1706500:Cord [Manufactured Object]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "9 months old."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]
Processing 00000000.tx.234: For homogenate, cytosol, Sarkosyl-soluble, and Sarkosyl-insoluble fraction, 36, 36, 14.4, and 36 g, respectively, of the original tissue weight was loaded per lane. 

Phrase: "For homogenate,"

Phrase: "cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "Sarkosyl-soluble,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "Sarkosyl-insoluble fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "36,"

Phrase: "36,"

Phrase: "14.4,"

Phrase: "and"

Phrase: "36 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "respectively,"

Phrase: "of the original tissue weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1705104:Weight [Idea or Concept]

Phrase: "was"

Phrase: "loaded per lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708639:Lane [Spatial Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.235: In both panels, the arrowheads indicate the position of the hyperphosphorylated tau referred to throughout.  

Phrase: "In both panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "the arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "indicate"

Phrase: "the position of the hyperphosphorylated tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to throughout."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]
Processing 00000000.tx.236: Fractionation of the CNS of tau-P301L mice demonstrated that mainly the Sarkosyl-insoluble fractions were enriched in phosphoepitopes and that AT8 and AT100 epitopes appeared nearly exclusively in this fraction (Fig. 3B). 

Phrase: "Fractionation of the CNS of tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0016640:fractionation [Laboratory Procedure]
   739   C0524811:fractionation [Therapeutic or Preventive Procedure]
   739   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "demonstrated"

Phrase: "that mainly"

Phrase: "the Sarkosyl-insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "enriched in phosphoepitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0359583:enriched [Food]

Phrase: "and"

Phrase: "that AT8"

Phrase: "and"

Phrase: "AT100 epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "nearly exclusively in this fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.237: Since these epitopes are very typical and pathologically carried by tau present in paired helical filaments and neurofibrillary tangles, we further extended the fractionation analysis. 

Phrase: "Since"

Phrase: "these epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitopes [Immunologic Factor]

Phrase: "are"

Phrase: "very typical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538928:Typical [Qualitative Concept]

Phrase: "and"

Phrase: "pathologically"

Phrase: "carried by tau present"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0150312:Present [Quantitative Concept]
   770   C0206243:carried [Activity]
   770   C0449450:Present [Idea or Concept]
   770   C0699809:carried [Finding]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "in paired helical filaments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C1709450:Paired [Qualitative Concept]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "and"

Phrase: "neurofibrillary tangles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "we further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "the fractionation analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.238: Cytosol and Sarkosyl-soluble and -insoluble fractions were prepared from brains of tau-P301L, tau-4R/2N, and tau-KOKI mice and spinal cord of tau-P301L and tau-4R/2N mice, all age-matched at 3 and 9 months. 

Phrase: "Cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "Sarkosyl-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "and -"

Phrase: "insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "prepared from brains of tau-P301L,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]
   719   C1521827:Prepare [Functional Concept]

Phrase: "tau-4R/2N,"

Phrase: "and"

Phrase: "tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "spinal cord of tau-P301L"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   806   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   760   C0521329:Spinal [Spatial Concept]
   760   C1550235:Cord [Body Part, Organ, or Organ Component]
   760   C1552938:cord [Quantitative Concept]
   760   C1706500:Cord [Manufactured Object]

Phrase: "and"

Phrase: "tau-4R/2N mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "all age-matched at 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1708943:Matched [Qualitative Concept]

Phrase: "and"

Phrase: "9 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.239: The level of human tau in the fractions was defined by Western blotting with mAb HT7 that is specific for human tau (Fig. 4). 

Phrase: "The level of human tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "defined by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1704788:Defined [Conceptual Entity]
   770   C1705493:Western [Spatial Concept]
   770   C3539106:Defined [Intellectual Product]

Phrase: "with mAb HT7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450571:HT7 [Body Location or Region]

Phrase: "that"

Phrase: "is"

Phrase: "specific for human tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.240: Besides tau, an unknown protein was detected with HT7 mainly in the Sarkosyl-soluble fraction in all mice, independent of age and genotype (Fig. 4A, large arrow). 

Phrase: "Besides tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "an unknown protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected with HT7 mainly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C0450571:HT7 [Body Location or Region]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in the Sarkosyl-soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "in all mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "independent of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "large arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.241: Since this protein was not detected with Tau-5 or with any of the other mAbs, it is neither human nor mouse protein tau and was not considered further. 

Phrase: "Since"

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected with Tau-5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "or with any of the"

Phrase: "other mAbs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "it"

Phrase: "is"

Phrase: "neither human nor mouse protein tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1421563:protein tau [Gene or Genome]
   804   C1720655:Tau [Intellectual Product]
   804   C1947974:Tau [Research Activity]
   708   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.242: View larger version (39K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.243: 4. 

Phrase: "4."
Processing 00000000.tx.244: Fractionation of brain and spinal cord of tau-P301L, tau-KOKI, and tau-4R/2N mice. 

Phrase: "Fractionation of brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016640:fractionation [Laboratory Procedure]
   790   C0524811:fractionation [Therapeutic or Preventive Procedure]
   790   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "spinal cord of tau-P301L,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   806   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   760   C0521329:Spinal [Spatial Concept]
   760   C1550235:Cord [Body Part, Organ, or Organ Component]
   760   C1552938:cord [Quantitative Concept]
   760   C1706500:Cord [Manufactured Object]

Phrase: "tau-KOKI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "tau-4R/2N mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.245: Shown is Western blotting with human tau-specific mAb HT7 of the specified fractions of brain (A) and spinal cord (B) from mice with the specified genotype at 3 and 9 months of age, as indicated. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "Western blotting with human tau-specific mAb HT7 of the specified fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   736 E C0949466:Western Blot [Laboratory Procedure]
   736   C1705493:Western [Spatial Concept]

Phrase: "of brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(A)"

Phrase: "and"

Phrase: "spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "(B) from mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "with the specified genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "at 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "9 months of age,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.246: Different amounts of homogenate, cytosol, Sarkosyl-soluble fraction, and Sarkosyl-insoluble fraction were loaded of forebrain (i.e. 3.6-, 3.6-, 14.4-, and 72-g equivalents, respectively) of the original brain weight per lane. 

Phrase: "Different amounts of homogenate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "Sarkosyl-soluble fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "Sarkosyl-insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "loaded of forebrain"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "(i.e. 3.6-,"

Phrase: "3.6-,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442759:3 6 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "14.4-,"

Phrase: "and"

Phrase: "72-g equivalents,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439185:Equivalents [Quantitative Concept]
   793 E C0205163:Equivalent [Qualitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "of the original brain weight"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0870228:brain weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0043100:Weight [Quantitative Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1705104:Weight [Idea or Concept]

Phrase: "per lane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.247: For spinal cord, identical amounts were loaded. 

Phrase: "For spinal cord,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "identical amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "loaded."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.248: Apparent molecular mass is indicated on the left in kDa. 

Phrase: "Apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "is"

Phrase: "indicated on the left"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]

Phrase: "in kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.249: In A, the arrow points to the unidentified cross-reacting protein in the Sarkosyl-soluble fraction also present in the equivalent spinal cord fraction. 

Phrase: "In A,"

Phrase: "the arrow points to the unidentified cross-reacting protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1552961:Point [Quantitative Concept]
   708   C2347617:point [Quantitative Concept]

Phrase: "in the Sarkosyl-soluble fraction also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: "present in the equivalent spinal cord fraction."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   778   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   748   C0150312:Present [Quantitative Concept]
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0439185:equivalent [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
   748   C0521329:Spinal [Spatial Concept]
   748   C1264633:Fraction [Quantitative Concept]
   748   C1550235:Cord [Body Part, Organ, or Organ Component]
   748   C1552938:cord [Quantitative Concept]
   748   C1554103:Fraction [Idea or Concept]
   748   C1706500:Cord [Manufactured Object]
Processing 00000000.tx.250: The arrowhead points to the slowest migrating tau species in the Sarkosyl-insoluble fraction.  

Phrase: "The arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: "points to the slowest migrating tau species"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0232902:migrating [Functional Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   748   C2347617:point [Quantitative Concept]
   714   C0439834:Slow [Qualitative Concept]

Phrase: "in the Sarkosyl-insoluble fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.251: Most conspicuous were the electrophoretically slow tau forms detected in the Sarkosyl-insoluble fraction from the spinal cords (Fig. 4B) and from the brains (Fig. 4A, arrowhead) of old tau-P301L mice, which were immunohistochemically shown to contain neurofibrillary tangles (see below). 

Phrase: "Most conspicuous"

Phrase: "were"

Phrase: "the electrophoretically slow tau forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]

Phrase: "detected in the Sarkosyl-insoluble fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0074071:sarkosyl [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0442726:Detected [Finding]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "from the spinal cords"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0037925:Spinal Cords [Body Part, Organ, or Organ Component]
   966 E C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   827   C1550235:Cord [Body Part, Organ, or Organ Component]
   827   C1552938:cord [Quantitative Concept]
   827   C1706500:Cord [Manufactured Object]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: "and from the brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "of old tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "which"

Phrase: "were"

Phrase: "immunohistochemically"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.252: These tau species were never observed in extracts of tau-4R/2N and tau-KOKI mice (Fig. 4, A and B) and are therefore the biochemical equivalent of the aggregated tau in tangle-bearing neurons. 

Phrase: "These tau species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "observed in extracts of tau-4R/2N"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1441672:Observed [Functional Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   714   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "therefore"

Phrase: "the biochemical equivalent of the aggregated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0439185:equivalent [Quantitative Concept]

Phrase: "in tangle-bearing neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.253: The close similarity of the pattern in fractions of brain and spinal cord of tau-4R/2N and tau-P301L mice also demonstrates that functionally widely divergent neurons in different regions of the CNS reacted similarly but distinctively to each transgene. 

Phrase: "The close similarity of the pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similarity [Qualitative Concept]

Phrase: "in fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "of brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord of tau-4R/2N"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   790   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   753   C0521329:Spinal [Spatial Concept]
   753   C1550235:Cord [Body Part, Organ, or Organ Component]
   753   C1552938:cord [Quantitative Concept]
   753   C1706500:Cord [Manufactured Object]

Phrase: "and"

Phrase: "tau-P301L mice also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "demonstrates"

Phrase: "that functionally widely divergent neurons in different regions of the CNS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0027882:Neurons [Cell]
   732   C0682701:Central neuron [Cell]

Phrase: "reacted"

Phrase: "similarly"

Phrase: "but"

Phrase: "distinctively to each transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.254: This is an important finding, since it demonstrates that the molecular characteristics of each tau species (tau-4R/2N and tau-P301L) are actually the major determinants for each distinctive response (axonopathy or tauopathy). 

Phrase: "This"

Phrase: "is"

Phrase: "an important finding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "since"

Phrase: "it"

Phrase: "demonstrates"

Phrase: "that"

Phrase: "the molecular characteristics of each tau species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "(tau-4R/2N"

Phrase: "and"

Phrase: "tau-P301L"

Phrase: ")"

Phrase: "are"

Phrase: "actually"

Phrase: "the major determinants for each distinctive response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1521761:Determinant [Functional Concept]

Phrase: "(axonopathy"

Phrase: "or"

Phrase: "tauopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathy [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.255: Pathological Epitopes on Tau-P301L but Not on Tau-4R/2N Accumulate in Somata in Old MiceMice of all genotypes were analyzed immunohistochemically for tau phosphoepitopes. 

Phrase: "Pathological Epitopes on Tau-P301L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003316:Epitopes [Immunologic Factor]

Phrase: "but"

Phrase: "Not on Tau-4R/2N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1518422:Not [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "Accumulate in Somata"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C0599444:soma [Cell Component]
   756   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   718 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "in Old MiceMice"

Phrase: "of all genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "immunohistochemically for tau phosphoepitopes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.256: In both tau-4R/2N and tau-P301L mice, immunoreactivity with AT180, AT270, and AD2 was present in neurons in brain and spinal cord in a pattern similar to that with HT7, but less intense and mainly confined to the somatodendritic compartment (results not shown). 

Phrase: "In both tau-4R/2N"

Phrase: "and"

Phrase: "tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "immunoreactivity with AT180,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597879:immunoreactivity [Molecular Function]

Phrase: "AT270,"

Phrase: "and"

Phrase: "AD2"

Phrase: "was"

Phrase: "present in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord in a pattern"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   806   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   760   C0521329:Spinal [Spatial Concept]
   760   C1550235:Cord [Body Part, Organ, or Organ Component]
   760   C1552938:cord [Quantitative Concept]
   760   C1706500:Cord [Manufactured Object]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "with HT7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450571:HT7 [Body Location or Region]

Phrase: "but"

Phrase: "less intense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intense [Qualitative Concept]

Phrase: "and"

Phrase: "mainly"

Phrase: "confined to the somatodendritic compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.257: mAb AT8 highlighted the most marked difference between tau-4R/2N and tau-P301L mice, staining mainly the neuropil in tau-4R/2N mice (Fig. 5A, e and f) as opposed to the somatodendritic compartments of neurons in tau-P301L mice (Fig. 5A, c and d). 

Phrase: "mAb AT8"

Phrase: "highlighted"

Phrase: "the most marked difference between tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "mainly"

Phrase: "the neuropil in tau-4R/2N mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0228081:Neuropil [Cell Component]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "e"

Phrase: "and"

Phrase: "f)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "as"

Phrase: "opposed to the somatodendritic compartments of neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0027882:Neurons [Cell]
   748   C1185625:Compartments [Body Space or Junction]
   748   C1382196:Compartments [Natural Phenomenon or Process]
   714 E C2986730:Compartment [Spatial Concept]

Phrase: "in tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "c"

Phrase: "and"

Phrase: "d)."
Processing 00000000.tx.258: In old tau-P301L mice, reactivity with AT8 and also AD2 was more intense in neurons scattered throughout the cortex and the zona incerta of the thalamus, in brain stem, in deep nuclei of the cerebellum, and in spinal cord. 

Phrase: "In old tau-P301L mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "reactivity with AT8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "also AD2"

Phrase: "was"

Phrase: "more intense in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intense [Qualitative Concept]

Phrase: "scattered throughout the cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C0439742:Scattered [Spatial Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "the zona incerta of the thalamus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0152350:Zona Incerta [Body Part, Organ, or Organ Component]
   790   C1289613:Zona incerta [Body Part, Organ, or Organ Component]
   753   C0019360:Zona [Disease or Syndrome]

Phrase: "in brain stem,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in deep nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]

Phrase: "of the cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "and in spinal cord."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   833   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   770   C0521329:Spinal [Spatial Concept]
   770   C1515981:And [Idea or Concept]
   770   C1550235:Cord [Body Part, Organ, or Organ Component]
   770   C1552938:cord [Quantitative Concept]
   770   C1706500:Cord [Manufactured Object]
Processing 00000000.tx.259: This was observed already in some tau-P301L mice at 6 months of age while prominent in all old tau-P301L mice (Fig. 5A). 

Phrase: "This"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "already in some tau-P301L mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "at 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "while"

Phrase: "prominent in all old tau-P301L mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205402:Prominent [Qualitative Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.260: View larger version (159K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(159K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.261: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.262: Somatodendritic relocalization of hyperphosphorylated tau in tau-P301L mice with age. 

Phrase: "Somatodendritic relocalization of hyperphosphorylated tau"

Phrase: "in tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "with age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.263: A, AT8-immunoreactive neurons in cortex (a, c, and e) and brain stem (b, d, and f) of tau-P301L mice at 6 months (a and b) and 9 months (c and d) and of tau-4R/2N mouse at 9 months (e and f). 

Phrase: "A,"

Phrase: "AT8-immunoreactive neurons in cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "("

Phrase: "a,"

Phrase: "c,"

Phrase: "and"

Phrase: "e)"

Phrase: "and"

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "f) of tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   760   C0439133:(f) [Intellectual Product]
   760   C1553038:[f] [Quantitative Concept]

Phrase: "at 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "("

Phrase: "a"

Phrase: "and"

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "9 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "(c"

Phrase: "and"

Phrase: "d)"

Phrase: "and of tau-4R/2N mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1515981:And [Idea or Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "at 9 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "(e"

Phrase: "and"

Phrase: "f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.264: B, AP422 (a and b) and AT100 (cf) immunoreactive neurons in cortex (a, c, and e) and brain stem (b, d, and f) of tau-P301L mouse (ad) and tau-4R/2N mouse (e and f) at 9 months of age. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "AP422"

Phrase: "("

Phrase: "a"

Phrase: "and"

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "AT100"

Phrase: "(cf) immunoreactive neurons in cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "("

Phrase: "a,"

Phrase: "c,"

Phrase: "and"

Phrase: "e)"

Phrase: "and"

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "f) of tau-P301L mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   760   C0439133:(f) [Intellectual Product]
   760   C1553038:[f] [Quantitative Concept]

Phrase: "(ad)"

Phrase: "and"

Phrase: "tau-4R/2N mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "(e"

Phrase: "and"

Phrase: "f) at 9 months of age."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.265: Saggital sections were used. 

Phrase: "Saggital sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.266: Original magnifications were x40.  

Phrase: "Original magnifications"

Phrase: "were"

Phrase: "x40."
Processing 00000000.tx.267: The pathological AT100, AP422, and PG5 epitopes were also confined mainly to the neuronal soma of all old tau-P301L mice, while detectable also in some 6-month-old tau-P301L mice (Fig 5B, ad). 

Phrase: "The pathological AT100,"

Phrase: "AP422,"

Phrase: "and"

Phrase: "PG5 epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "were"

Phrase: "also"

Phrase: "confined"

Phrase: "mainly to the neuronal soma of all old tau-P301L mice,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0599444:Soma of neuron [Cell Component]
           soma
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0521390:Neuronal [Immunologic Factor]
   738   C0580836:Old [Temporal Concept]
   738   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   738   C1720655:Tau [Intellectual Product]
   738   C1947974:Tau [Research Activity]
   714   C2952302:Neuronal somata [Cell Component]

Phrase: "while"

Phrase: "detectable also in some 6-month-old tau-P301L mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0439231:month [Temporal Concept]
   739   C0439507:/month [Temporal Concept]
   739   C0580836:Old [Temporal Concept]
   739   C1720655:Tau [Intellectual Product]
   739   C1947974:Tau [Research Activity]

Phrase: "(Fig 5B,"

Phrase: "ad"

Phrase: ")."
Processing 00000000.tx.268: Reaction with AT100, AP422, and PG5 was completely absent in tau-4R/2N mice (Fig. 5B, e and f, and results not shown), whereas none of the antibodies reacted appreciably with brain or spinal cord from tau-KOKI mice or from non-transgenic mice (results not shown). 

Phrase: "Reaction with AT100,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443286:Reaction [Functional Concept]
   790   C1114821:Reaction [Clinical Attribute]

Phrase: "AP422,"

Phrase: "and"

Phrase: "PG5"

Phrase: "was"

Phrase: "completely absent in tau-4R/2N mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:Absent [Quantitative Concept]
   748   C2699517:ABSENT [Finding]

Phrase: "(Fig. 5B,"

Phrase: "e"

Phrase: "and"

Phrase: "f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "none of the antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "reacted"

Phrase: "appreciably with brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "spinal cord from tau-KOKI mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C1522592:Mouse Spinal Cord [Tissue]
   764   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   764   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   742   C0521329:Spinal [Spatial Concept]
   742   C1550235:Cord [Body Part, Organ, or Organ Component]
   742   C1552938:cord [Quantitative Concept]
   742   C1706500:Cord [Manufactured Object]

Phrase: "or from non-transgenic mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0025936:Mice, Transgenic [Mammal]
   781   C1513853:NON Mouse [Mammal]
   760   C0003069:Transgenic [Animal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1518422:Non [Functional Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.269: The histochemical analysis extends the biochemical data on hyperphosphorylated tau accumulation in tau-P301L mice and not in tau-4R/2N mice, with the extra information on the subcellular localization (i.e. concentration into the somato-dendritic compartments within the brain of old tau-P301L mice). 

Phrase: "The histochemical analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the biochemical data on hyperphosphorylated tau accumulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "in tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "not in tau-4R/2N mice,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1518422:Not [Functional Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "with the extra information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "on the subcellular localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "(i.e. concentration into the somato-dendritic compartments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "within the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of old tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.270: This is completely in line with observations of neurofibrillary tangles in neuronal soma in human tauopathies. 

Phrase: "This"

Phrase: "is"

Phrase: "completely in line with observations of neurofibrillary tangles"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   744   C0205132:Line [Spatial Concept]
   744   C0205197:Completely [Qualitative Concept]
   744   C0302523:observations [Research Activity]
   744   C0700325:observations [Health Care Activity]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C3244290:observations [Functional Concept]
   737 E C3543859:neurofibrillary tangle [Cell Component]
   711 E C1964257:Observation [Diagnostic Procedure]

Phrase: "in neuronal soma"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   958   C2952302:Neuronal somata [Cell Component]
   861   C0599444:soma [Cell Component]
   861   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   805 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   768 E C2986476:Somatic [Qualitative Concept]

Phrase: "in human tauopathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0949664:Tauopathies [Disease or Syndrome]
Processing 00000000.tx.271: Tauopathy and Conformational Epitopes Characterize Tau-P301L Mice and Are Absent in Tau-4R/2N MiceNeurofibrillary pathology was evident in all old tau-P301L mice by silver impregnation (Fig. 6A, d and e) and fluorescent staining with thioflavin S and X-34 (Fig. 6A, a and c) (36). 

Phrase: "Tauopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "and"

Phrase: "Conformational Epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "Characterize"

Phrase: "Tau-P301L Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "Are"

Phrase: "Absent in Tau-4R/2N MiceNeurofibrillary pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:Absent [Quantitative Concept]
   748   C2699517:ABSENT [Finding]

Phrase: "was"

Phrase: "evident in all old tau-P301L mice"

Phrase: "by silver impregnation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293950:silver impregnation [Laboratory Procedure]
   861   C0015914:impregnation [Organism Function]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "e)"

Phrase: "and"

Phrase: "fluorescent staining with thioflavin S"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0303920:Fluorescent stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Fluorescent
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "X-34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0960674:X-34 [Organic Chemical]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "a"

Phrase: "and"

Phrase: "c) (36"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.272: Positive neurons were abundant in brain and spinal cord of all tau-P301L mice of 9 months and older and absent or weak in CNS of younger tau-P301L mice. 

Phrase: "Positive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "abundant in brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "spinal cord of all tau-P301L mice of 9 months"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   761   C1522592:Mouse Spinal Cord [Tissue]
   760   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   760   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   739   C0521329:Spinal [Spatial Concept]
   739   C1550235:Cord [Body Part, Organ, or Organ Component]
   739   C1552938:cord [Quantitative Concept]
   739   C1706500:Cord [Manufactured Object]

Phrase: "and"

Phrase: "older"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0580836:Old [Temporal Concept]

Phrase: "and"

Phrase: "absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "weak in CNS of younger tau-P301L mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0004093:Weak [Sign or Symptom]
   739   C1762617:Weak [Qualitative Concept]
Processing 00000000.tx.273: Reaction with thioflavin S or X-34 was completely absent from CNS of tau-KOKI mice or tau-4R/2N mice even when very old (2230 months) (results not shown), confirming the total absence of tauopathy in tau-4R/2N mice (16). 

Phrase: "Reaction with thioflavin S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "or"

Phrase: "X-34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0960674:X-34 [Organic Chemical]

Phrase: "was"

Phrase: "completely absent from CNS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "of tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "or"

Phrase: "tau-4R/2N mice even"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "when"

Phrase: "very old (2230 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439231:months [Temporal Concept]
   779 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the total absence of tauopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.274: View larger version (60K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(60K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.275: 6. 

Phrase: "6."
Processing 00000000.tx.276: Tauopathy in old tau-P301L mice. 

Phrase: "Tauopathy in old tau-P301L mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0949664:Tauopathy [Disease or Syndrome]
Processing 00000000.tx.277: A, thioflavin S staining of spinal cord of old tau-P301L mouse (a) and tau-4R/2N mouse (b). 

Phrase: "A,"

Phrase: "thioflavin S"

Phrase: "staining of spinal cord of old tau-P301L mouse"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   784   C1522592:Mouse Spinal Cord [Tissue]
   764   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   764   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0487602:Staining [Laboratory Procedure]
   742   C0521329:Spinal [Spatial Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1550235:Cord [Body Part, Organ, or Organ Component]
   742   C1552938:cord [Quantitative Concept]
   742   C1704680:Staining [Finding]
   742   C1706500:Cord [Manufactured Object]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(a)"

Phrase: "and"

Phrase: "tau-4R/2N mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "(b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.278: c1c4, staining with X-34 of neurons in brain stem of tau-P301L mouse. 

Phrase: "c1c4,"

Phrase: "staining with X-34 of neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0960674:X-34 [Organic Chemical]
   753   C0027882:Neurons [Cell]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of tau-P301L mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
Processing 00000000.tx.279: Gallyas silver impregnation of spinal cord of tau-P301L mouse (d) and nontransgenic mouse (e) is shown. 

Phrase: "Gallyas silver impregnation of spinal cord of tau-P301L mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1293950:silver impregnation [Laboratory Procedure]
   739   C0015914:impregnation [Organism Function]
   739   C0037125:Silver [Element, Ion, or Isotope]
   739   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   739   C1305285:Silver [Qualitative Concept]
   739   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "d)"

Phrase: "and"

Phrase: "nontransgenic mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "(e)"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.280: Higher magnification (d, inset) demonstrates argyrophilic grains in dendrites of tau-P301L mouse. 

Phrase: "Higher magnification"

Phrase: "(d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "inset"

Phrase: ")"

Phrase: "demonstrates"

Phrase: "argyrophilic grains in dendrites of tau-P301L mouse."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0007757:Grains [Food]
   744   C0086369:Grains [Plant]
   711 E C1552950:Grain [Quantitative Concept]
Processing 00000000.tx.281: f1, granular degeneration in neurites in brain stem of tau-P301L mouse visualized with AT8. 

Phrase: "f1,"

Phrase: "granular degeneration in neurites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0333437:Granular degeneration [Pathologic Function]
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "in brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of tau-P301L mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "visualized with AT8."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.282: Note also globular structures in neuronal somata (inset, higher magnification). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "also globular structures in neuronal somata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0678594:structures [Spatial Concept]
   748   C0682678:neurons structures [Cell Component]

Phrase: "(inset,"

Phrase: "higher magnification"

Phrase: ")."
Processing 00000000.tx.283: f2, axonal dilatations (inset, higher magnification) in brain stem of age-matched tau-4R/2N mouse visualized with AT8 (see also Ref. 16). 

Phrase: "f2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439453:F2 [Quantitative Concept]
  1000   C1414504:F2 [Gene or Genome]

Phrase: "axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "(inset,"

Phrase: "higher magnification"

Phrase: ")"

Phrase: "in brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of age-matched tau-4R/2N mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]

Phrase: "visualized with AT8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "also Ref. 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.284: Images and sections are representative of 36 mice analyzed for each genotype at 912 months of age. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "are"

Phrase: "representative of 36 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]

Phrase: "analyzed for each genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017431:Genotype [Organism Attribute]
   770   C0936012:Analyzed [Research Activity]

Phrase: "at 912 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.285: Images a, b, c1c4, d, and e are coronal, and f1f2 are saggital. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "a,"

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "c1c4,"

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "e"

Phrase: "are"

Phrase: "coronal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205123:Coronal [Spatial Concept]

Phrase: "and"

Phrase: "f1f2"

Phrase: "are"

Phrase: "saggital."
Processing 00000000.tx.286: Original magnification was x40 for a, b, and c1c4 and x20 for d, e, and f1f2. 

Phrase: "Original magnification"

Phrase: "was"

Phrase: "x40 for a,"

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "c1c4"

Phrase: "and"

Phrase: "x20 for d,"

Phrase: "e,"

Phrase: "and"

Phrase: "f1f2."
Processing 00000000.tx.287: B, tau filaments isolated from old tau-P301L mouse labeled by immunogold (10-nm particles) with primary antibodies as indicated. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "tau filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "isolated from old tau-P301L mouse"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "labeled by immunogold"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(10-nm particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597177:particles [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "with primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.288: The filaments are 1520 nm wide. 

Phrase: "The filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "are"

Phrase: "1520 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "wide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332464:Wide [Spatial Concept]
Processing 00000000.tx.289: C, tau filaments isolated from old tau-P301L mouse imaged by atomic force microscopy (left) with height distribution (right) along the longitudinal axis of the filament indicated by the arrowheads. 

Phrase: "C,"

Phrase: "tau filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "isolated from old tau-P301L mouse"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "imaged by atomic force microscopy"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "with height distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "along the longitudinal axis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1704551:Longitudinal Axis [Spatial Concept]
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "of the filament"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010851:Filament [Cell Component]
   928 E C1979891:Filamentous [Qualitative Concept]

Phrase: "indicated by the arrowheads."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1080898:Arrowheads [Plant]
   770   C1444656:Indicated [Finding]
   737 E C0453107:Arrowhead [Food]
Processing 00000000.tx.290: The periodicity of the filaments is 6070 nm, with the height of tops about 9 nm and valleys about 7 nm.  

Phrase: "The periodicity of the filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031084:Periodicity [Temporal Concept]

Phrase: "is"

Phrase: "6070 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "with the height"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0489786:Height [Organism Attribute]
   928 E C0205250:High [Qualitative Concept]
   928 E C1299351:High [Qualitative Concept]
   928 E C1522410:Highest [Qualitative Concept]
   928 E C2700149:HIGH [Intellectual Product]

Phrase: "of tops"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0076833:tops [Medical Device]
   966 E C1704458:Top [Spatial Concept]

Phrase: "about 9 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "valleys about 7 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0563004:valleys [Spatial Concept]
Processing 00000000.tx.291: The tauopathy in old tau-P301L mice was also visualized with AT8 (Figs. 5A and 6A, f1), showing immunoreactivity in soma, proximal dendrites, and dendritic branches and spines of affected neurons. 

Phrase: "The tauopathy in old tau-P301L mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "was"

Phrase: "also"

Phrase: "visualized with AT8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]

Phrase: "(Figs. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "and"

Phrase: "6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "f1"

Phrase: ")"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "immunoreactivity in soma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597879:immunoreactivity [Molecular Function]

Phrase: "proximal dendrites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011305:Dendrites [Cell Component]

Phrase: "and"

Phrase: "dendritic branches"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C2752556:dendritic branch [Cell Component]
   827   C1253959:Branch [Body Part, Organ, or Organ Component]
   827   C1881507:Branch [Chemical Viewed Structurally]
   827   C2700383:Branch [Plant]
   827   C2826234:BRANCH [Intellectual Product]

Phrase: "and"

Phrase: "spines of affected neurons."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   786   C2752558:Neuron spine [Cell Component]
       E   spine
   770   C0037949:spines [Body Part, Organ, or Organ Component]
   737 E C1267072:Spine [Body Part, Organ, or Organ Component]
   737 E C1280065:Spine [Body Part, Organ, or Organ Component]
Processing 00000000.tx.292: Remarkably, AT8 immunoreactivity in younger tau-P301L animals was present in fine granules, whereas in older animals also large, intensely staining granules and clusters were evident (Fig. 6A, f2). 

Phrase: "Remarkably,"

Phrase: "AT8 immunoreactivity in younger tau-P301L animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "present in fine granules,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "whereas in older animals also large, intensely staining granules"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0003062:Animals [Animal]
   742   C0010837:Granules [Cell Component]
   742   C0487602:Staining [Laboratory Procedure]
   742   C0549177:Large [Quantitative Concept]
   742   C0993609:Granules [Biomedical or Dental Material]
   742   C1704680:Staining [Finding]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   708   C0580836:Old [Temporal Concept]

Phrase: "and"

Phrase: "clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "were"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "f2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439453:F2 [Quantitative Concept]
  1000   C1414504:F2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.293: These clusters and granules were also argyrophilic, although this reaction was more confined to proximal dendrites and somata (Fig. 6A, d and e). 

Phrase: "These clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "and"

Phrase: "granules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0010837:Granules [Cell Component]
  1000   C0993609:Granules [Biomedical or Dental Material]
   916 E C0205248:Granular [Qualitative Concept]

Phrase: "were"

Phrase: "also argyrophilic,"

Phrase: "although"

Phrase: "this reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "confined to proximal dendrites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011305:Dendrites [Cell Component]
   770   C0205107:Proximal [Spatial Concept]

Phrase: "and"

Phrase: "somata"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0599444:soma [Cell Component]
   966   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   928 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   900 E C2986476:Somatic [Qualitative Concept]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "e"

Phrase: ")."
Processing 00000000.tx.294: Besides the pathological AP422 and AT100 epitopes (Fig. 5B, ad), also the conformational epitopes defined by MC1 and TG3 were ominously present in brain of tau-P301L (Fig. 7). 

Phrase: "Besides the pathological AP422"

Phrase: "and"

Phrase: "AT100 epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "(Fig. 5B,"

Phrase: "ad"

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "the conformational epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "defined by MC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "and"

Phrase: "TG3"

Phrase: "were"

Phrase: "ominously"

Phrase: "present in brain of tau-P301L"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.295: mAb MC1 defines a complex, nonlinear epitope combining the N terminus of tau with the microtubule binding domain (38). 

Phrase: "mAb MC1"

Phrase: "defines"

Phrase: "a complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "nonlinear epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "the N terminus of tau"

Phrase: "with the microtubule binding domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1149274:microtubule binding [Molecular Function]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.296: The MC1 reaction was observed in CNS of all old tau-P301L mice (Fig. 7, A, D, and E), whereas it was absent or rare in 6-month-old tau-P301L mice and totally absent in CNS of tau-4R/2N, nontransgenic, and tau-KOKI mice at any age (up to 24 months) (Fig. 7, B and C, and results not shown). 

Phrase: "The MC1 reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "observed in CNS of all old tau-P301L mice"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   775   C0927232:Central Nervous System [Body System]
   775   C1269563:Central nervous system [Body System]
   775   C1522730:Mouse Central Nervous System [Tissue]
   756   C0027763:Nervous System [Body System]
   756   C0422837:NERVOUS SYSTEM [Finding]
   756   C1269560:Nervous system [Body System]
   755   C1518255:Mouse Nervous System [Tissue]
   754   C0027762:Nervous Mice [Mammal]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0027769:Nervous [Sign or Symptom]
   738   C0205099:Central [Spatial Concept]
   738   C0449913:System [Functional Concept]
   738   C0580836:Old [Temporal Concept]
   738   C0599851:Nervous [Functional Concept]
   738   C1441672:Observed [Functional Concept]
   738   C1553451:System [Manufactured Object]
   738   C1704459:System [Medical Device]
   738   C1720655:Tau [Intellectual Product]
   738   C1879652:Central - [Laboratory Procedure]
   738   C1947974:Tau [Research Activity]
   700 E C0205494:Neurologic [Qualitative Concept]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "it"

Phrase: "was"

Phrase: "absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "rare in 6-month-old tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0521114:Rare [Temporal Concept]
   744   C0522498:Rare [Qualitative Concept]
   744   C1514917:RARE [Gene or Genome]

Phrase: "and"

Phrase: "totally absent in CNS of tau-4R/2N,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332197:Absent [Quantitative Concept]
   739   C2699517:ABSENT [Finding]

Phrase: "nontransgenic,"

Phrase: "and"

Phrase: "tau-KOKI mice at any age ("
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C0206745:Knock-out Mice [Mammal]
   762   C1517676:Knock-in [Research Activity]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "up to 24 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.297: Significantly, MC1-immunoreactive neurons were present in similar numbers and distributed like AT100-, AP422-, and PG5-reactive neurons (compare Fig. 5B, ad, with Fig. 7, D and E). 

Phrase: "Significantly,"

Phrase: "MC1-immunoreactive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "present in similar numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "distributed like AT100-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704711:Distributed [Functional Concept]

Phrase: "AP422-,"

Phrase: "and"

Phrase: "PG5-reactive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig. 5B,"

Phrase: "ad,"

Phrase: "with Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.298: The extent of correlation was illustrated by double labeling with the rabbit polyclonal antibody AP422 and the mAbs MC1, AT8, AT100, or HT7. 

Phrase: "The extent of correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "illustrated by double labeling"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205173:Double [Functional Concept]
   770   C1167624:Labeling [Mental Process]
   770   C1705764:Double [Activity]
   770   C1705765:Double [Qualitative Concept]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   737 E C0181496:Label [Manufactured Object]

Phrase: "with the rabbit polyclonal antibody AP422"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "the mAbs MC1,"

Phrase: "AT8,"

Phrase: "AT100,"

Phrase: "or"

Phrase: "HT7."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450571:HT7 [Body Location or Region]
Processing 00000000.tx.299: Essentially, AP422 reacted with the same neurons as MC1, AT100, and AT8 in subcortical areas (Fig. 7, G and H), whereas HT7 evidently stained more neurons in all brain regions (Fig. 7I). 

Phrase: "Essentially,"

Phrase: "AP422"

Phrase: "reacted with the same neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027882:Neurons [Cell]
   760   C0445247:Same [Qualitative Concept]

Phrase: "as MC1,"

Phrase: "AT100,"

Phrase: "and"

Phrase: "AT8 in subcortical areas"

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "HT7 evidently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450571:HT7 [Body Location or Region]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "more neurons in all brain regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "(Fig. 7I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552171:7i [Medical Device]

Phrase: ")."
Processing 00000000.tx.300: View larger version (129K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(129K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.301: 7. 

Phrase: "7."
Processing 00000000.tx.302: Conformational tau epitopes in tau-P301L mice and co-localization with phosphorylation epitopes. 

Phrase: "Conformational tau epitopes in tau-P301L mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003316:Epitopes [Immunologic Factor]

Phrase: "and"

Phrase: "co-localization with phosphorylation epitopes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.303: Immunohistochemistry with MC1 demonstrates immunoreactive neurons in spinal cord (A), brain cortex (D), and midbrain (E) of tau-P301L mice (A, D, and E) but not in tau-4R/2N mice (B) and nontransgenic mice (C). 

Phrase: "Immunohistochemistry with MC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "demonstrates"

Phrase: "immunoreactive neurons in spinal cord"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "brain cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "("

Phrase: "D)"

Phrase: ","

Phrase: "and"

Phrase: "midbrain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
  1000   C1280997:Midbrain [Body Part, Organ, or Organ Component]

Phrase: "(E) of tau-P301L mice"

Phrase: "(A,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E)"

Phrase: "but"

Phrase: "not in tau-4R/2N mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1518422:Not [Functional Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "nontransgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.304: F, TG3-immunoreactive neurons in the coronal section of the brain stem of a 9-month-old tau-P301L mouse. 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "TG3-immunoreactive neurons in the coronal section of the brain stem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0027882:Neurons [Cell]

Phrase: "of a 9-month-old tau-P301L mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]
Processing 00000000.tx.305: Shown is double immunostaining MC1/AP422 (G) and AT8/AP422 in the brain stem (H) and HT7/AP422 in the medial fastigial nucleus (I). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "double immunostaining MC1/AP422"

Phrase: "(G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "AT8/AP422 in the brain stem"

Phrase: "(H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "HT7/AP422 in the medial fastigial nucleus"

Phrase: "(I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.306: The substrates for staining with AP422 (rabbit polyclonal antibody) produced a red precipitate, whereas staining with mAbs MC1, HT7, and AT8 produced a blue precipitate, resulting in a purple mixed color when co-localized. 

Phrase: "The substrates for staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "with AP422"

Phrase: "(rabbit polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "produced"

Phrase: "a red precipitate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "whereas"

Phrase: "staining with mAbs MC1,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   737   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "HT7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450571:HT7 [Body Location or Region]

Phrase: "and"

Phrase: "AT8"

Phrase: "produced"

Phrase: "a blue precipitate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "resulting in a purple mixed color"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0332294:Resulting in [Functional Concept]
   783   C0439542:Purple color [Qualitative Concept]
           Purple
   753   C0009393:Color [Natural Phenomenon or Process]
   753   C0205430:Mixed [Functional Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   753   C1705245:Color [Pharmacologic Substance]
   753   C3160715:Mixed [Finding]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "when"

Phrase: "co-localized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:Localized [Spatial Concept]
Processing 00000000.tx.307: All mice were 9 months of age. 

Phrase: "All mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "9 months of age."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.308: The section used for F was counterstained with hematoxylin. 

Phrase: "The section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "used for F"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   790   C0439133:(f) [Intellectual Product]
   790   C1273517:used [Finding]
   790   C1553038:[f] [Quantitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "counterstained with hematoxylin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.309: Original magnification was x20 for AF and x40 for GI.  

Phrase: "Original magnification"

Phrase: "was"

Phrase: "x20 for AF"

Phrase: "and"

Phrase: "x40 for GI."
Processing 00000000.tx.310: The demonstrated co-localization of MC1 with AP422 can therefore be extended to AT100 and AT8. 

Phrase: "The demonstrated co-localization of MC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "with AP422"

Phrase: "can"

Phrase: "therefore"

Phrase: "be"

Phrase: "extended to AT100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0231448:Extended [Functional Concept]
   790   C0231449:Extended [Spatial Concept]
   790   C0439792:extended [Spatial Concept]

Phrase: "and"

Phrase: "AT8."
Processing 00000000.tx.311: We conclude from these data that the conformational change of tau defined by MC1 is mechanistically closely related to hyperphosphorylation defined by AT100 and AT8 and to the aggregation process, since all three characteristics are confined to the same neurons. 

Phrase: "We"

Phrase: "conclude from these data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "that"

Phrase: "the conformational change of tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0301641:Conformational change [Molecular Function]
   797   C0025320:The change [Physiologic Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "defined by MC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "is"

Phrase: "mechanistically closely"

Phrase: "related to hyperphosphorylation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]

Phrase: "defined by AT100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "and"

Phrase: "AT8"

Phrase: "and to the aggregation process,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "since"

Phrase: "all three characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "are"

Phrase: "confined to the same neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027882:Neurons [Cell]
   760   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.312: Some neurons, located mainly in brain stem and spinal cord of old tau-P301L mice, reacted also with TG3 and appeared shrunken and irregular with an eccentrically placed nucleus, resembling ghosts or tomb neurons, since hematoxylin counterstaining did not reveal nuclei (Fig. 7F). 

Phrase: "Some neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "located"

Phrase: "mainly in brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
   833   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0242767:Stem [Plant]
   770   C1186763:Stem [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord of old tau-P301L mice,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   788   C1522592:Mouse Spinal Cord [Tissue]
   778   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   778   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   748   C0521329:Spinal [Spatial Concept]
   748   C1550235:Cord [Body Part, Organ, or Organ Component]
   748   C1552938:cord [Quantitative Concept]
   748   C1706500:Cord [Manufactured Object]

Phrase: "reacted"

Phrase: "also with TG3"

Phrase: "and"

Phrase: "appeared shrunken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332513:Shrunken [Functional Concept]
   827 E C0205230:shrink [Spatial Concept]

Phrase: "and"

Phrase: "irregular with an eccentrically placed nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205271:Irregular [Qualitative Concept]

Phrase: "resembling"

Phrase: "ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014776:ghosts [Cell Component]

Phrase: "or"

Phrase: "tomb neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "since"

Phrase: "hematoxylin counterstaining"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 7F"

Phrase: ")."
Processing 00000000.tx.313: Tau filaments isolated from old tau-P301L mice were ultrastructurally defined as filaments of 1020-nm width and were straight or twisted (Fig. 6B). 

Phrase: "Tau filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "isolated from old tau-P301L mice"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "ultrastructurally"

Phrase: "defined as filaments of 1020-nm width"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0312860:NM [Cell Function]
   748   C0487742:Width [Quantitative Concept]
   748   C1704788:Defined [Conceptual Entity]
   748   C3539106:Defined [Intellectual Product]
   714   C0010851:Filament [Cell Component]

Phrase: "and"

Phrase: "were"

Phrase: "straight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445291:Straight [Spatial Concept]

Phrase: "or"

Phrase: "twisted"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0231467:Twisted [Spatial Concept]
   966 E C0040480:twist [Physiologic Function]
   928 E C0231458:Rotated [Spatial Concept]
   907 E C1265748:Twisting [Pathologic Function]
   907 E C1881716:TWISTING [Phenomenon or Process]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.314: The filaments were immunogold-labeled with primary antibodies AT100, AT8, and HT7 and also with MC1 and TG3, demonstrating that the filaments contained conformationally altered hyperphosphorylated tau. 

Phrase: "The filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "were"

Phrase: "immunogold-"

Phrase: "labeled with primary antibodies AT100,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "AT8,"

Phrase: "and"

Phrase: "HT7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450571:HT7 [Body Location or Region]

Phrase: "and"

Phrase: "also with MC1"

Phrase: "and"

Phrase: "TG3,"

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "conformationally"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "hyperphosphorylated tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]
Processing 00000000.tx.315: Atomic force microscopy demonstrated these tau filaments to be more regular than observed by electron microscopy (Fig. 6C). 

Phrase: "Atomic force microscopy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "demonstrated"

Phrase: "these tau filaments to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "be"

Phrase: "more regular than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205272:Regular [Qualitative Concept]

Phrase: "observed by electron microscopy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0026019:Electron Microscopy [Laboratory Procedure]
   833   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   770   C0013852:Electron [Quantitative Concept]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C1441672:Observed [Functional Concept]
   770   C3463986:Electron [Bird]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.316: They appeared as left-handed helical structures with a periodicity of 6070 nm. 

Phrase: "They"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "as"

Phrase: "left-handed helical structures with a periodicity of 6070 nm."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0230371:Structure of left hand [Body Part, Organ, or Organ Component]
   753   C0018563:Structure of hand [Body Part, Organ, or Organ Component]
           Hand structure
   739   C0678594:structures [Spatial Concept]
Processing 00000000.tx.317: Height measurements along the longitudinal axis of a filament revealed peaks of 9 nm and valleys of 7 nm (Fig. 6C). 

Phrase: "Height measurements along the longitudinal axis of a filament revealed peaks of 9 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0242485:measurements [Functional Concept]

Phrase: "and"

Phrase: "valleys of 7 nm (Fig. 6C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0563004:valleys [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.318: All filamentous structures on the silicon surface displayed very similar characteristics, except for their apparent difference in length. 

Phrase: "All filamentous structures on the silicon surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:structures [Spatial Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "very similar characteristics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521970:Characteristics [Qualitative Concept]

Phrase: "except for their apparent difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "in length."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]
Processing 00000000.tx.319: The combined data are strongly indicative of the close association of hyperphosphorylation, conformational change, and fibril formation in neurons located throughout the CNS, which underlie the neurodegeneration and the moribund tauopathy of tau-P301L mice. 

Phrase: "The combined data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "strongly indicative of the close association of hyperphosphorylation,"

Phrase: "conformational change,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0301641:Conformational change [Molecular Function]
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "fibril formation in neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "located throughout the CNS,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0927232:Central Nervous System [Body System]
   833   C1269563:Central nervous system [Body System]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0205099:Central [Spatial Concept]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1879652:Central - [Laboratory Procedure]
   734 E C0205494:Neurologic [Qualitative Concept]

Phrase: "which"

Phrase: "underlie"

Phrase: "the neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the moribund tauopathy of tau-P301L mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0949664:Tauopathy [Disease or Syndrome]
Processing 00000000.tx.320: All of these characteristics were absent in all tau-4R/2N and tau-KOKI mice analyzed at all ages, indicating that the P301L mutation procured a direct pathological trait not present on or acquired by tau-4R/2N in transgenic mouse brain.  

Phrase: "All of these characteristics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C1521970:Characteristics [Qualitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "were"

Phrase: "absent in all tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "analyzed at all ages,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   770   C0936012:Analyzed [Research Activity]

Phrase: "indicating"

Phrase: "that"

Phrase: "the P301L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "procured"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3274540:Procure [Immunologic Factor,Pharmacologic Substance]

Phrase: "a direct pathological trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599883:Trait [Organism Attribute]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present on"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0150312:Present [Quantitative Concept]
   833   C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "acquired by tau-4R/2N"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439661:Acquired [Temporal Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   760   C3245488:acquired [Intellectual Product]
   726 E C1706701:Acquire [Activity]

Phrase: "in transgenic mouse brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1521713:Mouse Brain [Tissue]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0025936:Mouse, Transgenic [Mammal]
Processing 00000000.tx.321: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  We compared three transgenic mouse strains that express the longest isoform of human protein tau (i.e. tau-4R/2N with four microtubule binding domains and two N-terminal inserts) (39). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "three transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mouse, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "that"

Phrase: "express"

Phrase: "the longest isoform of human protein tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform

Phrase: "(i.e. tau-4R/2N"

Phrase: "with four microtubule binding domains"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1149274:microtubule binding [Molecular Function]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "two N-terminal inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0813036:Inserts [Medical Device]
   779 E C0441587:Insert [Health Care Activity]
   779 E C1743766:Insert [Medical Device]
   779 E C1883719:Insert [Functional Concept]

Phrase: ")"

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.322: Tau-4R/2N mice develop axonopathy with axonal dilatations (spheroids) originating from inhibition of axonal transport due to excessive binding of tau-4R/2N to microtubules (16, 32). 

Phrase: "Tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "develop"

Phrase: "axonopathy with axonal dilatations"

Phrase: "(spheroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1844596:Spheroids [Finding]

Phrase: ")"

Phrase: "originating from inhibition of axonal transport"

Phrase: "due to excessive binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "of tau-4R/2N"

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "(16,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.323: Two new strains were generated (i.e. tau-P301L mice that carry the FTDP-17 mutant P301L in the tau-4R/2N isoform and tau-KOKI mice that express none of the mouse tau isoforms and only human tau-4R/2N at levels similar to endogenous tau levels in wild-type mice). 

Phrase: "Two new strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "(i.e. tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "the FTDP-17 mutant P301L in the tau-4R/2N isoform"

Phrase: "and"

Phrase: "tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "express"

Phrase: "none of the mouse tau isoforms"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "only human tau-4R/2N at levels"

Phrase: "similar to endogenous tau levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.324: Importantly, the three transgenic mouse strains express the same tau-4R/2N isoform, all driven by the same murine thy1 gene promoter and in the same genetic background. 

Phrase: "Importantly,"

Phrase: "the three transgenic mouse strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C1513684:Mouse Strains [Mammal]
   812   C0080194:Strains [Injury or Poisoning]
   812   C0456178:strains [Intellectual Product]
   779 E C1518614:Strain [Organism]
   779 E C2987481:Strain [Mental Process]

Phrase: "express"

Phrase: "the same tau-4R/2N isoform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "all"

Phrase: "driven by the same murine thy1 gene promoter"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1420728:THY1 gene [Gene or Genome]
           THY1
   767   C0314621:Promoter gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0026809:Murine [Mammal]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0445247:Same [Qualitative Concept]
   744   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   711   C0013126:Drive [Mental Process]

Phrase: "and in the same genetic background."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.325: Moreover, we selected the tau-P301L strain carefully to express mutant tau-P301L at the same level as tau-4R/2N, leaving the mutation P301L as the only difference. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "the tau-P301L"

Phrase: "strain"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "carefully to"

Phrase: "express"

Phrase: "mutant tau-P301L at the same level"

Phrase: "as tau-4R/2N,"

Phrase: "leaving"

Phrase: "the mutation P301L as the only difference."
Processing 00000000.tx.326: This strict transgenic approach combined with standardized analytical methods applied to these three strains was implemented to obviate any potential controversy from differences in intrinsic parameters or methods. 

Phrase: "This strict transgenic approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "combined with standardized analytical methods"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0178476:analytical methods [Intellectual Product]
   781   C1704537:Combined Method [Therapeutic or Preventive Procedure]
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0205195:Combined [Qualitative Concept]
   760   C0449851:Methods [Functional Concept]
   760   C0936012:Analytical [Research Activity]
   726 E C0336789:Combine [Manufactured Object]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "applied to these three strains"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0080194:Strains [Injury or Poisoning]
   760   C0185125:Applied [Health Care Activity]
   760   C0205449:Three [Quantitative Concept]
   760   C0456178:strains [Intellectual Product]
   726 E C1518614:Strain [Organism]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]
   726 E C2987481:Strain [Mental Process]

Phrase: "was"

Phrase: "implemented"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obviate"

Phrase: "any potential controversy from differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680243:controversy [Social Behavior]

Phrase: "in intrinsic parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "or"

Phrase: "methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.327: Major Phenotypic Parameters of Tau-4R/2N, Tau-P301L, and Tau-KOKI MiceThe dramatic differences in phenotype between tau-4R/2N and tau-P301L mice are summarized in Table II. 

Phrase: "Major Phenotypic Parameters of Tau-4R/2N,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0449381:Parameters [Finding]
   714 E C0549193:Parameter [Spatial Concept]
   714 E C1704769:Parameter [Conceptual Entity]
   714 E C2350001:Parameter [Quantitative Concept]

Phrase: "Tau-P301L,"

Phrase: "and"

Phrase: "Tau-KOKI MiceThe dramatic differences in phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "between tau-4R/2N"

Phrase: "and"

Phrase: "tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "summarized in Table II."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.328: Tau-4R/2N mice have early motor impairment and axonopathy without tau aggregation, as opposed to late and morbid neurofibrillary tauopathy in tau-P301L mice with late but minor motor problems. 

Phrase: "Tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "early motor impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "axonopathy without tau aggregation,"

Phrase: "as"

Phrase: "opposed to late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205087:Late [Temporal Concept]

Phrase: "and"

Phrase: "morbid neurofibrillary tauopathy in tau-P301L mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "with late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "but"

Phrase: "minor motor problems."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1546466:Problems [Idea or Concept]
   793 E C0033213:Problem [Finding]
Processing 00000000.tx.329: The gene-dosage effect in tau-4R/2N versus tau-KOKI mice provides considerable information on the mechanism involved. 

Phrase: "The gene-dosage effect in tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "versus"

Phrase: "tau-KOKI mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "considerable information on the mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.330: View this table: [in this window] [in a new window]  TABLE II Phenotypic characteristics of the tau-4R/2N transgenic mice The level of expression and the severity of the specified phenotypic traits are represented by a proportional number of signs (i.e. low (+), moderate (++), and severe (+++)). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE II Phenotypic characteristics of the tau-4R/2N transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1521970:Characteristics [Qualitative Concept]

Phrase: "The level of expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C3244092:expression level [Idea or Concept]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the severity of the specified phenotypic traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439793:Severity [Qualitative Concept]
   748   C2983285:Severity [Intellectual Product]

Phrase: "are"

Phrase: "represented by a proportional number of signs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205351:Proportional [Qualitative Concept]
   748   C0220912:signs [Functional Concept]
   748   C0220913:signs [Manufactured Object]
   748   C0237753:*Number [Quantitative Concept]
   748   C0311392:SIGNS [Finding]
   748   C0449788:Number [Quantitative Concept]
   714 E C1547188:Sign [Idea or Concept]
   714   C1882932:Represent [Activity]

Phrase: "(i.e. low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "(+"

Phrase: ")"

Phrase: ","

Phrase: "moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "(++"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "severe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severe [Qualitative Concept]

Phrase: "(+++"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.331: The equal sign denotes that the level is similar to endogenous mouse tau with all isoforms combined.  

Phrase: "The equal sign"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0311392:Sign [Finding]
   861   C1547188:Sign [Idea or Concept]

Phrase: "denotes"

Phrase: "that"

Phrase: "the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "similar to endogenous mouse tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "with all isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "combined."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.332: Tau-KOKI mice were inconspicuous in most phenotypic aspects, with normal embryonic and postnatal development, despite complete absence of tau until the second postnatal week, characteristic for the thy1 gene promoter used (27, 40). 

Phrase: "Tau-KOKI mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "inconspicuous in most phenotypic aspects,"

Phrase: "with normal embryonic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013935:Embryonic [Embryonic Structure]

Phrase: "and"

Phrase: "postnatal development,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1135598:postnatal development [Organism Function]
   861   C0243107:development [Physiologic Function]
   861   C0443281:Postnatal [Temporal Concept]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "despite complete absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "until the second postnatal week,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332174:/week [Temporal Concept]
   827   C0439230:week [Temporal Concept]

Phrase: "characteristic for the thy1 gene promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristic [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(27,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.333: Their motor impairment is minor but clearly demonstrates that even at normal levels, human tau-4R/2N has a much stronger impact on motor ability than mutant tau-P301L. 

Phrase: "Their motor impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684336:Impairment [Pathologic Function]

Phrase: "is"

Phrase: "minor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026193:Minor [Population Group]
  1000   C0205165:Minor [Qualitative Concept]

Phrase: "but"

Phrase: "clearly"

Phrase: "demonstrates"

Phrase: "that even at normal levels,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C2347086:% Normal [Quantitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "human tau-4R/2N"

Phrase: "has"

Phrase: "a much stronger impact on motor ability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "than mutant tau-P301L."
Processing 00000000.tx.334: This results in, and is dramatically illustrated by, the severe early motor impairment in the tau-4R/2N mice that correlates closely with the widespread occurrence of axonal dilatations or spheroids in all CNS regions (16). 

Phrase: "This results in,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "and"

Phrase: "is"

Phrase: "dramatically"

Phrase: "illustrated by,"

Phrase: "the severe early motor impairment in the tau-4R/2N mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0684336:Impairment [Pathologic Function]

Phrase: "that"

Phrase: "correlates"

Phrase: "closely with the widespread occurrence of axonal dilatations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   744   C0012359:Dilatations [Pathologic Function]
   744   C0205391:Widespread [Spatial Concept]
   744   C0243132:occurrence [Functional Concept]
   744   C1554210:occurrence [Idea or Concept]
   744   C2745955:Occurrence [Temporal Concept]

Phrase: "or"

Phrase: "spheroids in all CNS regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1844596:Spheroids [Finding]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.335: Significantly, despite similar expression levels of tau-P301L and tau-4R/2N, no axonal dilatations were observed in tau-P301L mice at any age, not even when terminally ill by the extensive tauopathy. 

Phrase: "Significantly,"

Phrase: "despite similar expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of tau-P301L"

Phrase: "and"

Phrase: "tau-4R/2N,"

Phrase: "no axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012356:Dilatations [Therapeutic or Preventive Procedure]
   861   C0012359:Dilatations [Pathologic Function]

Phrase: "were"

Phrase: "observed in tau-P301L mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1441672:Observed [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "at any age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "not even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "when"

Phrase: "terminally ill by the extensive tauopathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0039552:Terminally Ill [Patient or Disabled Group]
   753   C0231218:Ill [Sign or Symptom]
Processing 00000000.tx.336: Even more significant is the observation that tau-4R/2N, either at high levels or at normal levels in the absence of murine tau in the tau-KOKI mice, did not produce aggregates. 

Phrase: "Even more significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0237881:significant [Quantitative Concept]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "is"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that tau-4R/2N,"

Phrase: "either at high levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "or at normal levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of murine tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "in the tau-KOKI mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "produce"

Phrase: "aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.337: This differs from transgenic mice that overexpress the human tau gene in a murine tau knockout background (41). 

Phrase: "This"

Phrase: "differs from transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "the human tau gene in a murine tau knockout background"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0314604:Human gene [Gene or Genome]
   757   C0599772:Gene Knock Out [Molecular Biology Research Technique]
   739   C0017337:Gene [Gene or Genome]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.338: In these mice, the tau-3R isoforms accumulate, implying that a shift in tau isoforms and the absence of mouse tau-4R isoforms are the more important parameters in that model. 

Phrase: "In these mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "the tau-3R isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "accumulate"

Phrase: ","

Phrase: "implying"

Phrase: "that"

Phrase: "a shift in tau isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333051:Shift [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]

Phrase: "and"

Phrase: "the absence of mouse tau-4R isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "are"

Phrase: "the more important parameters in"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "that model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]
Processing 00000000.tx.339: The demonstration that axonal pathology and somal tau pathology can occur independently evidently does not exclude their combination as seen in patients (9) and in transgenic models (25, 42). 

Phrase: "The demonstration"

Phrase: "that axonal pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "somal tau pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "can"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "independently evidently"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "their combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "as"

Phrase: "seen in patients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "(9"

Phrase: ")"

Phrase: "and in transgenic models"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C1519606:Transgenic Model [Experimental Model of Disease]
   770   C0003069:Transgenic [Animal]
   770   C1515981:And [Idea or Concept]
   770   C3161035:Models [Intellectual Product]

Phrase: "(25,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.340: Significantly, the careful selection for expression and genetic background allowed us to study parameters that mediate axonopathy in tau-4R/2N mice as opposed to tauopathy in tau-P301L mice (i.e. hyper-phosphorylation, conformational changes, somato-dendritic relocation, and aggregation), as discussed below. 

Phrase: "Significantly,"

Phrase: "the careful selection for expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036576:selection [Genetic Function]

Phrase: "and"

Phrase: "genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "that"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "axonopathy in tau-4R/2N mice"

Phrase: "as"

Phrase: "opposed to tauopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "in tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(i.e. hyper-phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0424295:HYPER [Finding]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "conformational changes,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0301641:Conformational change [Molecular Function]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "somato-dendritic relocation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699029:Relocation [Activity]

Phrase: "and"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "discussed below."
Processing 00000000.tx.341: Tauopathy in Tau-P301L MiceThe pathology in our tau-P301L mice is similar to that in other mutant tau mice (2022, 25, 42) and is therefore not discussed in depth, except for three important aspects. 

Phrase: "Tauopathy in Tau-P301L MiceThe pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "in our tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in other mutant tau mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(2022,"

Phrase: "25,"

Phrase: "42"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "therefore"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "discussed in depth,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205125:Depth [Spatial Concept]
   718 E C1422002:DEEPEST [Gene or Genome]

Phrase: "except for three important aspects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1547011:Aspect [Quantitative Concept]
   793   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.342: Neurons of old tau-P301L mice contained numerous granular deposits that were argyrophilic and marked by pathological tau epitopes. 

Phrase: "Neurons of old tau-P301L mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "numerous granular deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "argyrophilic"

Phrase: "and"

Phrase: "marked by pathological tau epitopes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003316:Epitopes [Immunologic Factor]
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C0522501:Marked [Qualitative Concept]
   760   C1521733:Pathological [Functional Concept]
   760   C1706089:Marked [Qualitative Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
Processing 00000000.tx.343: Similar lesions, identified as either small neuropil threads or as argyrophilic grains, are encountered together in AD and in fronto-temporal dementia, whereas argyrophilic grain disease was recently classified as a sporadic tau-4R disease (43, 44). 

Phrase: "Similar lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "identified as either small neuropil threads"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0521175:Neuropil Threads [Acquired Abnormality]
   753   C0205396:Identified [Qualitative Concept]
   753   C0228081:Neuropil [Cell Component]
   753   C0700321:Small [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   719   C1710394:Thread [Manufactured Object]
   719   C1882475:Thread [Intellectual Product]

Phrase: "or as argyrophilic grains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0007757:Grains [Food]
   770   C0086369:Grains [Plant]
   737 E C1552950:Grain [Quantitative Concept]

Phrase: "are"

Phrase: "encountered"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0545082:Encounter [Behavior]
   966   C1512346:encounter [Health Care Activity]
   966   C1947978:Encounter [Behavior]

Phrase: "together in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883357:Together [Qualitative Concept]

Phrase: "and in fronto-temporal dementia,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0442043:Temporal [Spatial Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C1515981:And [Idea or Concept]
   760   C2362314:Temporal [Temporal Concept]

Phrase: "whereas"

Phrase: "argyrophilic grain disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007757:Grain [Food]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0086369:Grain [Plant]
   827   C1552950:Grain [Quantitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "classified as a sporadic tau-4R disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0008902:Classified [Classification]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205422:Sporadic [Temporal Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "(43,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.344: The grains were mainly dendritic in tau-P301L mice but were also evident in ascending axons in the cerebellum, despite very low expression of the transgene in the cerebellum. 

Phrase: "The grains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007757:Grains [Food]
  1000   C0086369:Grains [Plant]
   966 E C1552950:Grain [Quantitative Concept]

Phrase: "were"

Phrase: "mainly dendritic in tau-P301L mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011305:Dendritic [Cell Component]
   753   C0439640:Dendritic [Qualitative Concept]

Phrase: "but"

Phrase: "were"

Phrase: "also evident in ascending axons"

Phrase: "in the cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "despite very low expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0442811:Very low [Finding]

Phrase: "of the transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]

Phrase: "in the cerebellum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.345: This aspect deserves further characterization, which falls outside the current study. 

Phrase: "This aspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547011:Aspect [Quantitative Concept]
  1000   C1879746:Aspect [Qualitative Concept]

Phrase: "deserves"

Phrase: "further characterization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "which"

Phrase: "falls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085639:Fall [Finding]
  1000   C0238715:Fall [Temporal Concept]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the current study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.346: Tau filaments isolated from the tau-P301L mice are left-handed helical structures with a regular periodicity and resemble paired helical filaments in AD (45, 46). 

Phrase: "Tau filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "isolated from the tau-P301L mice"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "are"

Phrase: "left-handed helical structures with a regular periodicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0678594:structures [Spatial Concept]
   734   C0018563:Hand structure [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "resemble"

Phrase: "paired helical filaments in AD (45,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   753   C1709450:Paired [Qualitative Concept]
   719   C0010851:Filament [Cell Component]

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.347: The filaments were, however, only 9 nm high versus a reported 16 nm for paired helical filaments (46), which could be due to differences in tau isoform composition in AD, whereas such detailed information on filaments isolated from the brains of fronto-temporal dementia patients is, to our knowledge, not available. 

Phrase: "The filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "were"

Phrase: ","

Phrase: "however,"

Phrase: "only 9 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "versus"

Phrase: "a reported 16 nm for paired helical filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0312860:NM [Cell Function]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "could"

Phrase: "be due to differences"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in tau isoform composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0486616:Composition [Clinical Attribute]
   827   C1555710:composition [Idea or Concept]

Phrase: "in AD,"

Phrase: "whereas"

Phrase: "such detailed information on filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "isolated from the brains of fronto-temporal dementia patients"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   745   C1508538:Brain.temporal [Body Part, Organ, or Organ Component]
   742   C0006104:Brains [Body Part, Organ, or Organ Component]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0030705:Patients [Patient or Disabled Group]
   742   C0205409:Isolated [Functional Concept]
   742   C0442043:Temporal [Spatial Concept]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   742   C1548221:Isolated [Idea or Concept]
   742   C2362314:Temporal [Temporal Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1269537:Brain [Body Part, Organ, or Organ Component]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "is"

Phrase: ","

Phrase: "to our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "not available."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]
Processing 00000000.tx.348: Mechanistically most important is the intimate occurrence of hyperphosphorylation, conformational change(s), somato-dendritic accumulation, and aggregation in the tau-P301L mice, not seen in the tau-4R/2N mice. 

Phrase: "Mechanistically most important"

Phrase: "is"

Phrase: "the intimate occurrence of hyperphosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "conformational change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0301641:Conformational change [Molecular Function]
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "somato-dendritic accumulation,"

Phrase: "and"

Phrase: "aggregation in the tau-P301L mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in the tau-4R/2N mice."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205397:Seen [Qualitative Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]
Processing 00000000.tx.349: The reason why tau-4R/2N does not convert from its evident hyperphosphorylated state into the conformation that allows aggregates to form is unknown, but it could be due to binding to microtubules (see below). 

Phrase: "The reason why tau-4R/2N"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "convert from its evident hyperphosphorylated state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "into the conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "it"

Phrase: "could"

Phrase: "be due to binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.350: The observations on the P301L mutant mice demonstrate that mouse brain neurons are fully capable of forming tau aggregates and tangles, and consequently no essential kinase nor other factor(s) appear to be missing in mouse neurons, including the mechanism responsible for relocation of tau to the soma. 

Phrase: "The observations on the P301L mutant mice"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0302523:observations [Research Activity]
   748   C0700325:observations [Health Care Activity]
   748   C3244290:observations [Functional Concept]
   714 E C1964257:Observation [Diagnostic Procedure]

Phrase: "demonstrate"

Phrase: "that mouse brain neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   988   C1524046:Mouse Brain Neuron [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C1521713:Mouse Brain [Tissue]

Phrase: "are"

Phrase: "fully capable of forming tau aggregates"

Phrase: "and"

Phrase: "tangles,"

Phrase: "and"

Phrase: "consequently"

Phrase: "no essential kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "nor"

Phrase: "other factor(s"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   944   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   944   C2700256:Biotin [Laboratory Procedure]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "missing in mouse neurons,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1551393:Missing [Idea or Concept]
   770   C1705492:Missing [Qualitative Concept]
   770   C3272743:MISSING [Qualitative Concept]
   737 E C2349206:Miss [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for relocation of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "to the soma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]
Processing 00000000.tx.351: The crucial modification of tau-P301L that tau-4R/2N resists or has too high an energy barrier in mouse brain, which is postulated as the decisive parameter, is probably also active in healthy neurons and needs to be identified. 

Phrase: "The crucial modification of tau-P301L"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392747:Modification [Functional Concept]
   753   C1554963:modification [Qualitative Concept]

Phrase: "that tau-4R/2N"

Phrase: "resists"

Phrase: "or"

Phrase: "has"

Phrase: "too high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "an energy barrier in mouse brain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1706912:BARRIER [Medical Device]

Phrase: "which"

Phrase: "is"

Phrase: "postulated as the decisive parameter,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0549193:Parameter [Spatial Concept]
   760   C1704769:Parameter [Conceptual Entity]
   760   C2350001:Parameter [Quantitative Concept]

Phrase: "is"

Phrase: "probably also active in healthy neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.352: The current models with their polarized pathology are believed to be very informative in this respect. 

Phrase: "The current models with their polarized pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Models [Intellectual Product]

Phrase: "are"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "very informative in this respect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986490:Informative [Qualitative Concept]
Processing 00000000.tx.353: Molecular Differences of Tau-4R/2N and Tau-P301L: Mechanistic ImplicationsThe compartmental (axon versus soma) and temporal (early versus late) separation of pathology between the tau-4R/2N and tau-P301L transgenic mice is proposed to reflect intrinsic molecular characteristics between the types of tau expressed. 

Phrase: "Molecular Differences of Tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "Tau-P301L"

Phrase: ":"

Phrase: "Mechanistic ImplicationsThe"

Phrase: "compartmental"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C1185625:Compartment [Body Space or Junction]
   928   C1382196:Compartments [Natural Phenomenon or Process]
   928   C2986730:Compartment [Spatial Concept]

Phrase: "(axon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axon [Cell Component]

Phrase: "versus"

Phrase: "soma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "temporal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442043:Temporal [Spatial Concept]
  1000   C2362314:Temporal [Temporal Concept]

Phrase: "(early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "versus"

Phrase: "late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: ")"

Phrase: "separation of pathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "between the tau-4R/2N"

Phrase: "and"

Phrase: "tau-P301L transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "intrinsic molecular characteristics between the types of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1521970:Characteristics [Qualitative Concept]
   734   C3645613:Characteristic type [Intellectual Product]

Phrase: "expressed."
Processing 00000000.tx.354: Fundamentally, we can explain the observations in terms of the only known molecular action of tau (i.e. its binding to microtubules). 

Phrase: "Fundamentally,"

Phrase: "we"

Phrase: "can"

Phrase: "explain"

Phrase: "the observations in terms of the only known molecular action of tau"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   736   C0302523:observations [Research Activity]
   736   C0700325:observations [Health Care Activity]
   736   C3244290:observations [Functional Concept]
   734   C1292786:Observation - action [Functional Concept]
   703 E C1964257:Observation [Diagnostic Procedure]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "its binding to microtubules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1149274:microtubule binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: ")."
Processing 00000000.tx.355: The axonopathy and motor problems in tau-4R/2N mice result from inhibition of axonal transport by excessive binding of tau-4R/2N to microtubules, driven by mass action (overexpression) and high affinity of tau-4R/2N for microtubules (1618). 

Phrase: "The axonopathy"

Phrase: "and"

Phrase: "motor problems in tau-4R/2N mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1546466:Problems [Idea or Concept]
   714 E C0033213:Problem [Finding]

Phrase: "result from inhibition of axonal transport"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   820   C2259163:inhibition of transport [Cell Function]
   790   C0004462:Axonal Transport [Cell Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1274040:Result [Functional Concept]
   753   C1317949:Transport [Manufactured Object]
   753   C1546471:Result [Idea or Concept]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C2825142:Result [Finding]
   753   C3463820:Inhibition [Activity]
   753   C3495449:transport [Medical Device]

Phrase: "by excessive binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "of tau-4R/2N"

Phrase: "to microtubules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "driven by mass action"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441472:Action [Functional Concept]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]
   770   C3266814:Action [Activity]
   737   C0013126:Drive [Mental Process]

Phrase: "(overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: ")"

Phrase: "and"

Phrase: "high affinity of tau-4R/2N"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "for microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "(1618"

Phrase: ")."
Processing 00000000.tx.356: Phosphorylation of tau-4R/2N by GSK-3, particularly although not exclusively at Ser396/Ser404 (AD2 epitope), decreased the binding of tau to microtubules and corrected the axonopathy (17). 

Phrase: "Phosphorylation of tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "by GSK-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325174:GSK [Molecular Function]

Phrase: "particularly"

Phrase: "although"

Phrase: "not exclusively at Ser396/Ser404"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1518422:Not [Functional Concept]

Phrase: "(AD2 epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the binding of tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "and"

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "the axonopathy"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.357: Additional evidence is provided here by the gene-dosage effect of tau-KOKI versus tau-4R/2N mice; 

Phrase: "Additional evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "here by the gene-dosage effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0178655:Gene Dosage [Quantitative Concept]
   753   C0017337:Gene [Gene or Genome]
   753   C0178602:Dosage [Quantitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "of tau-KOKI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: "versus"

Phrase: "tau-4R/2N mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.358: due to the lower levels of tau-4R/2N in tau-KOKI mice, less is bound to microtubules, resulting in lesser motor deficits later in life and without axonal swellings (Table I). 

Phrase: "due to the lower levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of tau-4R/2N"

Phrase: "in tau-KOKI mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "is"

Phrase: "bound to microtubules,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026046:Microtubules [Cell Component]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "resulting in lesser motor deficits later in life"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   770   C0332294:Resulting in [Functional Concept]
   767   C0746626:deficits motor [Pathologic Function]
   744   C0376558:Life [Idea or Concept]
   744   C0547044:Lesser [Qualitative Concept]
   744   C0678226:resulting [Functional Concept]
   744   C1513492:Motor [Functional Concept]
   744   C1705994:Motor [Manufactured Object]
   744   C2987487:deficits [Qualitative Concept]
   711 E C0162429:Deficit, NOS [Disease or Syndrome]
   711   C0205087:Late [Temporal Concept]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "and without axonal swellings"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0544925:Axonal swelling [Cell or Molecular Dysfunction]
   770   C0013604:swellings [Pathologic Function]
   770   C0038999:swellings [Finding]
   770   C1515981:And [Idea or Concept]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.359: Conversely, the complete absence of axonal dilatations and the mild and late motor problems in tau-P301L mice is taken as the in vivo demonstration that mutant tau-P301L binds less to microtubules, as observed in vitro for this (37) and other missense tau mutants (9). 

Phrase: "Conversely,"

Phrase: "the complete absence of axonal dilatations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "the mild"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945599:Mild [Qualitative Concept]

Phrase: "and"

Phrase: "late motor problems in tau-P301L mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1546466:Problems [Idea or Concept]
   714 E C0033213:Problem [Finding]

Phrase: "is"

Phrase: "taken as the in vivo demonstration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   753   C1883727:Taken [Conceptual Entity]
   719 E C1515187:Take [Health Care Activity]

Phrase: "that mutant tau-P301L"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "less to microtubules,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026046:Microtubules [Cell Component]
   790   C0439092:less [Intellectual Product]
   790   C0547044:Less [Qualitative Concept]

Phrase: "as"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in vitro for this"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "(37"

Phrase: ")"

Phrase: "and"

Phrase: "other missense tau mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.360: Another conspicuous molecular difference between tau-P301L and tau-4R/2N is in their phosphorylation state (i.e. tau-P301L was overall less phosphorylated than tau-4R/2N). 

Phrase: "Another conspicuous molecular difference between tau-P301L"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "tau-4R/2N"

Phrase: "is in their phosphorylation state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]

Phrase: "(i.e. tau-P301L"

Phrase: "was"

Phrase: "overall less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282416:Overall [Intellectual Product]
   861   C1561607:Overall [Qualitative Concept]

Phrase: "phosphorylated than tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: ")."
Processing 00000000.tx.361: This could eventually increase the binding affinity of tau-P301L for microtubules, although we could not find indications that decreased phosphorylation is actually effective as a mechanism to overcome the effect of the mutation (i.e. reduced binding to microtubules). 

Phrase: "This"

Phrase: "could"

Phrase: "eventually"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the binding affinity of tau-P301L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for microtubules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "although"

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "indications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0392360:Indications [Idea or Concept]
   966 E C3146298:Indication [Functional Concept]

Phrase: "that decreased phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "actually effective as a mechanism to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:effective [Qualitative Concept]
   753   C1704419:Effective [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "the effect of the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "binding to microtubules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C1149274:microtubule binding [Molecular Function]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: ")."
Processing 00000000.tx.362: Molecular Differences of Tau-4R/2N and Tau-P301L: Conformation Makes the DifferenceThe prevailing hypothesis states that tau filaments are formed by increased phosphorylation, releasing tau from the microtubules to increase the pool of unbound phosphorylated tau that aggregates spontaneously. 

Phrase: "Molecular Differences of Tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "Tau-P301L"

Phrase: ":"

Phrase: "Conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "Makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the DifferenceThe prevailing hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "states"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "that tau filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "are"

Phrase: "formed by increased phosphorylation,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0205217:Increased [Quantitative Concept]
   770   C0205431:Formed [Functional Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "tau from the microtubules to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the pool of unbound phosphorylated tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "that"

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "spontaneously."
Processing 00000000.tx.363: If hyperphosphorylation was the initial trigger of filament formation, this should be reflected in the total pool of tau. 

Phrase: "If"

Phrase: "hyperphosphorylation"

Phrase: "was"

Phrase: "the initial trigger of filament formation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032930:Trigger [Clinical Attribute]
   753   C1444748:Trigger [Qualitative Concept]

Phrase: "this"

Phrase: "should"

Phrase: "be"

Phrase: "reflected in the total pool of tau."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0337051:Pool [Geographic Area]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0558058:reflected [Mental Process]
   748   C1509144:pool [Clinical Attribute]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   748   C2349200:Pool [Functional Concept]
Processing 00000000.tx.364: However, only a fraction of tau-P301L became hyperphosphorylated with age, whereas overall, tau-P301L remained less phosphorylated than tau-4R/2N. 

Phrase: "However,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a fraction of tau-P301L"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "became"

Phrase: "hyperphosphorylated with age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "whereas"

Phrase: "overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "tau-P301L"

Phrase: "remained"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "phosphorylated than tau-4R/2N."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
Processing 00000000.tx.365: Moreover, in tau-4R/2N transgenic mice, in tau-4R/2NxGSK-3 double transgenic mice and in tau-4R/2Nxcdk5xp35 triple transgenic mice, we did not detect tau aggregates, despite large intracellular pools of hyperphosphorylated tau (this study) (16, 17, 47) (results not shown). 

Phrase: "Moreover,"

Phrase: "in tau-4R/2N transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "in tau-4R/2NxGSK-3 double transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "and in tau-4R/2Nxcdk5xp35"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1515981:And [Idea or Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "triple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triple [Quantitative Concept]

Phrase: "transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "tau aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "despite large intracellular pools"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0337051:pools [Geographic Area]
   793 E C1509144:pool [Clinical Attribute]
   793 E C2349200:Pool [Functional Concept]

Phrase: "of hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "(16,"

Phrase: "17,"

Phrase: "47"

Phrase: ")"

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.366: Overexpression of different isoforms or mutants of tau in cells in vitro, in combination with various kinases or stimulatory treatments, has not yielded, as yet, a cellular model with filamentous tau aggregation, indicating that factors other than overexpression and hyperphosphorylation are involved, probably with conformational changes as intermediate. 

Phrase: "Overexpression of different isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "or"

Phrase: "mutants of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with various kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "stimulatory treatments,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "yielded"

Phrase: ","

Phrase: "as yet,"

Phrase: "a cellular model with filamentous tau aggregation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "indicating"

Phrase: "that factors other than overexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "hyperphosphorylation"

Phrase: "are"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "probably with conformational changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C0301641:Conformational change [Molecular Function]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C0750492:Probably [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "as intermediate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.367: The current study identifies in vivo the potentially most decisive differential aspect (i.e. the conformational change of tau-P301L, but not of tau-4R/2N). 

Phrase: "The current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "identifies"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the potentially most decisive differential aspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1547011:Aspect [Quantitative Concept]
   804   C1879746:Aspect [Qualitative Concept]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the conformational change of tau-P301L,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0301641:Conformational change [Molecular Function]
   783   C0025320:The change [Physiologic Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "but"

Phrase: "not of tau-4R/2N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1518422:Not [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: ")."
Processing 00000000.tx.368: The conformation of tau defined by antibody MC1 highlights the transition from soluble to aggregated filamentous tau, proposed to precede the formation of neurofibrillary tangles (38). 

Phrase: "The conformation of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026377:Conformation [Spatial Concept]

Phrase: "defined by antibody MC1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]

Phrase: "highlights"

Phrase: "the transition from soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0599156:Transition [Cell or Molecular Dysfunction]
   770   C2700061:Transition [Activity]

Phrase: "to aggregated filamentous tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "precede"

Phrase: "the formation of neurofibrillary tangles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.369: Conformational changes and aggregation of tau in brains of transgenic mice has not, to our knowledge, been demonstrated in the same mice or study. 

Phrase: "Conformational changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0301641:Conformational change [Molecular Function]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "aggregation of tau"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "has"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "to our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "been"

Phrase: "demonstrated in the same mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0445247:Same [Qualitative Concept]

Phrase: "or"

Phrase: "study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.370: In some tau transgenic mice, the same epitope defined by Alz50 was observed in a limited number of neurons that contained no tau aggregates (16, 48, 49). 

Phrase: "In some tau transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "the same epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "defined by Alz50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "was"

Phrase: "observed in a limited number of neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0027882:Neurons [Cell]
   748   C0237753:*Number [Quantitative Concept]
   748   C0439801:Limited [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1441672:Observed [Functional Concept]
   748   C3542948:Limited [Intellectual Product]

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "no tau aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "(16,"

Phrase: "48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.371: The strong somatodendritic reaction with MC1 in tau-P301L mice is completely absent in tau-4R/2N and tau-KOKI mice. 

Phrase: "The strong somatodendritic reaction with MC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "in tau-P301L mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "completely absent in tau-4R/2N"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "tau-KOKI mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0206745:Knock-out Mice [Mammal]
   858   C1517676:Knock-in [Research Activity]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.372: Moreover, MC1-positive neurons are spatially and temporally closely related to neurons that contain the AT100 and AP422 pathological phosphoepitopes typical for AD and fronto-temporal dementia. 

Phrase: "Moreover,"

Phrase: "MC1-positive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "spatially"

Phrase: "and"

Phrase: "temporally closely"

Phrase: "related to neurons"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0027882:Neurons [Cell]
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "that"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the AT100"

Phrase: "and"

Phrase: "AP422 pathological phosphoepitopes"

Phrase: "typical for AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3538928:Typical [Qualitative Concept]

Phrase: "and"

Phrase: "fronto-temporal dementia."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0442043:Temporal [Spatial Concept]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C2362314:Temporal [Temporal Concept]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.373: Interestingly, the AT100 epitope is formed by phosphorylation of Thr212 and Ser214 in vitro only after induction of conformational changes by polyanions (50), whereas polyanions also induce an intermediate state during filament formation of tau in vitro (51). 

Phrase: "Interestingly,"

Phrase: "the AT100 epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "is"

Phrase: "formed by phosphorylation of Thr212"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0205431:Formed [Functional Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "Ser214 in vitro only"

Phrase: "after"

Phrase: "induction of conformational changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by polyanions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071513:polyanions [Organic Chemical]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "polyanions also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0071513:polyanions [Organic Chemical]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an intermediate state during filament formation of tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.374: Moreover, the conformational change might render tau in turn a better substrate for other kinases (52). 

Phrase: "Moreover,"

Phrase: "the conformational change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0301641:Conformational change [Molecular Function]
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "might"

Phrase: "render"

Phrase: "tau in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "a better substrate for other kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.375: These in vitro studies are corroborated here in vivo by the intimate correlation of phosphorylation, conformation, and aggregation. 

Phrase: "These in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "are"

Phrase: "corroborated"

Phrase: "here in vivo by the intimate correlation of phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "conformation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.376: We conclude from our data in combination with published data, as discussed, that an as yet unspecified modification or interaction of tau is responsible for the conformational change that is the necessary intermediate for further phosphorylation and aggregation. 

Phrase: "We"

Phrase: "conclude from our data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with published data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "as"

Phrase: "discussed"

Phrase: ","

Phrase: "that"

Phrase: "an as yet unspecified modification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205370:Unspecified [Qualitative Concept]
   760   C0392747:Modification [Functional Concept]
   760   C1549663:Unspecified [Idea or Concept]
   760   C1554963:modification [Qualitative Concept]
   760   C2983689:UNSPECIFIED [Finding]

Phrase: "or"

Phrase: "interaction of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "responsible for the conformational"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "the necessary intermediate for further phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205103:Intermediate [Spatial Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.377: Wild-type tau-4R/2N appears to resist this modification, preventing a change in conformation and thereby aggregation. 

Phrase: "Wild-type tau-4R/2N"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "resist"

Phrase: "this modification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "a change in conformation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0301641:Conformational change [Molecular Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "thereby aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.378: The molecular mechanism needs to be further explored in mice that constitute excellent models for this purpose. 

Phrase: "The molecular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "explored in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "constitute"

Phrase: "excellent models for this purpose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]
Processing 00000000.tx.379: Subsequent analysis in diseased and aged human brain will eventually explain the aggregation of tau in tauopathies in which not mutant but wild-type tau is centrally involved.  

Phrase: "Subsequent analysis in diseased"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "aged human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "will"

Phrase: "eventually"

Phrase: "explain"

Phrase: "the aggregation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "in tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "in which"

Phrase: "not mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "wild-type tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "is"

Phrase: "centrally"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.380: FOOTNOTES  * This work was supported by Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, the European Economic Community (EEC) 5th Framework Program, the Rooms-fund, the KU Leuven Research Fund and KU Leuven-R&D, the Instituut voor Aanmoediging van Wetenschappelijk en Technisch Onderzoek, the European Space Agency, and the EEC Marie Curie Training Site of the EURON Ph.D. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Fonds voor Wetenschappelijk Onderzoek-Vlaanderen,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]

Phrase: "the European Economic Community (EEC) 5th Framework Program,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1709697:Program [Conceptual Entity]
   799   C2728259:Program [Pharmacologic Substance]
   799   C3484370:Program [Functional Concept]

Phrase: "the Rooms-fund,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016820:Fund [Quantitative Concept]

Phrase: "the KU Leuven Research Fund"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]

Phrase: "and"

Phrase: "KU Leuven-R&D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "the Instituut voor Aanmoediging van Wetenschappelijk en Technisch Onderzoek,"

Phrase: "the European Space Agency,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0237463:Agency [Organization]

Phrase: "and"

Phrase: "the EEC Marie Curie Training Site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0205145:Site [Spatial Concept]
   795   C1515974:Site [Body Location or Region]
   795   C2825164:Site [Spatial Concept]

Phrase: "of the EURON Ph.D."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1512022:Ph.D. [Intellectual Product]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.381: School for Neurosciences. 

Phrase: "School for Neurosciences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]
Processing 00000000.tx.382: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.383: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.384: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.385: These authors contributed equally to this work. 

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.386: || To whom correspondence should be addressed: Experimental Genetics Group-LEGT_EGG, Dept. 

Phrase: "||"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Experimental Genetics Group-LEGT_EGG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0013710:EGG [Food]
   804   C0029974:Egg [Cell]
   804   C1508746:Egg [Organic Chemical,Pharmacologic Substance]

Phrase: "Dept."
Processing 00000000.tx.387: Human Genetics, KU Leuven-Campus Gasthuisberg O&N 06, B-3000 Leuven, Belgium. 

Phrase: "Human Genetics,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C0086418:Human [Human]

Phrase: "KU Leuven-Campus Gasthuisberg O&N 06,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1532717:ku [Quantitative Concept]
   795   C1881335:kU [Quantitative Concept]

Phrase: "B-3000 Leuven,"

Phrase: "Belgium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]
Processing 00000000.tx.388: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.389: 32-16-34-58-88; 

Phrase: "32-16-34-58-88"

Phrase: ";"
Processing 00000000.tx.390: Fax: 32-16-34-58-71; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "32-16-34-58-71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0450389:71 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.391: E-mail: fredvl{at}med.kuleuven.ac.be . 1 The abbreviations used are: FTDP-17, fronto-temporal dementia with parkinsonism linked to chromosome 17; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "fredvl{at}med.kuleuven.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1412573:AC [Gene or Genome]
   804   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   804   C3539770:AC [Gene or Genome]

Phrase: "be . 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "FTDP-17,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: "fronto-temporal dementia with parkinsonism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0442043:Temporal [Spatial Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C2362314:Temporal [Temporal Concept]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.392: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.393: tau-KOKI, tau knock-out/knock-in; 

Phrase: "tau-KOKI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: "tau knock-out/knock-in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1517676:Knock-in [Research Activity]

Phrase: ";"
Processing 00000000.tx.394: ES, embryonic stem; 

Phrase: "ES,"

Phrase: "embryonic stem"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.395: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.396: TBS, Tris-buffered saline; 

Phrase: "TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.397: CNS, central nervous system; 

Phrase: "CNS,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.398: mAb, monoclonal antibody.  

Phrase: "mAb,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "monoclonal antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]
Processing 00000000.tx.399: ACKNOWLEDGMENTS  We thank H. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.400: Hirokawa, P. 

Phrase: "Hirokawa,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.401: Davies, A. 

Phrase: "Davies,"

Phrase: "A."
Processing 00000000.tx.402: Delacourte, and W. 

Phrase: "Delacourte,"

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.403: Klunk for generous gifts of reagents and for advice. 

Phrase: "Klunk for generous gifts of reagents"

Phrase: "and for advice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150600:Advice [Health Care Activity]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.404: We thank K. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.405: Spittaels, C. 

Phrase: "Spittaels,"

Phrase: "C."
Processing 00000000.tx.406: Van den Haute, L. 

Phrase: "Van den Haute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.407: Umans, L. 

Phrase: "Umans,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.408: Serneels, F. 

Phrase: "Serneels,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.409: Paulussen, H. 

Phrase: "Paulussen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.410: Geerts, and many others for advice and technical support.  

Phrase: "Geerts,"

Phrase: "and"

Phrase: "many others for advice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1955473:Others [Finding]

Phrase: "and"

Phrase: "technical support."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183683:Support [Medical Device]
   861   C1521721:Support [Conceptual Entity]
Processing 00000000.tx.411: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Goedert, M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: (1996) Ann. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.413: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.414: Y. 

Phrase: "Y."
Processing 00000000.tx.415: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.416: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.417: 777, 121-131 Bue, L., Bussire, T., Bue-Scherrer, V., Delacourte, A., and Hof, P. 

Phrase: "777,"

Phrase: "121-131 Bue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bussire,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bue-Scherrer,"

Phrase: "V.,"

Phrase: "Delacourte,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Hof,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538150:HOF [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.418: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.419: (2000) Brain Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.420: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.421: 33, 95-130[Medline] [OrderarticleviaInfotrieve] Lee, V. 

Phrase: "33,"

Phrase: "95-130"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lee,"

Phrase: "V."
Processing 00000000.tx.422: M., Goedert, M., and Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.423: Q. 

Phrase: "Q."
Processing 00000000.tx.424: (2001) Annu. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.425: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.426: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.427: 24, 1121-1159[CrossRef][Medline] [OrderarticleviaInfotrieve] Larcher, J. 

Phrase: "24,"

Phrase: "1121-1159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Larcher,"

Phrase: "J."
Processing 00000000.tx.428: C., Boucher, D., Ginzburg, I., Gros, F., and Denoulet, P. 

Phrase: "C., Boucher,"

Phrase: "D."

Phrase: ","

Phrase: "Ginzburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gros,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1332652:GRO [Amino Acid, Peptide, or Protein,Immunologic Factor]
   966   C1705593:GRO [Gene or Genome]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Denoulet,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.429: (1992) Dev. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Dev."
Processing 00000000.tx.430: Biol. 

Phrase: "Biol."
Processing 00000000.tx.431: 154, 195-204[Medline] [OrderarticleviaInfotrieve] Andorfer, C. 

Phrase: "154,"

Phrase: "195-204"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Andorfer,"

Phrase: "C."
Processing 00000000.tx.432: A., and Davies, P. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Davies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.433: (2000) Dev. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Dev."
Processing 00000000.tx.434: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.435: 22, 303-309[CrossRef][Medline] [OrderarticleviaInfotrieve] Terwel, D., Dewachter, I., and Van Leuven, F. 

Phrase: "22,"

Phrase: "303-309"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Terwel,"

Phrase: "D."

Phrase: ","

Phrase: "Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.436: (2002) Neuromol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuromol."
Processing 00000000.tx.437: Med. 

Phrase: "Med."
Processing 00000000.tx.438: 2, 151-165[CrossRef] Delacourte, A., and Bue, L. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "151-165"

Phrase: "[CrossRef"

Phrase: "] Delacourte,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Bue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.439: (2000) Curr. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.440: Opin. 

Phrase: "Opin."
Processing 00000000.tx.441: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.442: 13, 371-376[CrossRef][Medline] [OrderarticleviaInfotrieve] Heutink, P. 

Phrase: "13,"

Phrase: "371-376"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.443: (2000) Hum. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.444: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.445: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.446: 9, 979-986[Abstract/Free FullText] Ingram, E. 

Phrase: "9,"

Phrase: "979-986"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ingram,"

Phrase: "E."
Processing 00000000.tx.447: M., and Spillantini, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.448: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.449: (2002) Trends Mol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.450: Med. 

Phrase: "Med."
Processing 00000000.tx.451: 8, 555-562[CrossRef][Medline] [OrderarticleviaInfotrieve] Wang, J. 

Phrase: "8,"

Phrase: "555-562"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wang,"

Phrase: "J."
Processing 00000000.tx.452: Z., Gong, C. 

Phrase: "Z.,"

Phrase: "Gong,"

Phrase: "C."
Processing 00000000.tx.453: X., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. 

Phrase: "X.,"

Phrase: "Zaidi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Grundke-Iqbal,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Iqbal,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.454: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.455: Biol. 

Phrase: "Biol."
Processing 00000000.tx.456: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.457: 270, 4854-4860[Abstract/Free FullText] Friedhoff, P., Schneider, A., Mandelkow, E. 

Phrase: "270,"

Phrase: "4854-4860"

Phrase: "[Abstract/Free FullText"

Phrase: "] Friedhoff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schneider,"

Phrase: "A.,"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.458: M., and Mandelkow, E. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.459: (1998) Biochemistry 37, 10223-10230[CrossRef][Medline] [OrderarticleviaInfotrieve] Barghorn, S., Zheng-Fischhfer, Q., Ackmann, M., Biernat, J., von Bergen, M., Mandelkow, E. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10223-10230"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barghorn,"

Phrase: "S."

Phrase: ","

Phrase: "Zheng-Fischhfer,"

Phrase: "Q.,"

Phrase: "Ackmann,"

Phrase: "M."

Phrase: ","

Phrase: "Biernat,"

Phrase: "J.,"

Phrase: "von Bergen,"

Phrase: "M."

Phrase: ","

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.460: M., and Mandelkow, E. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.461: (2000) Biochemistry 39, 11714-11721[CrossRef][Medline] [OrderarticleviaInfotrieve] Alonso, A. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochemistry 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "11714-11721"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Alonso,"

Phrase: "A."
Processing 00000000.tx.462: C., Zaidi, T., Novak, M., Grundke-Iqbal, I., and Iqbal, K. 

Phrase: "C., Zaidi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Novak,"

Phrase: "M."

Phrase: ","

Phrase: "Grundke-Iqbal,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Iqbal,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.463: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.464: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.465: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.466: U. 

Phrase: "U."
Processing 00000000.tx.467: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.468: A. 

Phrase: "A."
Processing 00000000.tx.469: 98, 6923-6928[Abstract/Free FullText] Gamblin, T. 

Phrase: "98,"

Phrase: "6923-6928"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gamblin,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.470: C., Berry, R. 

Phrase: "C., Berry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005135:Berry [Food]
   861   C0982158:BERRY [Food]
   861   C3495134:BERRY [Organic Chemical,Pharmacologic Substance]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.471: W., and Binder, L. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Binder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0179302:Binder [Medical Device]
  1000   C1706253:Binder [Biomedical or Dental Material]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.472: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.473: (2003) Biochemistry 42, 15009-15017[CrossRef][Medline] [OrderarticleviaInfotrieve] Gotz, J., Streffer, J., David, D., Schild, A., Hoerndli, F., Pennanen, L., Kurosinski, P., and Chen, F. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "15009-15017"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gotz,"

Phrase: "J.,"

Phrase: "Streffer,"

Phrase: "J.,"

Phrase: "David,"

Phrase: "D."

Phrase: ","

Phrase: "Schild,"

Phrase: "A.,"

Phrase: "Hoerndli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Pennanen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kurosinski,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.474: (2004) Mol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.475: Psychiatry 7, 664-683 Spittaels, K., Van den Haute, C., Van Dorpe, J., Bruynseels, K., Vandezande, K., Laenen, I., Geerts, H., Mercken, M., Sciot, R., Van Lommel, A., Loos, R., and Van Leuven, F. 

Phrase: "Psychiatry 7,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "664-683 Spittaels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Van den Haute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Van Dorpe,"

Phrase: "J.,"

Phrase: "Bruynseels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vandezande,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Laenen,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Geerts,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Sciot,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Van Lommel,"

Phrase: "A.,"

Phrase: "Loos,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.476: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.477: J. 

Phrase: "J."
Processing 00000000.tx.478: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.479: 155, 2153-2165[Abstract/Free FullText] Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., Van Lint, J., Vandenheede, J., Moechars, D., Loos, R., and Van Leuven, F. 

Phrase: "155,"

Phrase: "2153-2165"

Phrase: "[Abstract/Free FullText"

Phrase: "] Spittaels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Van den Haute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Van Dorpe,"

Phrase: "J.,"

Phrase: "Geerts,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Bruynseels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lasrado,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vandezande,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Laenen,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Boon,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Van Lint,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0460968:lint [Medical Device]

Phrase: "J.,"

Phrase: "Vandenheede,"

Phrase: "J.,"

Phrase: "Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "Loos,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.480: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Biol. 

Phrase: "Biol."
Processing 00000000.tx.482: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.483: 275, 41340-41349[Abstract/Free FullText] Mandelkow, E. 

Phrase: "275,"

Phrase: "41340-41349"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mandelkow,"

Phrase: "E."
Processing 00000000.tx.484: M., Stamer, K., Vogel, R., Thies, E., and Mandelkow, E. 

Phrase: "M."

Phrase: ","

Phrase: "Stamer,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vogel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1080058:thies [Eukaryote]

Phrase: "E.,"

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.485: (2003) Neurobiol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.486: Aging 8, 1079-1085[CrossRef] Hutton, M., Lewis, J., Dickson, D., Yen, S. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "8,"

Phrase: "1079-1085"

Phrase: "[CrossRef"

Phrase: "] Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Lewis,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.487: H., and McGowan, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "McGowan,"

Phrase: "E."
Processing 00000000.tx.488: (2001) Trends Mol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.489: Med. 

Phrase: "Med."
Processing 00000000.tx.490: 7, 467-470[CrossRef][Medline] [OrderarticleviaInfotrieve] Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. 

Phrase: "7,"

Phrase: "467-470"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lewis,"

Phrase: "J.,"

Phrase: "McGowan,"

Phrase: "E.,"

Phrase: "Rockwood,"

Phrase: "J.,"

Phrase: "Melrose,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nacharaju,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Van Slegtenhorst,"

Phrase: "M."

Phrase: ","

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murphy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.491: P., Baker, M., Yu, X., Duff, K., Hardy, J., Corral, A., Lin, W. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Corral,"

Phrase: "A.,"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "W."
Processing 00000000.tx.492: L., Yen, S. 

Phrase: "L., Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1555429:Yen [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.493: H., Dickson, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.494: W., Davies, P., and Hutton, M. 

Phrase: "W., Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.495: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.496: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.497: 25, 402-405[CrossRef][Medline] [OrderarticleviaInfotrieve] Gtz, J., Chen, F., Barmettler, R., and Nitsch, R. 

Phrase: "25,"

Phrase: "402-405"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gtz,"

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Barmettler,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.498: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.499: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.500: Biol. 

Phrase: "Biol."
Processing 00000000.tx.501: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.502: 276, 529-534[Abstract/Free FullText] Allen, B., Ingram, E., Takao, M., Smith, M. 

Phrase: "276,"

Phrase: "529-534"

Phrase: "[Abstract/Free FullText"

Phrase: "] Allen,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ingram,"

Phrase: "E.,"

Phrase: "Takao,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.503: J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P. 

Phrase: "J.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Virdee,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshida,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Holzer,"

Phrase: "M."

Phrase: ","

Phrase: "Craxton,"

Phrase: "M."

Phrase: ","

Phrase: "Emson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.504: C., Atzori, C., Migheli, A., Crowther, R. 

Phrase: "C., Atzori,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Migheli,"

Phrase: "A.,"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.505: A., Ghetti, B., Spillantini, M. 

Phrase: "A.,"

Phrase: "Ghetti,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.506: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.507: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.509: 22, 9340-9351[Abstract/Free FullText] Braak, H., and Braak, E. 

Phrase: "22,"

Phrase: "9340-9351"

Phrase: "[Abstract/Free FullText"

Phrase: "] Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Braak,"

Phrase: "E."
Processing 00000000.tx.510: (1991) Acta Neuropathol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.511: 82, 239-259[Medline] [OrderarticleviaInfotrieve] Van Leuven, F. 

Phrase: "82,"

Phrase: "239-259"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.512: (2000) Prog. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.513: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.514: 61, 305-312[CrossRef][Medline] [OrderarticleviaInfotrieve] Lewis, J., Dickson, D. 

Phrase: "61,"

Phrase: "305-312"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lewis,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.515: W., Lin, W. 

Phrase: "W., Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0861352:LIN [Neoplastic Process]

Phrase: "W."
Processing 00000000.tx.516: L., Chisholm, L., Corral, A., Jones, G., Yen, S. 

Phrase: "L., Chisholm,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Corral,"

Phrase: "A.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.517: H., Sahara, N., Skipper, L., Yager, Eckman, C., Hardy, J., Hutton, M., and McGowan, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sahara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205654:Sahara [Geographic Area]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Skipper,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yager,"

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "McGowan,"

Phrase: "E."
Processing 00000000.tx.518: (2001) Science 293, 1487-1491[Abstract/Free FullText] Oddo, S., Caccamo, A., Shepherd, J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1487-1491"

Phrase: "[Abstract/Free FullText"

Phrase: "] Oddo,"

Phrase: "S."

Phrase: ","

Phrase: "Caccamo,"

Phrase: "A.,"

Phrase: "Shepherd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554210:Shepherd [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.519: D., Murphy, M. 

Phrase: "D."

Phrase: ","

Phrase: "Murphy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.520: P., Golde, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.521: E., Kayed, R., Metherate, R., Mattson, M. 

Phrase: "E.,"

Phrase: "Kayed,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Metherate,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.522: P., Akbari, Y., and LaFerla, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Akbari,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "LaFerla,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.523: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.524: (2003) Neuron 39, 409-421[Medline] [OrderarticleviaInfotrieve] Moechars, D., Lorent, K., De Strooper, B., Dewachter, I., and Van Leuven, F. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 39,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "409-421"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "Lorent,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.525: (1996) EMBO J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.526: 15, 1265-1274[Abstract] Chapman, P. 

Phrase: "15,"

Phrase: "1265-1274"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chapman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.527: F., White, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.528: L., Jones, M. 

Phrase: "L., Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.529: W., Cooper-Blacketer, D., Marshall, V. 

Phrase: "W., Cooper-Blacketer,"

Phrase: "D."

Phrase: ","

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "V."
Processing 00000000.tx.530: J., Irizarry, M., Younkin, L., Good, M. 

Phrase: "J.,"

Phrase: "Irizarry,"

Phrase: "M."

Phrase: ","

Phrase: "Younkin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Good,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205170:Good [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.531: A., Bliss, T. 

Phrase: "A.,"

Phrase: "Bliss,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.532: V., Hyman, B. 

Phrase: "V., Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.533: T., Younkin, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.534: G., and Hsiao, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.535: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.536: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.537: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.538: 2, 271-276[CrossRef][Medline] [OrderarticleviaInfotrieve] Fitzjohn, S. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "271-276"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Fitzjohn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.539: M., Morton, R. 

Phrase: "M."

Phrase: ","

Phrase: "Morton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.540: A., Kuenzi, F., Rosahl, T. 

Phrase: "A.,"

Phrase: "Kuenzi,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rosahl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.541: W., Shearman, M., Lewis, H., Smith, D., Reynolds, D. 

Phrase: "W., Shearman,"

Phrase: "M."

Phrase: ","

Phrase: "Lewis,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "D."

Phrase: ","

Phrase: "Reynolds,"

Phrase: "D."
Processing 00000000.tx.542: S., Davies, C. 

Phrase: "S."

Phrase: ","

Phrase: "Davies,"

Phrase: "C."
Processing 00000000.tx.543: H., Collingridge, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Collingridge,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.544: L., and Seabrook, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Seabrook,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.545: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.546: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.547: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.548: 21, 4691-4698[Abstract/Free FullText] Ris, L., Dewachter, I., Reverse, D., Godaux, E., and Van Leuven, F. 

Phrase: "21,"

Phrase: "4691-4698"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ris,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1428956:RIS [Gene or Genome]
  1000   C1555622:Ris [Language]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Reverse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "D."

Phrase: ","

Phrase: "Godaux,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.549: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.550: Biol. 

Phrase: "Biol."
Processing 00000000.tx.551: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.552: 278, 44393-44399[Abstract/Free FullText] Gureviciene, I., Ikonen, S., Gurevicius, K., Sarkaki, A., van Groen, T., Pussinen, R., Ylinen, H., and Tanila, H. 

Phrase: "278,"

Phrase: "44393-44399"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gureviciene,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ikonen,"

Phrase: "S."

Phrase: ","

Phrase: "Gurevicius,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sarkaki,"

Phrase: "A.,"

Phrase: "van Groen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pussinen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ylinen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tanila,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.553: (2004) Neurobiol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.554: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.555: 15, 188-195[CrossRef][Medline] [OrderarticleviaInfotrieve] Kunzi, V., Glatzel, M., Nakano, M. 

Phrase: "15,"

Phrase: "188-195"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kunzi,"

Phrase: "V.,"

Phrase: "Glatzel,"

Phrase: "M."

Phrase: ","

Phrase: "Nakano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.556: Y., Greber, U. 

Phrase: "Y.,"

Phrase: "Greber,"

Phrase: "U."
Processing 00000000.tx.557: F., Van Leuven, F., and Aguzzi, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Aguzzi,"

Phrase: "A."
Processing 00000000.tx.558: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.559: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.560: 22, 7471-7477[Abstract/Free FullText] Harada, A., Oguchi, K., Okabe, S., Kuno, J., Terada, S., Oshima, T., Sato-Yoshitake, R., Takei, Y., Noda, T., and Hirokawa, N. 

Phrase: "22,"

Phrase: "7471-7477"

Phrase: "[Abstract/Free FullText"

Phrase: "] Harada,"

Phrase: "A.,"

Phrase: "Oguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Okabe,"

Phrase: "S."

Phrase: ","

Phrase: "Kuno,"

Phrase: "J.,"

Phrase: "Terada,"

Phrase: "S."

Phrase: ","

Phrase: "Oshima,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sato-Yoshitake,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Takei,"

Phrase: "Y.,"

Phrase: "Noda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hirokawa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.561: (1994) Nature 369, 488-491[CrossRef][Medline] [OrderarticleviaInfotrieve] Umans, L., Serneels, L., Overbergh, L., Lorent, K., Van Leuven, F., and Van den Berghe, H. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 369,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "488-491"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Umans,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Serneels,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Overbergh,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lorent,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Van den Berghe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.562: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.563: Biol. 

Phrase: "Biol."
Processing 00000000.tx.564: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.565: 270, 19778-19785[Abstract/Free FullText] Gallyas, F. 

Phrase: "270,"

Phrase: "19778-19785"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gallyas,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.566: (1971) Acta Morphol. 

Phrase: "(1971"

Phrase: ")"

Phrase: "Acta Morphol."
Processing 00000000.tx.567: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.568: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.569: Hung. 

Phrase: "Hung."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]
Processing 00000000.tx.570: 19, 1-8[Medline] [OrderarticleviaInfotrieve] Styren, S. 

Phrase: "19,"

Phrase: "1-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Styren,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.571: D., Hamilton, R. 

Phrase: "D."

Phrase: ","

Phrase: "Hamilton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.572: L., Styren, G. 

Phrase: "L., Styren,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.573: C., and Klunk, W. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Klunk,"

Phrase: "W."
Processing 00000000.tx.574: E. 

Phrase: "E."
Processing 00000000.tx.575: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.576: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.577: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.578: 48, 1223-1232[Abstract/Free FullText] Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B. 

Phrase: "48,"

Phrase: "1223-1232"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Zhukareva,"

Phrase: "V.,"

Phrase: "Vogelsberg-Ragaglia,"

Phrase: "V.,"

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Reed,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.579: I., Geschwind, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Geschwind,"

Phrase: "D."
Processing 00000000.tx.580: H., Bird, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.581: D., McKeel, D., Goate, A., Morris, J. 

Phrase: "D."

Phrase: ","

Phrase: "McKeel,"

Phrase: "D."

Phrase: ","

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Morris,"

Phrase: "J."
Processing 00000000.tx.582: C., Wilhelmsen, K. 

Phrase: "C., Wilhelmsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.583: C., Schellenberg, G. 

Phrase: "C., Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.584: D., Trojanowski, J. 

Phrase: "D."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.585: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.586: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.587: (1998) Science 282, 1914-1917[Abstract/Free FullText] Weaver, C. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Science 282,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1914-1917"

Phrase: "[Abstract/Free FullText"

Phrase: "] Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "C."
Processing 00000000.tx.588: L., Espinoza, M., Kress, Y., and Davies, P. 

Phrase: "L., Espinoza,"

Phrase: "M."

Phrase: ","

Phrase: "Kress,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Davies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.589: (2000) Neurobiol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.590: Aging 21, 719-727[CrossRef][Medline] [OrderarticleviaInfotrieve] Goedert, M., Spillantini, M., Potier, M., Ulrich J., and Crowther, R. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "21,"

Phrase: "719-727"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."

Phrase: ","

Phrase: "Potier,"

Phrase: "M."

Phrase: ","

Phrase: "Ulrich J.,"

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.591: (1989) EMBO J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.592: 82, 393-399 Dewachter, I., Reverse, D., Caluwaerts, N., Ris, L., Kuiperi, C., Van den Haute, C., Spittaels, K., Umans, L., Serneels, L., Thiry, E., Moechars, D., Mercken, M., Godaux, E., and Van Leuven, F. 

Phrase: "82,"

Phrase: "393-399 Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Reverse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "D."

Phrase: ","

Phrase: "Caluwaerts,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ris,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1428956:RIS [Gene or Genome]
  1000   C1555622:Ris [Language]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kuiperi,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Van den Haute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Spittaels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Umans,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Serneels,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Thiry,"

Phrase: "E.,"

Phrase: "Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Godaux,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.593: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.594: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.595: 22, 3445-3453[Abstract/Free FullText] Andorfer, C., Kress, Y., Espinoza, M., de Silva, R., Tucker, K. 

Phrase: "22,"

Phrase: "3445-3453"

Phrase: "[Abstract/Free FullText"

Phrase: "] Andorfer,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kress,"

Phrase: "Y.,"

Phrase: "Espinoza,"

Phrase: "M."

Phrase: ","

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tucker,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.596: L., Barde, Y. 

Phrase: "L., Barde,"

Phrase: "Y."
Processing 00000000.tx.597: A., Duff, K., and Davies, P. 

Phrase: "A.,"

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Davies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.598: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.599: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.600: 86, 582-596[CrossRef][Medline] [OrderarticleviaInfotrieve] Lin, W. 

Phrase: "86,"

Phrase: "582-596"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "W."
Processing 00000000.tx.601: L., Lewis, J., Yen, S. 

Phrase: "L., Lewis,"

Phrase: "J.,"

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.602: H., Hutton, M., and Dickson, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.603: W. 

Phrase: "W."
Processing 00000000.tx.604: (2003) Am. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.605: J. 

Phrase: "J."
Processing 00000000.tx.606: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.607: 162, 213-218[Abstract/Free FullText] Tolnay, M., Mistl, C., Ipsen, S., and Probst, A. 

Phrase: "162,"

Phrase: "213-218"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tolnay,"

Phrase: "M."

Phrase: ","

Phrase: "Mistl,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ipsen,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Probst,"

Phrase: "A."
Processing 00000000.tx.608: (1998) Neuropathol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuropathol."
Processing 00000000.tx.609: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.610: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.611: 24, 53-59[Medline] [OrderarticleviaInfotrieve] Togo, T., Sahara, N., Yen, S., Cookson, N., Ishiwaza, T., Hutton, M., de Silva, R., Lees, A., and Dickson, D. 

Phrase: "24,"

Phrase: "53-59"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Togo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040363:Togo [Geographic Area]
  1000   C3463953:Togo [Eukaryote]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sahara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205654:Sahara [Geographic Area]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Cookson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ishiwaza,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lees,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.612: W. 

Phrase: "W."
Processing 00000000.tx.613: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.614: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.615: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.616: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.617: 61, 547-556[Medline] [OrderarticleviaInfotrieve] Crowther, R. 

Phrase: "61,"

Phrase: "547-556"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.618: A., and Wischik, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wischik,"

Phrase: "C."
Processing 00000000.tx.619: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.620: (1985) EMBO J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.621: 4, 3661-3665[Abstract] Moreno-Herrero, F., Prez, M., Baro, A. 

Phrase: "4,"

Phrase: "3661-3665"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Moreno-Herrero,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Prez,"

Phrase: "M."

Phrase: ","

Phrase: "Baro,"

Phrase: "A."
Processing 00000000.tx.622: M., and Avila, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Avila,"

Phrase: "J."
Processing 00000000.tx.623: (2004) Biophys. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.624: J. 

Phrase: "J."
Processing 00000000.tx.625: 86, 517-525[Abstract/Free FullText] Van den Haute, C., Spittaels, K., Van Dorpe, J., Lasrado, R., Vandezande, K., Laenen, I., Geerts, H., and Van Leuven, F. 

Phrase: "86,"

Phrase: "517-525"

Phrase: "[Abstract/Free FullText"

Phrase: "] Van den Haute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Spittaels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Van Dorpe,"

Phrase: "J.,"

Phrase: "Lasrado,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vandezande,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Laenen,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Geerts,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.626: (2001) Neurobiol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.627: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.628: 1, 32-44[CrossRef] Brion, J. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "32-44"

Phrase: "[CrossRef"

Phrase: "] Brion,"

Phrase: "J."
Processing 00000000.tx.629: P., Tremp, G., and Octave, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tremp,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Octave,"

Phrase: "J."
Processing 00000000.tx.630: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.631: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.632: J. 

Phrase: "J."
Processing 00000000.tx.633: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.634: 154, 255-270[Abstract/Free FullText] Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. 

Phrase: "154,"

Phrase: "255-270"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ishihara, T.,"

Phrase: "Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Nakagawa,"

Phrase: "Y.,"

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.635: K., Trojanowski, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.636: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.637: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.638: (1999) Neuron 24, 751-762[Medline] [OrderarticleviaInfotrieve] Zheng-Fischhfer, Q., Biernat, J., Mandelkow, E. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuron 24,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "751-762"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zheng-Fischhfer,"

Phrase: "Q.,"

Phrase: "Biernat,"

Phrase: "J.,"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.639: M., Illenberger, S., Godemann, R., and Mandelkow, E. 

Phrase: "M."

Phrase: ","

Phrase: "Illenberger,"

Phrase: "S."

Phrase: ","

Phrase: "Godemann,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.640: (1998) Eur. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.641: J. 

Phrase: "J."
Processing 00000000.tx.642: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.643: 252, 542-552[Abstract] Chirita, C. 

Phrase: "252,"

Phrase: "542-552"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chirita,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1014435:Chirita [Plant]

Phrase: "C."
Processing 00000000.tx.644: N., and Kuret, J. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Kuret,"

Phrase: "J."
Processing 00000000.tx.645: (2004) Biochemistry 43, 1704-17014[CrossRef][Medline] [OrderarticleviaInfotrieve] Hasegawa, M., Crowther, R. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biochemistry 43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "1704-17014"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.646: A., Jakes, R., and Goedert, M. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.647: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.648: Biol. 

Phrase: "Biol."
Processing 00000000.tx.649: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.650: 272, 33118-33124[Abstract/Free FullText] Mercken, M., Vandermeeren, M., Lubke, U., Six, J., Boons, J., Van Mechelen, E., Van de Voorde A., and Gheuens, J. 

Phrase: "272,"

Phrase: "33118-33124"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Vandermeeren,"

Phrase: "M."

Phrase: ","

Phrase: "Lubke,"

Phrase: "U.,"

Phrase: "Six,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "J.,"

Phrase: "Boons,"

Phrase: "J.,"

Phrase: "Van Mechelen,"

Phrase: "E.,"

Phrase: "Van de Voorde A.,"

Phrase: "and"

Phrase: "Gheuens,"

Phrase: "J."
Processing 00000000.tx.651: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.652: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.653: 58, 548-553[Medline] [OrderarticleviaInfotrieve] Riederer, B., and Binder, L. 

Phrase: "58,"

Phrase: "548-553"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Riederer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Binder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0179302:Binder [Medical Device]
  1000   C1706253:Binder [Biomedical or Dental Material]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.654: (1994) Brain Res. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.655: Bull. 

Phrase: "Bull."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007452:Bull [Mammal]
Processing 00000000.tx.656: 2, 155-161[CrossRef] Goedert, M., Jakes, R., and Vanmechelen, E. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "155-161"

Phrase: "[CrossRef"

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Vanmechelen,"

Phrase: "E."
Processing 00000000.tx.657: (1995) Neurosci Lett 189, 167-169[CrossRef][Medline] [OrderarticleviaInfotrieve] Goedert, M., Jakes, R., Crowther, R. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neurosci Lett 189,"

Phrase: "167-169"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.658: A., Cohen, P., Vanmechelen, E., Vandermeeren, M., and Cras, P. 

Phrase: "A.,"

Phrase: "Cohen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vanmechelen,"

Phrase: "E.,"

Phrase: "Vandermeeren,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Cras,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.659: (1994) Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.660: J. 

Phrase: "J."
Processing 00000000.tx.661: 301, 871-877[Medline] [OrderarticleviaInfotrieve] Bue-Scherrer, V., Condamines, O., Mourton-Gilles, C., Jakes, R., Goedert, M., Pau, B., and Delacourte, A. 

Phrase: "301,"

Phrase: "871-877"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bue-Scherrer,"

Phrase: "V.,"

Phrase: "Condamines,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Mourton-Gilles,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Pau,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Delacourte,"

Phrase: "A."
Processing 00000000.tx.662: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.663: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.664: 39, 79-88[Medline] [OrderarticleviaInfotrieve] Caillet-Boudin, M. 

Phrase: "39,"

Phrase: "79-88"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Caillet-Boudin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.665: L., and Delacourte, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Delacourte,"

Phrase: "A."
Processing 00000000.tx.666: (1996) NeuroReport 8, 307-310[Medline] [OrderarticleviaInfotrieve] Jicha, G. 

Phrase: "(1996"

Phrase: ")"

Phrase: "NeuroReport 8,"

Phrase: "307-310"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jicha,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.667: A., Lane, E., Vincent, I., Otvos, L., Jr., Hoffmann, R., and Davies, P. 

Phrase: "A.,"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "E.,"

Phrase: "Vincent,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Hoffmann,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Davies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.668: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.669: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.670: 69, 2087-2095[Medline] [OrderarticleviaInfotrieve]

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "2087-2095"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

